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Abstract 
The present dissertation describes the research performed at the Technical University of 
Denmark and The Scripps Research Institute in the period March 2006 – May 2009. The four 
different topics are not interlinked and can be read independently of each other. 
 
The first project describes a mechanistic study of the Barbier allylation of benzaldehydes with 
six different metals (Zn, In, Sb, Sn, Bi and Mg) in aqueous media. The mechanism of the 
allylation was investigated by means of Hammett plots and the secondary deuterium kinetic 
isotope effect. It was found that all metals except magnesium form a discrete allylmetal species 
and the rate-determining step is the polar addition to the carbonyl. For magnesium data indicates 
that the selectivity-determining step is generation of the radical anion of  the benzaldehyde. 
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Project I: Mechanistic study of the Barbier allylation. 
 
The second project discusses a concise  and enantiopure total synthesis of (+)-pancratistatin 
from renewable resources by means of methodology developed in the Madsen group. The key 
step comprises a one-pot zinc-mediated fragmentation of a functionalized carbohydrate and 
consecutive allylation. 
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Project II: Total synthesis of pancratistatin. 
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The third project was performed in the laboratories of Professor Phil Baran and consisted of the 
successful total synthesis of the cyclophane cavicularin, which contains a bent aromatic moiety. 
The pivotal step in the synthesis embodied a pyrone-alkyne Diels-Alder cycloaddition with CO2-
extrusion to deliver the bent aromatic residue. 
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Project III: Total synthesis of cavicularin. 
 
The fourth project involved further development of the conditions previously discovered in the 
Madsen group for the direct coupling of alcohols and amines to amides under dihydrogen 
liberation. The goal was to synthesize isolatable ruthenium catalysts and two 18-electron 
complexes capable of performing the reaction in excellent yields were prepared and 
characterized. Furthermore, it was found that several metathesis catalysts were found to be 
effective in the amidation. 
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Project IV:  Preparation of a isolatable Ru-catalyst for coupling of alcohols and amines. 
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Resumé 
Nærværende ph.d.-afhandling beskriver den forskning, der er udført på Danmarks Tekniske 
Universitet i tidsrummet marts 2006 – maj 2009. De fire forskellige emner er ikke forbundne og 
kan læses hver for sig. 
 
Det første projekt omhandler et mekanistisk studium af Barbier allylering af benzaldehyder med 
seks forskellige metaller (Zn, In, Sb, Sn, Bi og Mg). Mekanismen blev undersøgt ved hjælp af 
Hammett plots og den sekundære deuterium kinetiske isotop effekt. Det blev fundet, at alle 
metaller på nær magnesium danner en diskret allylmetal specie, og at det hastigheds-
bestemmende trin er den polære addition til carbonylen. For magnesium indikerer data, at det 
selektivitets-bestemmende trin er dannelsen af den radikale anion fra benzaldehydet. 
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Projekt I: Mekanistisk  studium af Barbier allylering. 
 
Det andet projekt beskriver en kort totalsyntese af (+)-pancratistatin fra fornybare 
udgangsstoffer ved hjælp af en i gruppen udviklet metode. Nøgletrinnet bestod af en one-pot 
zink-medieret fragmentering af et funktionaliseret kulhydrat og efterfølgende allylering. 
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Projekt II: Total syntese af pancratistatin. 
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Det tredje projekt blev udført in professor Phil Barans laboratorier og bestod i en succesfuld 
totalsyntese af cyclophanen cavicularin, der indeholder en bøjet aromatisk ring. Det afgørende 
trin i syntesen omfattede en pyron-alkyn Diels-Alder cykloaddition med frigørelse af CO2 til 
dannelse af den bøjede aromatiske ring. 
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Projekt III: Total syntese af cavicularin. 
 
Det fjerde projekt drejede sig om videreudvikling af de i gruppen fundne betingelser for den 
direkte kobling af alkoholer og aminer til amider under frigørelse af dihydrogen. 
Videreudviklingen bestod i fremstilling af en isolerbar katalysator baseret på ruthenium. To 18-
elektrons ruthenium-komplekser, der katalyserede reaktionen til udmærkede udbytter, blev 
fremstillet og karakteriseret. Desuden blev det opdaget, at adskillige metatese katalysatorer er 
effektive katalysatorer i koblingen. 
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Projekt IV: Fremstilling af isolerbar Ru-katalysator til kobling af alkoholer og aminer. 
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Abbreviations & Acronyms 
 
 )))  Sonication 
 Ac   Acetyl 
 AIBN  2,2′-Azobis(2-methylpropionitrile) 
 Anh  Anhydrous 
 APCI  Atmospheric pressure chemical ionization 
 aq.   Aqueous 
 BHT  2,6-Di-tert-butyl-4-methylphenol 
 BINAP  2,2′-Bis(diphenylphosphino)-1,1′-binaphthyl 
 Bn  Benzyl 
 br   Broad (NMR) 
 brsm  Based on recovered starting material 
 Bu   Butyl 
 c   Concentration 
 COD   1,5-Cyclooctadiene 
 COSY  Correlation spectroscopy  
 Cy   Cyclohexyl 
 Cyp   Cyclopentyl 
 d   Doublet (NMR) 
 d.r.   Diastereomeric ratio 
 DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
 DCB  o-Dichlorobenzene 
 DCC   N,N’-Dicyclohexylcarbodiimide 
 DCM  Dichloromethane 
 DCVC  Dry column vacuum chromatography  
 DDQ  2,3-Dichloro-5,6-dicyano-p-benzoquinone 
 DMA  N,N-Dimethylacetamide 
 DMAP   4-(Dimethylamino)-pyridine 
 DME   1,2-Dimethoxyethane 
 DMF   N,N-Dimethylformamide 
 DMSO   Dimethyl sulfoxide 
 dppf   1,1'-Bis(diphenylphosphino)ferrocene 
 DQF-COSY  Double quantum filtered correlation spectroscopy 
 EI  Electron ionization 
 ESI  Electrospray ionization 
 Et   Ethyl 
 Eq.  Equation 
 Equiv.  Equivalent(s) 
 FAB  Fast atom bombardment 
 GC   Gas chromatography 
 GCMS  Gas chromatography mass spectrometry 
 h   Hour(s) 
 HMBC  Heteronuclear multiple quantum coherence 
 HMPA  Hexamethylphosphoramide 
 HOBt   1-Hydroxybenzotriazole 
 HPLC   High performance liquid chromatography 
 HRMS  High resolution mass spectrometry 
 HSQC  Heteronuclear single quantum coherence 
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 i   Iso 
 ICy  1,3-Dicyclohexylimidazol-2-ylidene 
 IiPr  1,3-Di-iso-propylimidazol-2-ylidene 
 IMe   1,3-Dimethylimidazol-2-ylidene 
 IMes   1,3-Dimesitylimidazol-2-ylidene 
 Imid  Imidazole 
 IR   Infrared spectroscopy 
 ItBu  1,3-Di-tert-butylimidazol-2-ylidene 
 KHMDS  Potassium bis(trimethylsilyl)amide 
 LAH   Lithium aluminum hydride 
 LCMS  Liquid chromatography mass spectrometry 
 LDA  Lithium diisopropylamide   
 LiHMDS Lihium bis(trimethylsilyl)amide 
 Lindlar cat. Pd/CaCO3, lead-poisoned 
 LRMS  Low resolution mass spectrometry 
 m  Meta 
 m  Multiplet (NMR) 
 M  Molar 
 m-CPBA meta-Chloroperoxybenzoic acid 
 Me   Methyl 
 Mes   Mesityl 
 MOM  Methoxymethyl 
 Mp   Melting point 
 MS   Mass spectrometry 
 Ms  Mesyl; Methanesulfonyl 
 MW  Microwave 
 n   Normal 
 NBS  N-Bromosuccinamide 
 NHC   N-Heterocyclic carbene 
 NMO  N-Methylmorpholine-N-Oxide 
 NMR  Nuclear Magnetic Resonance 
 nOe   Nuclear Overhauser effect 
 NOESY Nuclear Overhauser enhancement spectroscopy 
 o   Ortho 
 p   Para 
 PCC  Pyridinium chlorochromate 
 Pent   Pentyl 
 Ph   Phenyl 
 Piv  Pivaloyl 
 PIFA  [Bis(trifluoroacetoxy)iodo]benzene  
 PMB  p-Methoxybenzyl 
 PPTS  Pyridinium p-toluenesulfonate 
 Pr   Propyl 
 Py   Pyridine 
 q   Quartet (NMR) 
 Q  Quantitative 
 RCM  Ring closing metathesis 
 Red Al   Sodium bis(2-methoxyethoxy)aluminum hydride 
 Rf  Retention Factor 
 rt  Room temperature 
Preface 
 viii 
 
 s   Singlet (NMR) 
 SDKIE  Secondary deuterium kinetic isotope effect 
 t   Triplet (NMR) 
 t  Tertiary 
 TBAF  Tetrabutylammonium fluoride 
 TBAI  Tetrabutylammonium iodide 
 TBS  tert-Butyldimethylsilyl 
 TC  Thiophene-2-carboxylate 
 TEMPO 2,2,6,6-Tetramethylpiperidine-1-oxyl 
 tert  Tertiary 
 TES  Triethylsilyl 
 Tf   Trifluoromethanesulfonyl 
 THF   Tetrahydrofuran 
 TIPS  Triisopropylsilyl 
 TLC   Thin layer chromatography 
 TMEDA  N,N,N’,N’-Tetramethylethylenediamine 
 TMS  Trimethylsilyl 
 TOF  Time of flight 
 Tol   Toluene 
 Trop  5-H-dibenzo[a,d]cyclohepten-5-yl 
 Ts   p-Toluenesulfonyl; Tosyl 
 TS  Transition state 
 TTMSS  Tris(trimethylsilyl)silane 
 Vitride  Sodium bis(2-methoxyethoxy)aluminum hydride 
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1 Mechanistic Investigation of the Barbier-Allylation 
1.1 Introduction 
In 1899, Barbier reported a one-pot coupling reaction between a carbonyl compound and an 
alkyl halide mediated by magnesium metal.1 His student V. Grignard turned the reaction into a 
two-step protocol by preforming the organometallic reagent.2 At the time the latter became the 
preferred method of the two, despite the major requisite of strict exclusion of moisture from the 
reaction media.3 Not until 1977, where Killinger et al.4 described the zinc-mediated allylation of 
carbonyl compounds in alcohols, were major progress made, in particular with the more reactive 
allyl halides.5-7 Nowadays, in contrast to the Grignard reaction, the one-pot Barbier reaction 
often performs much better in terms of simplicity and yield, when it is carried out in the 
presence of water as a (co)solvent.7 Additionally, by employing the Barbier reaction, instead of 
the Grignard protocol, a tedious protection-deprotection sequence can be avoided, contributing 
to much enhanced synthetic efficiency.  Moreover, a range of different metals are known to 
mediate the reaction in aqueous media, including zinc, indium, tin, antimony, bismuth, 
magnesium and manganese.4, 8-14 
In the literature, it has been speculated whether the mechanism of the Barbier reaction in 
aqueous media follows a radical pathway or goes through a discrete allylmetal species. For zinc 
and tin in aprotic media, the Barbier reaction is known to proceed through a direct polar 
addition,15, 16 whereas allylmagnesium bromide reacts by a single electron transfer process.17 In 
2005 Chang et al. provided a computational study showing that allylzinc, -indium, -tin, -
antimony and -bismuth species are more prone to allylate a carbonyl compound than being 
hydrolyzed by water.18 On the other hand, allylmagnesium bromide was predicted to be more 
reactive toward hydrolysis. Secondary deuterium kinetic isotope effects (SDKIE) indicate that 
the mechanism is highly dependent on the metal applied.17, 19, 20 For zinc, indium and tin an 
inverse SDKIE was obtained indicating a rate-determining, polar addition to the carbonyl 
substrate. Contrary, a normal SDKIE was obtained for the allylation with magnesium and 
antimony suggesting single electron transfer processes. Additional experimental support comes 
from NMR studies, which show that indium, tin and antimony react with allyl bromide in water 
to form allyl metal intermediates.21-24  
In the Madsen group we have on several occasions applied the Barbier reaction with zinc 
and indium as the key steps in total syntheses.25-30 The reactions have provided good yields, but 
occasionally the diastereomeric outcome have varied. For the different metals there are still a 
Mechanistic Investigation of the Barbier-Allylation 
 2 
 
number of unanswered questions with regard to the nature of the allyl metal species or single 
electron transfer processes. Therefore, we decided to perform a more systematic study of the 
mechanism for the Barbier allylation in aqueous media. By means of competitive Hammett 
studies and indirectly measured secondary deuterium kinetic isotope effects we anticipated to 
address the nature various metal species with regard to zinc, indium, antimony, tin, bismuth and 
magnesium. 
 
1.2 Initial Optimization of the Allylation Conditions 
Optimal reaction conditions for the zinc allylation were quickly found to correspond to those 
found by Pétrier and Luche.9 The highest yield of the homoallylic alcohols from benzaldehydes 
was obtained in a 1:1 mixture of THF and aqueous ammonium chloride, scheme 1.1. This 
mixture formed a two-phase system consisting of an aqueous THF phase and a saturated 
ammonium chloride phase. It was shown by GC that the aldehydes and the allylbromide were 
present in the THF phase, while no compounds could be detected in the ammonium chloride 
phase. The yields of the homoallylic alcohols were lower when the reactions were performed in 
a THF/water mixture, and this did not change by using ultrasound. 
 
O
X
Br
aq. media
OH
X
Zn, In, Sn, Sb, Bi or Mg
 
 
Scheme 1.1: General scheme for allylation of benzaldehydes. 
 
On the other hand, with indium, tin, and bismuth the THF-water mixture proved to give the best 
results. All three metals reacted significantly slower than zinc and it was necessary to heat the 
reactions with tin and bismuth to 60 ºC. Both the tin and the bismuth allylation were about 40 
min. to initiate and then quickly reacted to provide the homoallylalcohol. With indium the 
reaction rate could be dramatically increased by the addition of an equimolar amount of HCl. 
This did, however, result in pronounced formation of by-products – especially with electron-rich 
benzaldehydes. This additive was therefore abandoned. Over time the indium-powder clothed 
together, which might have slowed the reaction further, but the clumps still seemed able to react. 
Antimony and magnesium resulted in a slower reaction than all the other metals. With antimony 
it was necessary to use a solvent system of THF and 0.5 M hydrochloric acid.23 Furthermore, 
antimony had to be prepared from antimony(III) chloride and sodium borohydride31 in order to 
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give a good conversion while commercially available antimony powder reacted more sluggishly. 
By this activation procedure the amount of antimony could be reduced along with the reaction 
time, while conversion was maintained. We were not able to reduce the amount of antimony to 
the nearby equimolar level as Butsugan et al.32 It has previously been reported that antimony 
and bismuth can be activated by potassium fluoride for the allylation of aldehydes,33,14 but in our 
hands this procedure did not provide a more reactive metal. For the competitive studies we 
wanted to avoid a secondary metal functioning as a co-catalyst, i.e. generation of zero-valent 
antimony by in situ reduction of SbCl3 with iron or aluminum34, 35 – in this regard we decided to 
keep the system of activated antimony. 
Magnesium proved even more troublesome and we were unable to reproduce the original 
conditions with allyliodide in either a THF-water mixture or in a 0.1 M ammonium chloride 
solution.13, 36 In our hands these reactions did not go to completion and mainly led to pinacol 
coupling and reduction of the aldehyde even with a variety of different magnesium sources.37, 38 
Other solvent mixtures were investigated and it was found that 0.1 M ammonium chloride in 
either ethanol or DMF gave full conversion and fewer by-products. The best results were 
obtained in a 4:1 mixture of DMF and 0.1 M ammonium chloride. 
 
1.3 Hammett Studies of the Allylation 
The Hammett studies were performed as a series of competition experiments, where the 
reaction progress was determined by measuring the disappearance of aldehyde using 
naphthalene as internal standard. This method is valid when the starting materials are converted 
cleanly into the desired product. If the reactions are of first order in aldehydes, the 
concentrations of the aldehydes will follow eq. 1.1, where subscript ‘0’ denotes the initial 
concentration, X is the concentration of the para-substituted aldehyde and H is the concentration 
of benzaldehyde at the same conversion. Plotting ln(H0/H) against ln(X0/X) gives a gradient 
equal to the relative rate constant, krel = kX/ kH. 
                                           
 )ln()ln( 00
H
Hk
X
X
rel=    (1.1) 
 
We then plot log(krel) versus σ in the standard Hammett plot to obtain the reactivity parameter ρ 
as the slope and also to check the correlation against different types of σ-values.  
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The competition experiments were carried out with 1 equiv. of benzaldehyde, 1 equiv. of 
one of the six different para-substituted benzaldehydes, 1–2 equiv. of allylbromide and 1–2 
equiv. of the metal. Zinc was the first metal to be investigated and the experiments were 
performed by adding zinc in portions of approximately 0.1 equiv. because the reaction was 
otherwise too fast to be adequately monitored. The reaction was also highly exothermic and led 
to extensive formation of by-products if the temperature was not maintained at room 
temperature. It was not possible to extend the Hammett plot to include the para-
nitrobenzaldehyde or para-dimethylamino-benzaldehyde since these aldehydes with strongly 
electron-withdrawing or –donating substituents were resistant to the allylation conditions.  
 
Table 1.1: Yields for the allylations in Scheme 1.1. 
Yielda (in %) with  
Entry Znb Inc Snc Sbd Bic Mge 
1 -CN 99 (94f) 90 94 93 98 - 
2 -COOMe 98 (93f) 87 (99g) 82 (85g) 95 83 (88g) 25 (26g) 
3 -CF3 99 (91f) 98 99 66 (90g) 94 60 (65g) 
4 -Cl 96 (90f) 75 (80g) 95 87 (92g) 84 (92g) 60 (62g) 
5 -H 96 (92f) 92 94 69 88 49f 
6 -Me 99 (95f) 75 (81g) 82 (93g) 50 (83g) 71 (84g) 14 (79g) 
7 -tBu 99 (92f) 56 (81g) - - 63 (82g) - 
8 -OMe 76 (82f) - 18 (41g) - 37 (72g) - 
9 -OBu 83 (90f) - - - - - 
a Yields determined by GC. b Performed in 1:1 THF:saturated aqueous NH4Cl with acid-washed 
zinc. c Performed in 1:1 THF:H2O. d Performed in 7:3 THF:0.5 M HCl with antimony metal 
prepared from reduction of SbCl3 with NaBH4. e Performed with allyliodide in 4:1 DMF:0.1 M 
NH4Cl. f Isolated yield. g Yield based on converted aldehyde. 
 
In all cases, the correlation coefficient was better than 0.99, when ln(X0/X) was plotted 
against ln(H0/H) (Figure 1.1).  
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Figure 1.1: Kinetic data for the competitive zinc allylation. 
The obtained krel values are used to construct the Hammett plot in figure 1.2. When applying 
the “regular” σ−values a plot with a small positive slope was obtained for the electron-
withdrawing substituent (right hand side). However, this line could not be extended to include 
the electron-donating substituents, where a significantly steeper line was obtained. Surprisingly, 
we found a linear correlation when using σ+−values, in spite of the fact that these values were 
originally developed for reactions in which a cation is developed.39 Although the fit to the 
σ+−values usually implies the involvement of a cation, the slope of the line is positive for both 
sets of σ−values, indicating that a small negative charge is being developed at the benzylic 
position, thus suggesting that the use of σ+−values should be avoided. The methoxy− and 
butoxy−substituents caused the reaction to proceed slower than would be expected from the 
standard σ−values, which suggests that for these substituents there could be a change of rate-
determining step.40 In any case, the poor correlation with the σ•−values suggests that a radical 
intermediate is not involved in the allylation reaction. 
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Figure 1.2: Hammett plot for the zinc-mediated allylation. σ−values were obtained from Hansch et al.41 
 
The method applied for the zinc allylation was also used in the competitive allylations with 
indium, tin, antimony, bismuth, and magnesium, i.e. the disappearance of the starting material 
was monitored during the progress of the reaction. Compared to the zinc allylation these 
reactions were all slower and required several hours to reach full conversion. As a result, it was 
not necessary to add the metals in portions and the entire portion of metal was therefore added at 
the beginning of each experiment. For tin and bismuth the reaction took 1-4 h to initiate, and 
then went to completion in 3-4 h.  
The kinetic data and the full Hammett plots have been included in the experimental section. 
For the four metals indium, tin, antimony, and bismuth a good correlation is obtained using 
ordinary σ−values, although the methoxy-substituent again deviates from the straight line 
(Figure 1.3). The slopes of the lines are positive with a slightly larger ρ−value than previously 
observed with zinc, indicating a larger build-up of negative charge in the selectivity-determining 
step (selection between which aldehyde to react with). The reactions with magnesium only led 
to the desired allylation products for the para-substituents Me, Cl, CF3, and COOMe, and only 
in the former three cases in reasonable GC yields (Table 1.1). The Hammett plot for magnesium 
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indicates build-up of a significant negative charge in the benzylic position and clearly 
distinguishes this metal from the other five which are all very similar.  
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Figure 1.3: The Hammett plots for the allylations with zinc, indium, tin, antimony, bismuth, and magnesium. 
The similarity between the first five metals is somewhat surprising when the differences in 
reaction conditions are taken into account, but gives a strong indication that a common 
mechanism is operating. The relatively small slope of the lines indicates that only a partial 
negative charge is built up in the transition state, which is what would be expected from a 
closed, six-membered transition state. For magnesium the significantly larger slope indicates 
that a significant negative charge is present in the selectivity-determining step. This would be 
expected, for instance, if the generation of a radical anion in the benzylic position is the 
selectivity-determining step as suggested earlier, which is then followed by a fast allylation 
reaction.13 This mechanism is supported by two earlier Hammett studies where substituted 
benzophenones were reacted with t-butylmagnesium chloride,41 and allylmagnesium bromide,42 
respectively. When t-butylmagnesium chloride was employed, a Hammett ρ−value of 3.0 was 
found, which is similar to the result in this study and in line with the formation of a radical anion 
by electron transfer from the Grignard reagent. On the contrary, when preformed 
allylmagnesium chloride was used, the reaction rate was completely unaffected by the nature of 
the para-substituents, which gave a slope of zero in the Hammett plot.43 The results obtained for 
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magnesium indicate that under Barbier conditions the radical anion of benzaldehyde is generated 
first, as indicated by the high ρ−value, and that the following allylation is neither rate- nor 
selectivity-determining i.e. the ease of formation is determined by the stability of the radical 
from a given aldehyde.  
 
1.4 Secondary Deuterium Kinetic Isotope Effect 
To add further mechanistic support to the closed, six-membered transition state a study of 
the secondary deuterium kinetic isotope effect (SDKIE) was undertaken. The polar addition of a 
nucleophile to the aldehyde carbonyl involves a transition state with an additional bond. The 
addition will increase the bending frequencies and result in a greater lowering of the zero point 
energy upon deuterium substitution (sp2→sp3). In turn this leads to an inverse SDKIE. The 
formation of a radical ketyl anion will posses looser bonds than the starting aldehyde and will 
result in a normal SDKIE. Hence, an inverse SDKIE (kH/kD < 1) is a strong indication of a polar 
addition as the rate-determining step, whereas a normal SDKIE (kH/kD > 1) would be compatible 
with the formation of a radical species.17, 19, 20 
 By means of two separate competition experiments the relative rate of allylation of 
benzaldehyde and d-benzaldehyde could be determined relative to p-tolualdehyde. The 
comparison of the rates was carried out indirectly since standard GC is unable to differentiate 
between d-benzaldehyde and benzaldehyde. With zinc the SDKIE was determined to be as large 
as 0.83, which suggests a relatively “late” TS. With tin, antimony and bismuth almost equally 
large values were determined (kH/kD = 0.85 (Sn), 0.75 (Sb), and 0.85 (Bi), respectively), 
whereas the use of indium resulted in only a minor effect (kH/kD = 0.95) suggesting that a much 
“earlier” TS is operating for this metal. In a related study by Lucas et al.20 a significantly lower 
SDKIE was found for indium (kH/kD = 0.82), and due to the obvious disagreement we decided to 
also perform a direct determination of the SDKIE for indium with GC-MS. Using selected ion 
monitoring (SIM) for the molecular ions of both benzaldehyde and d-benzaldehyde (m/z = 106 
and 107, respectively) it was possible to quantify the disappearance of these aldehydes relative 
to the molecular ion of the internal standard (naphthalene, m/z = 128). This experiment gave a 
SDKIE of 0.92, which corroborates the slightly higher value (0.95) obtained in the indirect 
competition experiment. Also for antimony there are significant differences in the SDKIE 
determined here (0.75) and the one reported earlier by Lucas et al. (1.07). However, in their case 
a 2 M potassium fluoride solution was used as solvent, whereas we have used a 0.5 M solution 
of hydrochloric acid, which may significantly alter the pathway of the reaction. In contrast to the 
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other five metals the use of magnesium resulted in a normal SDKIE. The exact value was 1.04 
which is very close to the value obtained by Lucas et al. (1.06).20 The finding of a normal 
SDKIE for magnesium can be taken as an indication that a radical anion forms in the selectivity-
determining step, in sharp contrast to all the previously investigated metals where the SDKIE 
below unity clearly indicates that C-C bond formation is rate-limiting. 
 
1.5 Conclusion 
The Barbier allylation of a series of para-substituted benzaldehydes with allylbromide in the 
presence of Zn, In, Sn, Sb, Bi, and Mg was investigated using competition experiments under 
aqueous conditions. For the first five metals linear Hammett plots were obtained with “regular” 
σ−values and therefore radicals did not seem to be involved in the rate-determining step. Also, 
for Zn, In, Sn, Sb, and Bi an inverse secondary kinetic isotope effect was found (kH/kD = 0.75-
0.95), which is compatible with the formation of a discrete organometallic species prior to polar 
allylation via a closed six-membered transition state. With Mg a significantly larger build-up of 
negative charge from the Hammet correlation along with a small normal secondary deuterium 
kinetic isotope effect (kH/kD = 1.06) indicates that the selectivity-determining step is generation 
of the radical anion of benzaldehyde. 
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1.6 Experimental Section 
General procedures 
THF was distilled from Na/benzophenone under nitrogen, while DMF and CH2Cl2 were 
dried over 3 Å and 4 Å molecular sieves, respectively. Solvents used for chromatography were 
of HPLC grade. Zinc dust (8.0 g, 122 mmol, Fluka 00618, ≥ 99.0%) was activated by stirring 
with 2 M HCl (150 mL) for 10 min, then filtered and washed successively with water (75 mL), 
methanol (75 mL) and ether (75 mL) and dried with a heatgun under high vacuum for 10 min to 
leave a fine, light grey powder. Antimony was prepared by a revised procedure31: SbCl3 (2.32 g, 
10.2 mmol) was suspended in water (50 mL) and stirred with NaBH4 (1.15 g, 30.4 mmol) under 
argon for 5 min. The precipitated metal was isolated by filtration and washed successively with 
water (50 mL), methanol (50 mL) and ether (50 mL) and dried with a heatgun under high 
vacuum for 10 min to leave a fine black powder. Indium powder (Aldrich 264032, -100 mesh, 
99.99%), tin powder (Aldrich 265632, -325 mesh, 99.8%), bismuth powder (Aldrich 26562, -
100 mesh, 99.5%) and magnesium powder (Strem 931298, 99%) were used as received. p-
Tolualdehyde and p-anisaldehyde were purified by fractional distillation before use.  
Thin layer chromatography was performed on aluminum plates coated with silica gel 60. 
Visualization was done by UV-radiation and/or charring with a heatgun after dipping in a 
solution of cerium(IV)sulfate (2.5 g) and ammonium molybdate (6.25 g) in 10% aqueous 
sulfuric acid (250 mL). Flash chromatography was performed with Matrex 60 Å silica gel (35-
70 μm). NMR spectroscopy was performed on a Varian Mercury 300 MHz, Unity Inova 500 
MHz or a Bruker AC-200 spectrometer. Signal positions were measured relative to the signals 
of residual CHCl3 (δH = 7.26 ppm)/ CDCl3 (δC = 77.0 ppm) or DMSO (2.50 ppm)/ DMSO-d6 
(39.4 ppm) as the internal standards. IR spectra were obtained for thin films on AgCl plates or 
KBr pellets on a Perkin-Elmer 1600 FTIR or as neat compounds on a Bruker Alpha-P FT-IR 
spectrophotometer. Mass spectrometry was obtained with a Shimadzu GCMS-QP5000. HRMS 
was obtained from the Department of Chemistry, University of Copenhagen or Department of 
Physics and Chemistry, University of Southern Denmark. Microanalyses were obtained from the 
Microanalytical Laboratory, University of Vienna, Austria. Sonication was performed on either 
a 1210 or a 2210 Branson cleaning bath (~47 KHz) with 1-2 vol% liquid detergent for 
reproducibility. All KHMDS- and butyllithium-solutions were titrated according to literature 
procedures to a sharp blue endpoint.44, 45 
For the Hammett studies: Reaction progress was monitored by taking out samples of 100 μL 
and diluting with 0.9 mL of THF. Excess metal powder was removed by centrifugation. All 
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samples were stored at 5 ºC immediately after being taken out. Analysis was performed by gas 
chromatography on a Shimadzu GC-2010 equipped with a 30 m × 0.25 mm × 0.25 μm Supelco 
Equity-1 capillary column. Retention times for all compounds are shown below. The 
homoallylic alcohols were prepared according to the general procedure for the competitive zinc 
allylation. The corresponding pinacols were prepared as a mixture of isomers according to a 
literature procedure.46 
The secondary kinetic isotope effect (SDKIE) was determined for each metal by a competition 
experiment using d-benzaldehyde and p-tolualdehyde, thus allowing straightforward separation 
by GC. The SDKIE could then be determined by comparison to the value determined in the 
competition experiment with p-tolualdehyde and benzaldehyde. 
 
General procedure for competitive zinc allylation used for the Hammett plot 
Benzaldehyde (0.5 mmol), the p-substituted benzaldehyde (0.5 mmol) and naphthalene (0.25 
mmol) were dissolved in anhydrous THF (5.0 mL). A sample was taken out for analysis and 
allylbromide (173 μL, 2.0 mmol) was added. Another sample was taken out for analysis and 
saturated aqueous NH4Cl (5.0 mL) was added. Portions of activated zinc dust (~ 13 mg, 0.2 
mmol) were added at 5 min intervals on a water bath at rt until 2 equivalents of zinc was 
reached. Before each addition of zinc the vigorous stirring was discontinued and a sample was 
taken out for analysis. 
 
General procedure for indium allylation used for the Hammett plot 
Benzaldehyde (0.5 mmol), the p-substituted benzaldehyde (0.5 mmol) and naphthalene (0.25 
mmol) were dissolved in THF (7.0 mL) and deionized H2O (3.0 mL) at rt. A sample was taken 
out for analysis and allylbromide (130 μL, 1.5 mmol) was added. Another sample was taken out 
for analysis and indium powder (172 mg, 1.5 mmol) was added. Samples were then taken out 
every 20-30 min until the reaction had gone to completion (~5 h). 
 
General procedure for tin allylation used for the Hammett plot 
Benzaldehyde (0.5 mmol), the p-substituted benzaldehyde (0.5 mmol) and naphthalene (0.25 
mmol) were dissolved in THF (7.0 mL) and deionized H2O (3.0 mL) in a two-necked flask fitted 
with a reflux condenser. A sample was taken out for analysis and allylbromide (173 μL, 2.0 
mmol) was added. Another sample was taken out for analysis followed by addition of tin 
powder (119 mg, 1.0 mmol) and heating the suspension in an oil bath to 60 ºC. After 
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approximately 40 min where the allylation initiated samples were taken out at the following 
intervals: 30, 5, 2×2.5, 5×2, 2×3, 4, 2×5, 8, 12, 2×15, and 2×30 min. 
 
General procedure for antimony allylation used for the Hammett plot 
Benzaldehyde (0.5 mmol), the p-substituted benzaldehyde (0.5 mmol) and naphthalene (0.25 
mmol) were dissolved in THF (7.0 mL) and 0.5 M aqueous HCl (3.0 mL) at rt. A sample was 
taken out for analysis and allylbromide (216 μL, 2.5 mmol) was added. Another sample was 
taken out for analysis and activated antimony powder (244 mg, 2.0 mmol) was added. Samples 
were then taken out every hour until the reaction had gone to completion (~12-16 h). The 
reaction was run under an argon atmosphere. 
 
General procedure for bismuth allylation used for the Hammett plot 
Benzaldehyde (0.5 mmol), the p-substituted benzaldehyde (0.5 mmol) and naphthalene (0.25 
mmol) were dissolved in THF (5.0 mL) and deionized H2O (5.0 mL) in a two-necked flask fitted 
with a reflux condenser. A sample was taken out for analysis and allylbromide (173 μL, 2.0 
mmol) was added. Another sample was taken out for analysis followed by addition of bismuth 
powder (418 mg, 2.0 mmol) and heating the suspension in an oil bath to 60 ºC. After 
approximately 40 min where the allylation initiated samples were taken out at the following 
intervals: 30, 5, 2×2.5, 5×2, 2×3, 4, 2×5, 8, 12, 2×15, and 2×30 min. 
 
General procedure for competitive magnesium allylation used for the Hammett plot 
Benzaldehyde (0.5 mmol), the p-substituted benzaldehyde (0.5 mmol) and naphthalene (0.25 
mmol) were dissolved in DMF (8.0 mL). A sample was taken out for analysis and allylbromide 
(457 μL, 5.0 mmol) was added. Another sample was taken out for analysis and 0.1 M aqueous 
NH4Cl (2.0 mL) was added. Magnesium powder (486 mg, 20 mmol) was then added and the 
slurry was stirred at rt. Samples were drawn at regular time intervals and filtered through a small 
plug of cotton, which was washed with 0.8 mL of DMF. The samples were analyzed 
immediately by GC using a 15 m × 0.10 mm × 0.10 μm Supelco Equity-1 capillary column 
(FastGC). The temperature program was 100 ºC (hold 5 min) and then a ramp (20 ºC /min) to 
300 ºC. 
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General procedure for the preparation of the corresponding pinacols 
Benzaldehyde (5 mmol) was dissolved in methanol (10 mL) and aluminum powder (0.27 g, 10 
mmol) was added followed by KOH (2.53 g, 45 mmol). After 10 min where the vigorous 
reaction had subsided, the slurry was filtered and 50 mL of H2O was added. Extraction with 3 × 
50 mL of ethyl acetate, drying with Na2SO4 and concentration in vacuo left a white, crude solid 
of the mixed pinacols in quantitative yield. 
 
LiAlD4 (1.02 g, 24.3 mmol) was added to 50.0 mL of THF in a three-necked flask 
fitted with a reflux-condenser and a drying-tube (CaCl2). The suspension was 
refluxed for 15 min., before dropwise addition of benzoic acid (1.20 g, 9.83 mmol in 10.0 mL 
THF) by syringe. The slurry was refluxed for 1 h after the full addition at which point it was 
quenched with aq. NaHCO3. The slurry was filtered through a pad of Celite and washed with 
100 mL of Et2O. The phases were separated and the aqueous phase was neutralized with 6 M aq. 
HCl. The combined organic phases were dried with MgSO4, filtered and evaporated in vacuo. 
Yield (0.993 g, 95 %). The alcohol (0.720 g, 6.54 mmol) was dissolved in 40.0 mL of anhydrous 
CH2Cl2 under Ar and cooled to -40 ºC, where NEt3 (3.6 mL, 26.1 mmol) and anhydrous DMSO 
(4.2 mL) were added. Then, a pre-mixed solution of SO3·py (3.12 g, 19.6 mmol) in anhydrous 
DMSO (12.5 mL) was added by syringe. The solution was allowed to warm to rt, where 100 mL 
of CH2Cl2 was added and washed with 150 mL of sat. aq. CuSO4 and 3 x 100 mL of 2 M HCl. 
The organic phase was dried with MgSO4, filtered and concentrated in vacuo without heating. 
The residue was purified by flash chromatography in 1→5 % Et2O in pentane to yield 0.494 g of 
the aldehyde (71 %).47, 48 1H-NMR (400 MHz, CDCl3): δ 7.86-7.91 (m, 2H), 7.60-7.66 (m, 1H), 
7.50-7.56 (m, 2H). 13C-NMR (100.6 MHz, CDCl3): δ 191.9 (t, J = 26.4, 1*C), 136.3 (t, J = 3.6, 
1*C), 134.3 (s, 1*C), 129.6 (s, 2*C), 128.9 (s, 2*C). HRMS (ESI-TOF) [M+H]+: calcd 
108.0553, found 108.0554. 
 
Rf = 0.47, 3:7 EtOAc:Heptane (v/v). 1H-NMR (300 MHz, CDCl3): δ 2.10 (s, 1H), 
2.49-2.60 (m, 2H), 4.74 (dd, 1H, J = 5.5, 7.4 Hz), 5.12-5.21 (m, 2H), 5.82 (tdd, 
1H, J = 7.1, 10.2, 17.1 Hz), 7.25-7.43 (m, 4H). 13C NMR (75 MHz, CDCl3, δ): 43.7, 73.2, 118.2, 
125.7, 127.4, 128.3, 134.4, 143.8. IR (neat, cm-1): br 3383, 3029, 2906, 1950, 1641, 1493, 1455, 
1314, 1198, 1046, 916. MS m/z: 148. Anal. Calcd for C10H12O: C, 81.04; H, 8.16. Found: C, 
80.85; H, 8.29. 
 
OH
O
D
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Rf = 0.30, 3:7 EtOAc:Heptane (v/v). 1H-NMR (300 MHz, CDCl3): δ 2.33-
2.55 (m, 2H), 2.59 (bs, 1H), 4.77 (dd, 1H, J = 5.0, 7.8 Hz), 5.09-5.19 (m, 
2H), 5.68-5.82 (m, 1H), 7.42-7.48 (m, 2H), 7.57-7.62 (m, 2H). 13C NMR (75 
MHz, CDCl3, δ): 43.6, 72.2, 110.8, 118.8, 119.2, 126.4, 132.1, 133.3, 149.2. IR (neat, cm-1): br 
3460, 3076, 2907, 2228, 1641, 1608, 1504, 1414, 1055, 921, 843. MS m/z: 173. Anal. Calcd for 
C11H11NO: C, 76.28; H, 6.40; N, 8.09. Found: C, 76.02; H, 6.44; N, 7.94. 
 
Rf = 0.47, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 2.19 
(bs, 1H), 2.39-2.59 (m, 2H), 4.79 (dd, 1H, J = 4.8, 7.9 Hz), 5.14-5.22 (m, 
2H), 5.71-5.86 (m, 1H), 7.44 (m, 2H), 7.57-7.63 (m, 2H). 13C NMR (75 
MHz, CDCl3, δ): 43.9, 72.5, 119.5, 124.1 (q, J = 272.0 Hz), 125.3 (q, J = 3.8 Hz), 126.0, 129.6 
(q, J = 32.3 Hz), 133.6, 147.7. IR (neat, cm-1): br 3380, 3079, 2910, 1928, 1643, 1621, 1416, 
1327, 1168, 1124, 1070. MS m/z: 216. Anal. Calcd for C11H11F3O: C, 61.11; H, 5.13. Found: C, 
60.92; H, 5.14. 
 
Rf = 0.33, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 2.39-
2.53 (m, 2H), 2.89 (bs, 1H), 3.86 (s, 3H), 4.74 (dd, 1H, J = 5.5, 7.5 Hz), 
5.06-5.14 (m, 2H), 5.66-5.82 (m, 1H), 7.34-7.39 (m, 2H), 7.92-7.97 (m, 
2H). 13C NMR (75 MHz, CDCl3, δ): 43.6, 52.0, 72.9, 118.6, 125.6, 128.9, 129.5, 133.8, 149.0, 
166.9. IR(neat, cm-1): br 3475, 3075, 2951, 1938, 1721, 1641, 1611, 1436, 1286, 1110. MS 
(ESP+) for C22H26O3 [M+Na]+: 229.1. Found: 229.1. Anal. Calcd for C12H14O3: C, 69.88; H, 
6.84. Found: C, 69.69; H, 6.95. 
 
Rf = 0.43, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 2.35-
2.53 (m, 2H), 2.40 (s, 1H), 4.66 (dd, 1H, J = 5.5, 7.4 Hz), 5.09-5.18 (m, 2H), 
5.75 (tdd, 1H, J = 7.1, 9.7, 17.2 Hz), 7.22-7.33 (m, 4H). 13C NMR (75 MHz, 
CDCl3, δ): 43.7, 72.5, 118.7, 127.1, 128.4, 133.0, 133.9, 142.2. IR (neat, cm-1): br 3373, 3078, 
2907, 1901, 1641, 1597, 1493, 1411, 1091, 1014. MS m/z: 182. Anal. Calcd for C10H11ClO: C, 
65.76; H, 6.07; Cl, 19.41. Found: C, 65.71; H, 6.17; Cl, 19.27. 
 
Rf = 0.47, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 2.08 (s, 
1H), 2.36 (s, 3H), 2.48-2.56 (m, 2H), 4.70 (t, 1H, J = 6.5 Hz), 5.12-5.21 (m, 
2H), 5.82 (tdd, 1H, J = 7.1, 10.2, 17.2 Hz), 7.15-7.21 (m, 2H), 7.23-7.30 (m, 2H). 13C NMR (75 
OH
N
OH
F3C
OH
Cl
OH
MeOOC
OH
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MHz, CDCl3, δ): 21.1, 43.7, 73.1, 118.1, 125.7, 129.0, 135.6, 137.1, 140.9. IR (neat, cm-1): br 
3383, 3077, 2922, 1904, 1640, 1514, 1435, 1307, 1198, 1044, 915, 816. MS m/z: 162. Anal. 
Calcd for C11H14O: C, 81.44; H, 8.70. Found: C, 81.52; H, 8.91. 
 
Rf = 0.43, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 1.33 (s, 
9H), 2.13 (s, 1H), 2.46-2.57 (m, 2H), 4.66-4.73 (m, 1H), 5.13-5.22 (m, 2H), 
5.83 (tdd, 1H, J = 5.1, 10.1, 17.3 Hz), 7.26-7.42 (m, 4H). 13C NMR (75 MHz, 
CDCl3, δ): 31.3, 34.5, 43.6, 73.1, 118.1, 125.3, 125.5, 134.7, 140.8, 150.4. IR (neat, cm-1): br 
3362, 3076, 2964, 1641, 1509, 1410, 1363, 1269, 1109, 1051, 914, 835. MS m/z: 204. Anal. 
Calcd for C14H20O: C, 82.30; H, 9.87. Found: C, 82.20; H, 9.85. 
 
Rf = 0.33, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 2.24 (s, 
1H), 2.46-2.52 (m, 2H), 3.80 (s, 3H), 4.66 (t, 1H, J = 6.6 Hz), 5.09-5.18 (m, 
2H), 5.79 (tdd, 1H, J = 7.1, 10.2, 17.2 Hz), 6.85-6.91 (m, 2H), 7.24-7.31 (m, 
2H). 13C NMR (75 MHz, CDCl3, δ): 43.6, 55.2, 72.9, 113.6, 118.1, 127.0, 134.6, 136.0, 158.9. 
IR (neat, cm-1): br 3404, 3075, 2934, 2836, 1612, 1514, 1464, 1302, 1250, 1177, 1038. MS m/z: 
178. Anal. Calcd for C11H14O2: C, 74.13; H, 7.92. Found: C, 73.98; H, 8.02.  
 
Rf = 0.38, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 0.98 (t, 
3H, J = 7.4 Hz), 1.43-1.56 (m, 2H), 1.71-1.82 (m, 2H), 2.11 (bs, 1H), 2.46-
2.52 (m, 2H), 3.95 (t, 2H, J = 6.5 Hz), 4.66 (t, 1H, J = 6.5 Hz), 5.09-5.19 (m, 
2H), 5.79 (tdd, 1H, J = 7.1, 10.1, 17.2 Hz), 6.84-6.91 (m, 2H), 7.23-7.29 (m, 2H). 13C NMR (75 
MHz, CDCl3, δ): 13.8, 19.2, 31.3, 43.7, 67.6, 73.0, 114.3, 118.1, 127.0, 134.6, 135.8, 158.5. IR 
(neat, cm-1): br 3385, 3075, 2961, 1707, 1617, 1507, 1246, 1173, 1035, 917, 833. MS m/z: 220. 
Anal. Calcd for C14H20O2: C, 76.33; H, 9.15. Found: C, 76.07; H, 9.14. 
 
Rf = 0.47, 3:7 EtOAc:Heptane (v/v). 1H NMR (300 MHz, CDCl3): δ 
2.26-2.42 (m, 2H), 2.47-2.65 (m, 2H), 3.83 (s, 6H), 4.03-4.09 (m, 2H), 
4.89-5.00 (m, 4H), 5.59-5.75 (m, 2H), 6.86 (m, 4H), 7.14 (m, 4H). 13C 
NMR (75 MHz, CDCl3, δ): 43.1, 55.5, 77.7, 113.9, 116.8, 128.6, 
134.3, 135.4, 159.3. IR (neat, cm-1): 3072, 2933, 2834, 1610, 1513, 1302, 1249, 1170, 1073. 
HRMS (ESP+) for C22H26O3 [M+Na]+: 361.1780. Found: 361.1777. 
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tBu
OH
MeO
OH
BuO
O
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General method for GC-analysis (Method A): 
Temperature (ºC) Hold Time (min.) 
100.0 12.0 (ramp 20) 
200.0 10.0 (ramp 20) 
300.0 5.0 
 
Retention times for reaction components (Method A): 
 Aldehyde Benzylalcohol Pinacols (dl/ meso) Homoallyl 
-CN 11.40 16.08 - 18.13 
-CF3 3.80 6.47 21.67/ 22.09 13.70 
-COOMe 15.47 17.29 - 19.44 
-Cl 8.48 12.46 30.34/ 30.57 18.81 
-H 4.01 5.15 22.04/ 21.06 12.51 
-tBu 14.88 15.56 31.98/ 32.16 18.00 
-OMe 12.98 13.94 31.16/ 31.35 17.18 
-OBu 17.73 17.86 - 20.37 
 
Method for p-Tolualdehyde GC-analysis (Method B): 
Temperature (ºC) Hold Time (min.) 
120.0 10.0 (ramp 20) 
200.0 10.0 (ramp 20) 
300.0 5.0 
 
Retention times for reaction components (Method B): 
 Aldehyde Benzylalcohol Pinacols (dl/ meso) Homoallyl 
-H 3.10 3.52 18.72/ 17.73 6.84 
-Me 4.18 4.72 23.02/ 23.58 10.38 
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Table A: Data for the competition experiments with zinc. 
X kX/kH R2 log(kX/kH) σ σ▪, 
Creary 
σ+ σ- 
t-Bu 0.68 0.997 0.167491 -0.2 0.13 -0.26 -0.13 
OMe 0.39 0.997 0.408935 -0.27 0.24 -0.78 -0.26 
Me 0.74 0.998 0.130768 -0.17 0.11 -0.31 -0.17 
Cl 1.45 0.998 -0.16137 0.23 0.12 0.11 0.19 
COOMe 2.29 0.997 -0.35984 0.45 0.35 0.49 0.75 
CF3 2.16 0.999 -0.33445 0.54 0.08 0.61 0.65 
CN 2.98 0.997 -0.47422 0.66 0.46 0.66 1 
 
Hammett Plot, Zn
y = 0.67x
R2 = 0.96
y = 1.37x
R2 = 0.77
y = 0.60x
R2 = 0.97
-0.5
-0.25
0
0.25
0.5
-1 -0.75 -0.5 -0.25 0 0.25 0.5 0.75 1
σ
log(kX/kH)
σ
σ▪, Creary
σ+
σ-
 
Figure A: Hammett plot for the allylation with zinc. 
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Table B: Data for the competition experiments with indium. 
X kX/kH R2 log(kX/kH) σ σ▪, 
Creary 
σ+ σ- 
Me 0.62 0.999 -0.20761 -0.17 0.11 -0.31 -0.17 
Cl 1.62 0.997 0.209515 0.23 0.12 0.11 0.19 
COOMe 2.31 0.991 0.363612 0.45 0.35 0.49 0.75 
CN 3.18 0.988 0.502427 0.66 0.46 0.66 1 
t-Bu 0.58 0.999 -0.23657 -0.2 0.13 -0.26 -0.13 
CF3 2.12 0.995 0.326336 0.54 0.08 0.61 0.65 
Me 0.62 0.999 -0.20761 -0.17 0.11 -0.31 -0.17 
 
Hammett Plot, In
ρ = 0.76x
R2 = 0.954
-0.5
-0.25
0
0.25
0.5
-1 -0.75 -0.5 -0.25 0 0.25 0.5 0.75 1
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σ
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Figure B: Hammett plot for the allylation with indium. 
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Table C: Data for the competition experiments with tin. 
X kX/kH R2 log(kX/kH) σ σ▪, 
Creary 
σ+ σ- 
OMe 0.267 0.997 -0.57349 -0.27 0.24 -0.78 -0.26 
Me 0.614 0.999 -0.21183 -0.17 0.11 -0.31 -0.17 
Cl 1.32 0.998 0.120574 0.23 0.12 0.11 0.19 
COOMe 2.76 0.995 0.440909 0.45 0.35 0.49 0.75 
CF3 3.04 0.997 0.482874 0.54 0.08 0.61 0.65 
CN 4.42 0.999 0.645422 0.66 0.46 0.66 1 
 
Hammett Plot, Sn
ρ = 1.02x
R2 = 0.901
-0.75
-0.5
-0.25
0
0.25
0.5
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Figure C: Hammett plot for the allylation with tin. 
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Table D: Data for the competition experiments with antimony. 
X kX/kH R2 log(kX/kH) σ σ▪, 
Creary 
σ+ σ- 
OMe 0.32 0.987 -0.49485 -0.27 0.24 -0.78 -0.26 
Me 0.72 0.999 -0.14267 -0.17 0.11 -0.31 -0.17 
Cl 1.45 0.997 0.161368 0.23 0.12 0.11 0.19 
COOMe 2.56 0.991 0.40824 0.45 0.35 0.49 0.75 
CN 5.3 0.988 0.724276 0.66 0.46 0.66 1 
CF3 3.25 0.995 0.511883 0.54 0.08 0.61 0.65 
 
Hammett Plot, Sb
ρ = 0.76x
R2 = 0.954
-0.75
-0.5
-0.25
0
0.25
0.5
0.75
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Figure D: Hammett plot for the allylation with antimony. 
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Table E: Data for the competition experiments with bismuth. 
X kX/kH R2 log(kX/kH) σ σ▪, 
Creary 
σ+ σ- 
OMe 0.383 0.997 -0.4168 -0.27 0.24 -0.78 -0.26 
Me 0.682 0.999 -0.16622 -0.17 0.11 -0.31 -0.17 
Cl 1.54 0.995 0.187521 0.23 0.12 0.11 0.19 
COOMe 2.59 0.998 0.4133 0.45 0.35 0.49 0.75 
CF3 3.5 0.993 0.544068 0.54 0.08 0.61 0.65 
CN 5.07 0.996 0.705008 0.66 0.46 0.66 1 
t-Bu 0.723 0.999 -0.14086 -0.2 0.13 -0.26 -0.13 
 
Hammett Plot, Bi
ρ = 1.01x
R2 = 0.962
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Figure E: Hammett plot for the allylation with bismuth. 
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Table F: Data for the competition experiments with magnesium. 
X kX/kH R2 log(kX/kH) σ σ▪, 
Creary 
σ+ σ- 
Me 0.256 0.999 -0.59176 -0.17 0.11 -0.31 -0.17 
Cl 4.09 0.995 0.611723 0.23 0.12 0.11 0.19 
COOMe 45.6 0.998 1.658965 0.45 0.35 0.49 0.75 
CF3 32.6 0.993 1.513218 0.54 0.08 0.61 0.65 
 
Hammett Plot, Mg
ρ = 3.13x
R2 = 0.97
-0.75
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-0.25
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Figure F: Hammett plot for the allylation with magnesium. 
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2 Pancratistatin – An Overview 
2.1 Introduction 
Since the isolation of pancratistatin from the roots of the tropical spider lily Pancratium 
Littorale in 1984 by Pettit et al., it has received a large amount of attention from the organic 
synthetic community.49-54 This is in part due to the promising activity against a variety of 
different cancer cell lines, vira and parasites, but also because of the low bioavailability of 0.039 
% based on dry plant material.50, 55-57 
O
O NH
OH
OHHO
OH
R O
A B
C
O
O NH
OH
OH
OH
R O
Pancratistatin, R = OH
7-Deoxypancratistatin, R = H
Narciclasine, R = OH
Lycoricidine, R = H
1
2
3
4
4a10b
7
2.1
2.2  
Figure 2.1: Structure of (+)-pancratistatin and related alkaloids from the Amaryllidaceae plant family. 
 
Furthermore, the structure of pancratistatin offers a great synthetic challenge with its six 
continuous stereocenters and a highly electron-rich pentasubstituted aromatic moiety. 
Several other compounds with similar activity and scarce availability have been isolated, but 
pancratistatin remains one of the more active compounds of the more than 100 isolated 
compounds from various Amaryllidaceae species.58 In this connection a multitude of studies 
concerning the pharmacophore of pancratistatin have been reported.52 The issue of its very low 
solubility in water (53 μg/mL) has been solved by installing a phosphate-residue on either the 
phenolic position or by generating a cyclic phosphate with the two C-ring cis-hydroxyl groups, 
which raises the solubility to 20 mg/mL.59 The high activity of pancratistatin is hard to retain in 
unnatural and truncated analogues – even the phosphate functionalized analogues exhibit 
slightly lower activity.59 It seems that at least 2-3 hydroxyls on the C-ring, the full 
phenanthridone ring-system along with the trans-relationship between the B and C-rings are not 
necessary for retaining high activity. As such even the dioxolane and the phenol-residue cannot 
be removed without loss of activity. Also the amide linkage in the B-ring is of importance. 
Removing the lactam-oxygen or replacing the lactam for a lactone lowers the cytotoxicity more 
than 10-fold in comparison to its natural congener.52, 55, 60 However, simpler constituents than 
those shown in figure 2.1 have been isolated from natural sources and tested for activity. Pettit et 
al. found 1-deoxypancratistatin and 1,7-dideoxypancratistatin to be equally potent as 
pancratistatin itself when tested against a minipanel of human cancer cell lines, and at present 
Pancratistatin – An Overview 
 24 
 
they comprise the minimum pharmacophore.61-63 The development of this pharmacophore has 
come a long way despite the fact that the exact mechanism on a cellular level is unknown. 
McLachlan et al. suggest that pancratistatin induces apoptosis selectively in cancer cells.64 More 
importantly, Kekre et al. have shown that pancratistatin does not harm healthy cells, which in 
turn could open up for efficient and non-toxic chemotherapy.65, 66 
In regard to the synthesis of pancratistatin and its congeners many ingenious total syntheses 
have been reported.52 The first synthesis was accomplished in 1989 by Danishefsky and Lee 
yielding racemic pancratistatin over 26 steps in less than 0.2 % yield. (See table 2.1). Not until 
1995 was the first enantioselective synthesis achieved by Hudlicky et al. in one of the shortest 
feats still in a 2 % overall yield over 14 steps. Since then eight total syntheses, including two 
formal ones and a semi-synthetic, have been reported spanning from 0.4 % to 7.4 % yield over 
10 to 22 steps.67-76  
In the following section each published total synthesis of pancratistatin will be discussed 
shortly with focus on the key steps that have enabled the full synthesis. 
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Table 2.1: Overview of the existing total syntheses of pancratistatin. 
Synthesized by Publication 
year 
Total 
steps 
Starting material Comments 
Danishefsky & Lee67 1989 26 Pyrogallol Racemic,  
< 0.2 % yield, linear. 
Hudlicky & Co-
workers58, 68 
1995 14 Bromobenzene & 
 piperonylic acid 
Enantioselective,  
2 % yield, 
convergent. 
Trost & Pulley69 1995 17 Benzoquinone & o-vanillin Enantioselective, 
7.4 % yield, 
convergent. 
Haseltine & Co-
workers70 
1997 22a Anthrone, benzoquinone & 
 piperonol 
Formal synthesis, 
4.7 % yielda, 
convergent. 
Magnus & Sebhat71, 77 1998 22 o-Vanillin & 1,4-cyclohexanedione 
monoethylene acetal 
Enantioselective,  
1.2 % yield, 
convergent. 
Rigby, Maharoof & 
Mateo72 
2000 22 2,3-dihydroxybenzaldehyde & 
 3-cyclohexene-1-carboxylic acid 
Enantioselective, 
 < 0.4 % yield, 
convergent. 
Pettit, Melody & 
Herald73 
2001 10 Narciclasine Semi synthetic,  
3.6 % yield. 
Kim & Co-workers74, 78 2002 21 Methyl gallate & 
5-bromo-3-methoxysalicylaldehyde 
Racemic (2.1 % 
yield) +  formal 
enantioselective, 
both linear.  
Li, Wu & Zhou75 2006 12 Pinitol &  
2,3-dihydroxybenzaldehyde 
Enantioselective, 
 2.2 % yield, 
convergent. 
Crich & 
Krishnamurthy76 
2006 ~10b Resorcinol  Formal synthesisb, 
linear. 
Dam & Madsenc 2009 15 Piperonal & D-xylose Enantioselective,  
7.1 % yield, 
convergent. 
a) 5 steps short. b) 14 steps short. c) This dissertation. 
 
2.2 Danishefsky & Lee’s Approach 
In the Danishefsky and Lee total synthesis from 1989 pyrogallol served as the starting 
material for the linear synthesis.67 (Scheme 2.1). After a rather low-yielding sequence to produce 
diene 2.3 for the Diels-Alder reaction, the C-ring and the fully functionalized A-ring were 
formed. Attempts to halolactonize onto cyclohexene 2.4 failed due to steric repulsion between 
the silyl ether and an intermediate iminium ion. Removal of the TBS-group provided a free 
phenol that performed sluggishly in the lactonization. Increasing the nucleophilicity of the 
amide functionality by stannylation of the phenol produced the desired lactone 2.5 in a moderate 
67 % yield. Unfortunately, all attempts to generate the conjugated diene from 2.5 by treatment 
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with base yielded a fully aromatized C-ring. A rather lengthy deroute, containing a series of 
dihydroxylations and a Moffatt transposition, gave rise to the mono-protected diol 2.7 – the 
Danishefsky lactone.79, 80 The transposition with 2-acetoxyisobutyryl bromide afforded a 
mixture of two isomers in a ratio of 63:25 in favor of the desired product. 
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O
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O
O
O
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OBn
O
O
O
O
AcO
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i) OsO4, NMO
ii) Bu2SnO then PMBBr
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i) DDQ, H2O
ii) Zn, AcOH
   61 % (2 steps)
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O
O
AcO
Br
OBn
OPMB
2.3 2.4
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Scheme 2.1: Danishefsky and Lee’s approach. 
 
With the lactone 2.7 in hand focus was turned to completing the synthesis based on the lactone 
to lactam reorganization (2.9 to 2.10) in accordance with previously published accounts by Ohta 
et al. and Paulsen and Stubbe, scheme 2.2.81, 82 The elegant endgame started out with an 
Overman rearrangement,83, 84 which was accomplished under interesting conditions: It was most 
efficiently achieved under pyrolysis-like conditions, i.e. the imidate was heated to ~100 ºC at 
~0.1 mmHg for 1.2 h to provide the rearranged product 2.8 in acceptable 56 % yield (from the 
imidate). Next followed the dihydroxylation of 2.8 from the concave face of the bicyclic system. 
It was found that the lactamization to produce 2.10 would not take place in refluxing methanol 
and K2CO3 – instead Danishefsky and Lee speculated that an amino acid was formed, and by 
treatment with DCC the lactam was produced in good yield.  
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Scheme 2.2: End-game in Danishefsky and Lee’s approach. 
 
Global deprotection delivered pancratistatin in 26 steps and an overall yield of less than 0.2 %. 
 
2.3 Hudlicky & Co-workers’ Approach 
The total synthesis by Hudlicky and co-workers took off by elaborating the pancratistatin C-
ring (scheme 2.3).58, 68 The enantiodiscriminating step was the first transformation in the 
synthesis and involved a whole cell oxidation of bromobenzene with Pseudomonas Putida 39/D. 
Key to the synthesis was the selective 1,2-addition of a nucleophile to C-10b (pancratistatin 
numbering) on a functionalized vinylaziridine 2.11 from the concave face of the system. This 
transformation was best done by a higher order cuprate-addition to afford aziridine opening, 
where other cuprates and Grignard reagents afforded 1,4-addition from the convex face. 
Pancratistatin – An Overview 
 28 
 
Br
P. putida
Br
OH
OH
i) TsOH, 
ii) PhI=NTs, Cu(acac)2
   54 % (2 steps)
iii) Bu3SnH, AIBN, Δ
   78 %
O
O
TsN
sBuLi, TMEDA, -90 °C
then
CuCN, -90 °C     -20°C
then 0.33 eq. 2.11, -78 °C
            75 %
O
O
TBSO O
NMe2
O
O
TBSO
O
O
NHTs
CONMe2
3 steps
Piperonylic acid
2.11
10 steps
2.1
OMe
OMe
 
Scheme 2.3: Hudlicky & Co-workers’ approach. 
 
After some protection group interchange and C-ring manipulation the total synthesis was 
completed in a total of 14 steps in a 2 % overall yield. 
 
2.4 Trost & Pulley’s Approach 
Within the same year as Hudlicky and co-workers’ account, the second asymmetric total 
synthesis appeared.69 (Scheme 2.4). Like in Hudlicky’s approach, the enantioselectivity was 
determined early in the synthesis by a palladium-catalyzed desymmetrization with a chiral 
ligand. Again, the pivotal issue was the stereocontrolled Sn2’-addition to form the A- to C-ring 
connection. Trost and Pulley found that a one-pot addition of a low-order cuprate from the 
concave face of 2.12 would yield the desired product. It was immediately dihydroxylated due to 
purification difficulties. 
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Scheme 2.4: Trost & Pulley’s approach. 
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This formed a similar intermediate as in the Hudlicky approach, and pancratistatin was 
synthesized in another eight steps in a 7.4 % overall yield. 
 
2.5 Haseltine & Co-workers’ Approach 
Haseltine et al. saw that a similar conduritol (2.12 and 2.13) as in Trost and Pulley’s 
synthesis could be synthesized in a different manner.70 By employing a published protocol 
utilizing a Diels-Alder cycloaddition between the potassium salt of anthrone and benzoquinone 
they were able to obtain a protected conduritol. Retro Diels-Alder with KH released the 
functionalized product and one enzymatic acetylation generated the conduritol 2.13 selectively 
after some protecting group manipulations. An enzymatic acetylation was applied to 
differentiate between the two alcohols ultimately leading to an asymmetric synthesis. 
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Scheme 2.5: Haseltine & Co-workers’ approach. 
 
Simple ether formation generated compound 2.15 containing the A- and C-ring. Haseltine et al. 
quickly found that having the pentasubstituted A-ring only led to a low yield of the desired 
product when treated with triflic anhydride and base. Instead, they were able to form the B-ring 
in good yield without the phenolic residue in the 7-position. The phenolic oxygen was installed 
by a late stage lateral metallation. They concluded the formal synthesis by synthesizing the 
Danishefsky intermediate 2.7 in another 9 steps – 5 steps short of a total synthesis.
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2.6 Magnus & Sebhat’s Approach 
In the total synthesis by Magnus and Sebhat treatment of a prochiral cyclohexanone 2.16 
with a chiral lithium amide was key to synthesize an enantiomerically enriched silyl enolate 2.17 
in excellent yield.71, 77 
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Scheme 2.6: Magnus & Sebhat’s approach. 
 
Subsequent treatment with iodosyl benzene and trimethylsilyl azide installed the allylic azide as 
a 3.5:1 mixture of diastereoisomers in favor of the desired trans isomer. A lengthy sequence was 
necessary to set up the stereocenters on the C-ring and make the proper B-ring connectivity. It 
took Magnus and Sebhat five steps to introduce the new stereocenter in 2.19 and protect the 
amine. Another five steps were required to install the epoxide of 2.20 and reduce the ketone 
selectively. The synthesis was completed in four steps from 2.20, where the B-ring was secured 
by a Bischler-Napieralski reaction with Tf2O, providing (+)-pancratistain in a longest linear 
sequence of 22 steps and a 1.2 % overall yield. 
 
2.7 Rigby, Maharoof & Mateo’s Approach 
In the Rigby, Maharoof and Mateo total synthesis, the pivotal issue was a hydrogen bond-
controlled aryl enamide photocyclization.72 (Scheme 2.7). It was soon realized that without 
protection of the nitrogen in 2.21, the photocyclization yielded an undesired regioisomer. The 
isocyanate 2.22a was originally thought to have the proper setting for the C-ring 
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functionalization. Instead, it generated the wrong trans relationship between the B and C-ring 
during photocyclization to 2.23. The requisite enamide precursor 2.22 was synthesized in 10 
steps including an enzymatic resolution. This is three steps shorter than for 2.22a, but 
necessitated inversion of a stereocenter on the C-ring of 2.23 through an unpleasant 
deprotection, oxidation-reduction and reprotection sequence to give 2.24. 
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Scheme 2.7: Rigby, Maharoof & Mateo’s approach. 
 
Attempts to improve the yield of the photocyclization by switching to a solvent with less light 
absorbance failed, and unreacted enamide 2.21 was recycled. With the full phenanthridone 
system completed, the C-ring was elaborated in another four steps to give pancratistatin in a 
0.35 % overall yield. 
 
2.8 Pettit, Melody & Herald’s Approach 
While pancratistatin is scarce in plant material, narciclasine is much more abundant (up to 
200 mg/ Kg wet plant material). Pettit, Melody and Herald reported a transformation of 
narciclasine into pancratistatin in an effort to make the latter more abundant, scheme 2.8.73  
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Scheme 2.8: Pettit, Melody & Herald’s approach. 
 
After global protection of narciclasine a low-yielding epoxidation followed to yield 2.25. The 
epoxide was opened by hydrogenation and successive saponification of the esters generated 
2.26. Only 28 % of the desired product 2.26 was isolated with another 48 % combined yield of 
three other isomeric compounds. Transforming the diol 2.26 into a cyclic sulfate suffered from 
difficulties in oxidizing the sulfite epimers and hence a superstoichiometric amount of periodate 
was applied leading to a low yield. Although Pettit, Herald and Melody only required a ten-step 
procedure to synthesize pancratistatin, a number of low-yielding steps were involved giving an 
overall yield of only 3.6 %. Interestingly, all their compounds from narciclasine were screened 
for biological activity and compound 2.27 was found to possess increased activity compared to 
both narciclasine and pancratistatin. 
 
2.9 Kim & Co-workers’ Approaches 
In the Kim and co-workers’ first approach74, 78 the highlight of the synthesis encompassed a 
Claisen rearrangement of 2.28 to afford the unfunctionalized C-ring in good yield (Scheme 2.9). 
The reaction was performed at 250 ºC because the reaction had to go through a boat-like 
transition state. The remaining stereocenters and the B-ring was completed in another 14 steps to 
yield pancratistatin in 2.1 % overall yield. 
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Scheme 2.9: Kim & Co-workers’ approaches. 
 
The second approach involved an enantioselective Ireland-Claisen rearrangement of 2.29, where 
the stereogenic information from the enzymatically available alcohol 2.30 was transferred into 
two stereocenters under very mild conditions. Two diastereoisomers were formed, but first 
separated after ring-closing metathesis and iodolactonization, where the undesired isomer did 
not react. Fortunately, the desired isomer 2.31 was the major product from the rearrangement of 
2.29. Although their enantioselective route was shorter, Kim et al. did not complete the 
synthesis to produce pancratistatin enantioselectively. 
 
2.10 Li, Wu & Zhou’s Approach 
The total synthesis by Li, Wu and Zhou represents the shortest route to date.75 The synthesis 
started from the rather expensive pinitol containing five of the six stereocenters in pancratistatin 
(Scheme 2.10). They were only able to protect pinitol in a very low yield eventually affording 
one fragment, 2.32, for further coupling to their activated acid chloride, 2.33. 
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Scheme 2.10: Li, Wu & Zhou’s approach. 
 
After some experimentation, it was found that transmetallation to afford a softer cerium-
nucleophile would lead to the desired opening of the cyclic sulfate of 2.34 and set the last 
stereocenter required for the pancratistatin configuration. By applying sonication, they achieved 
full conversion and shortened the reaction time. After careful global deprotection in two steps, 
pancratistatin was synthesized in 2.2 % overall yield over 12 steps.  
 
2.11 Crich & Krishnamurthy’s Approach 
As part of a method development program about dearomatizing benzene Crich and 
Krishnamurthy produced compound 2.35, which is an intermediate in the synthesis by Lee and 
Danishefsky (Scheme 2.11).76 The synthesis was not completed as it required additional 14 steps 
to yield racemic pancratistatin and therefore represents a formal synthesis. 
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Scheme 2.11: Crich & Krishnamurthy’s approach. 
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Crich and Krishnamurthy were only able to cut about three steps off the original synthesis. 
Because of the low yield in the radical dearomatization and the issue of the required Moffat 
transposition – see scheme 2.1 – from intermediate 2.35 the synthesis does not really address the 
original problem with regard to improved availability and synthetic efficiency. 
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3 Total Synthesis of (+)-Pancratistatin 
3.1 Introduction 
Carbohydrates are densely functionalized compounds and are as such an interesting 
renewable starting material for chemical synthesis. Madsen et al. have in a series of studies 
reported the successful application of carbohydrates as chiral pool starting materials for total 
synthesis.25, 26, 28-30, 85, 86  
In this connection a sequence for converting a properly functionalized carbohydrate into a 
cyclohexene with retention of the absolute stereochemistry has been developed in the group. In 
this sequence it is not only some of the stereocenters that are set, but the carbocyclic framework 
is also formed. The method comprises a fragmentation of a carbohydrate to provide an enal that 
contains two new handles for further manipulations, an alkene and an aldehyde. By reaction 
with the proper allylating reagent a new stereocenter can be created along with chain elongation. 
Ring closing metathesis will form the carbocyclic framework. An example of the sequence is 
shown in scheme 3.1.30 
 
Zn
4:1 THF:H2O
40 °C, )))
Br OBz
O
O OH
OBz
O
O OH
OBzHO
HO OH
O
Gabosine N
85 %
dr 2:1
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86 %
O
O O
I OMe
O O
O
 
Scheme 3.1: Example of the one-pot fragmentation-allylation reaction. 
 
In connection to the allylation study in chapter 1 it was decided to undertake the enantioselective 
synthesis of (+)-pancratistatin along the lines of the previous synthesis in the group of 7-
deoxypancratistain.28 In this synthesis the fragmentation-allylation sequence produced an 
advanced intermediate eventually leading to 7-deoxypancratistatin.28 With improved knowledge 
of the mechanism behind the Barbier-allylation the hope was to improve the overall yield. The 
methodology would additionally be pushed to the limit because of the increased steric bulk and 
large electron density in the allylating reagent. 
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3.2 Retrosynthetic Analysis 
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Figure 3.1: Retrosynthetic analysis for the synthesis of (+)-pancratistatin. 
 
The strategy was to intercept the synthesis of Danishefsky and Lee by synthesizing the 
allylic alcohol, A, an intermediate in their pioneering synthesis.67 This alcohol was envisioned to 
be synthesized from the allylating reagent B and the ω-iodoribofuranoside C by means of the 
fragmentation-allylation protocol earlier applied in the Madsen group.25, 28-30, 87 The absolute 
stereochemistry of the alcohol A would originate from the functionalized carbohydrate C with 
ribo-configuration. In order to differentially protect the two alcohols in the furanoside, this 
substrate was generated from D-xylose by a procedure previously utilized in the synthesis of 7-
deoxypancratistatin. The allylating reagent B could arise from commercially available piperonal 
or the carboxylic acid equivalent, piperonylic acid. 
 
3.3 Synthesis of the Allyl Bromide 
The work towards the allylating reagent was inspired by the work of PhD Anders Håkansson 
et al. in their total synthesis of 7-deoxypancratistatin.28 While their tetrasubstituted allylating 
reagent was accessible in six steps, the synthesis of the pentasubstituted allylating reagent 3.1 to 
provide pancratistatin was a bit steppier. Although piperonylic acid is commercially available it 
was chosen to start the synthesis with piperonal in course of the much higher price of the acid 
and the ease by which the aldehyde was oxidized under Pinnick conditions.88 In order to obtain 
synthetically useful yields, a tertiary amide (3.5) was implemented as directing group to install 
the phenol required for the full substitution pattern in pancratistatin. Substantially lower yields 
were obtained, when an oxazole 3.2 (8%), a 1,3-dimethylimidazolidine 3.3 (33%) or the N-
cyclohexylimine 3.4 (69%) were used as directing groups.89  
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Scheme 3.2: Installation of the phenolic residue with different directing groups. 
 
Early studies toward the desired allylating reagent showed that regioselective bromination was 
troublesome. Thus electrophilic bromination with Br2 on the system containing the required 
phenolic residue to eventually provide the full pentacyclic system for pancratistatin went in low 
yield to the wrong regioisomer. Directed ortho metalation of the amide 3.6 and quench with 
iodine provided useful yields of the substrate 3.7 for the Heck cross-coupling, but first the amide 
had to be manipulated. In accordance with Keck et al. conversion of the tertiary amide to the 
methyl ester 3.8 with Meerwein’s reagent was low-yielding, when both ortho positions next to 
the amide are blocked by permanent substituents.90, 91  
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Scheme 3.3: Attempted conversion of the tertiary amide. 
 
Furthermore all attempts to deprotect the methyl ether 3.7 were met with failure under a range of 
standard conditions (e.g. LiI, LiCl and NaCN in DMF, propanethiolate, thiophenolate  and BBr3) 
due to simultaneous removal of the dioxolane. Further optimization of this conversion proved 
unsuccessful and focus was turned to applying the protocol reported by Keck et al. 
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Scheme 3.4: Successful conversion of the amide to the methyl ester. 
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Therefore the phenol 3.9 was quantitatively TBS-protected, the iodide was installed in excellent 
yield and the tertiary amide was then converted to the methyl ester without event. It was chosen 
to protect the phenol as the corresponding benzyl derivative 3.10 since the synthesis eventually 
would intercept the total synthesis by Danishefsky and Lee and the formal synthesis by Doyle et 
al.67, 70 Initially the Heck cross-coupling conditions earlier applied in the group was utilized, but 
only provided the desired product (3.11) in moderate yield. It is known that addition of 
phosphines can suppress cross-coupling, when the substrate is an aryl iodide.92 Under Jeffery 
conditions the addition of phosphines is not required and the coupling was performed under 
these conditions in quantitative yield, only dropping slightly on a 11 g-scale.93 
 
O
O
O
OMe
OBn
I
O
O
O
OMe
OBn
COOH
Pd(OAc)2, NBu3,
TBAI, Acrylic acid
DMF
Cl
O
OEt
a) i)
ii) NaBH4 (95%)
, NEt3
Q
O
O
O
OMe
OBn
Brb) Ms2O, NEt3,
    LiBr (93%)
3.10 3.11 3.1  
Scheme 3.5: Preparation of the allylating reagent. 
 
Subsequent reduction of the carboxylic acid without affecting the ester was carried out via the 
carbonic anhydride. A one-pot displacement of the primary alcohol was accomplished using 
methanesulfonic anhydride and LiBr. Hydrobromic acid was utilized in the work-up to avoid the 
formation of the primary chloride. The allylating reagent 3.1 was now available in multigram 
quantities in nine steps from commercially available piperonylic acid. The reagent is fully stable 
up to seven months at ambient temperature, but decomposes rapidly on dry silica gel. 
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3.4 Synthesis of the ω-Iodoribofuranoside 
The carbohydrate coupling partner 3.12 was synthesized uneventfully in similar yields as 
Håkansson et al.28 
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Scheme 3.6: Synthesis of the ω-iodoribofuranoside. 
 
3.5 Synthesis of the Danishefsky Lactone 
With both the iodosugar 3.12 and the allylating reagent 3.1 in hand attention turned to the 
fragmentation-allylation-metathesis sequence. Initially, conditions applied by our group in the 
synthesis of 7-deoxypancratistatin were low-yielding.28, 87 The use of activated zinc-powder was 
found to be a necessary precaution since the Vasella-type reductive fragmentation otherwise 
would be slow to initiate.94, 95 When Zn* was applied the fragmentation was smooth and full 
conversion to the corresponding enal was achieved within 1-2 h without racemization. It was 
also quickly realized that the compounds were reluctant to lactonize and consequently produced 
an inseparable mixture of two diastereoisomers. This obstacle was overcome by basic 
lactonization in refluxing CH3CN and after RCM the two isomers 3.13 and 3.14 could be 
separated by flash chromatography. The Hoveyda-Grubbs 2nd generation catalyst was found 
better than Grubbs 2nd generation catalyst in terms of purification of the product. Although the 
yield was comparable to the yield in the synthesis of 7-deoxypancratistatin the diastereomeric 
ratio was somewhat poorer. Efforts to improve this ratio included allylation conditions earlier 
investigated by us.96 Stepwise fragmentation and allylation with tin and indium did not provide 
any product and allylation in aqueous NH4Cl with zinc only led to minor diastereomeric excess 
in low yields. Changing the H2O:THF-ratio from 1:3 to 1:9 did indeed improve the ratio to 5:1 
in favor of the desired product, but still not in synthetically useful yields. The most successful 
conditions were found to correspond to the Jaworsky and Gilman conditions to minimize Wurtz 
coupling.97-99 These conditions included large excess of metal, high dilution of reagents and 
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slow addition of the allylating reagent. Hence the excess of the more inaccessible allylating 
reagent could be lowered to 1.5 equiv. from 3 equiv. by Håkansson et al.28 In this work higher 
yields were obtained with Jaworsky conditions and when simultaneous fragmentation and 
allylation in 1:3 H2O:THF during sonication and slow, continuous addition of the allylating 
reagent were applied. Although this procedure suffered from poor diastereomeric excess the 
good yield provided material to finish the synthesis. Reproducible yields were obtained on a 
routinely basis when 1-2 vol % of a liquid detergent was added to the sonication bath for better 
dispersion of the ultrasound. 
 
Table 3.1: One-pot fragmentation, allylation and ring-closing metathesis. 
O
O O
OOBn
OBn
OH
a) i) Zn,
    ii) Amberlite IR-120
b) K2CO3, CH3CN
c) Hoveyda-Grubbs
    2nd gen. cat., CH2Cl2
O
O
O
OMe
OBn
BrO
OBnTESO
OMe
I
O
O O
OOBn
OBn
OH
3.13 3.14
 
Method A: The carbohydrate was fragmented with Zn under sonication, filtered through Celite and redissolved in 
THF: H2O. The allylating reagent and the metal were added and the slurry was stirred (without sonication) for 
several hours. In the case of Sn the slurry was heated to 60 ºC in accordance with previous work.96 
Method B: The carbohydrate was fragmented with Zn under sonication – after complete fragmentation sat. aq. 
NH4Cl was added and the allylating reagent was added slowly by syringe plunger under vigorous stirring (without 
sonication). 
Method C: The carbohydrate was fragmented with Zn under sonication while the allylating reagent was added by 
syringe plunger over 5 h. 
Entry Metal Method dr (3.13:3.14) Yield (%) Comment 
1 Sn A - 0  
2 In A - 0  
3 Zn B (NH4Cl) 1.3:1 to 1.7:1 24-27  
4 Zn C 1.5:1 14 40 % H2O in THF 
5 Zn C 5:1 22 10 % H2O in THF 
6 Zn C 1.5:1 38 25 % H2O in dioxane 
7 Zn C 1.1:1 67 25 % H2O in THF 
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The diastereomeric outcome of the allylation can be rationalized from the Felkin-Anh model and 
the Cram chelate model.100-103 Earlier Paquette and Mitzel reported minor erosion of the 
diastereoselectivity in the allylation of α-oxygenated aldehydes with indium when water was 
present and sonication was applied.104 Therefore chelation control must still be applicable. If the 
chelate model should yield the two observed diastereomers the transition state involves a high-
energy boat conformation in both cases, figure 3.2, eq. A and B. This seems unlikely. Evans et 
al. have shown that under non-chelating conditions anti-α,β-bisalkoxy aldehydes yield products 
with an anti-relationship with regard to the newly formed stereocenter and the α-alkoxy 
substituent with high selectivity.105 In accordance with this and applying the polar Felkin-Anh 
model the unwanted isomer 3.14 (setting the α-benzyloxy-substituent perpendicular to the π-face 
of the carbonyl) is favored, figure 3.2, eq. C.  
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Figure 3.2: Projections and transitions states applied to explain the diastereomeric outcome. L> M> S. 
 
As zinc was also used for the fragmentation of the aldehyde and the allylating reagent is added 
slowly there should be a large excess of Zn2+ present. By employing chelation between Zn2+ and 
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the aldehyde and the α-alkoxy-substituent the substrate would be locked in a 5-membered ring 
rendering attack possible only from the anti-Felkin face, figure 3.2, eq. D. This yields the 
desired isomer 3.13. Also uncoordinated zinc (to the α-benzyloxy-substituent) in a six-
membered transition state in a chair-conformation seems more likely. The two reasonable 
explanations clarifies, why the two products are formed in a nearly 1:1 ratio. 
 
3.6 Toward Pancratistatin 
The attention was now focused on replicating the end game toward pancratistatin by 
Danishefsky and Lee. The Overman rearrangement to 3.15 was to be performed. By applying 
the conditions optimized by Håkansson et al.28 the imidate of 3.13 was cleanly formed keeping 
the temperature below -20 ºC in the presence of DBU. Above -20 ºC extensive and fast 
decomposition was observed.  
O
O O
OOBn
OBn
OH
O
OOBn
OBn
HNi) DBU, Cl3CCN,
ii)135 ºC, 0.1 mmHg,
   21 h, neat
64 % (2 steps)
OCl3C
O
O
3.13 3.15  
Scheme 3.7: Imidate formation and Overman rearrangement. 
 
Interestingly, the imidate proved completely stable under the conditions used by Danishefsky 
and Lee, i.e. no conversion was observed when the imidate was heated to 100 ºC for 1 h under 
high vacuum (~ 0.1 mmHg). Danishefsky and Lee reported that the rearrangement was worked 
up after 1.2 h. In accordance with earlier work in our group higher temperature was required and 
increasing the temperature to 135 ºC and the reaction time to 21 h did bring about the 
rearrangement in good yield - 64 % of 3.15 over two steps in comparison to 42 % by 
Danishefsky and Lee. Following the Overman rearrangement came the dihydroxylation. As 
expected the reaction required a rather high catalyst loading to achieve a reasonable reaction rate 
as it was to take place from the concave side of the bicyclic system. Reaction times of up to 24 
days with a catalyst loading of 10 % were observed.  
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Scheme 3.8: Dihydroxylation on the concave face. 
 
The next step toward pancratistatin was the methanolysis of the lactone and the amide in 3.16 
with subsequent lactamization to afford the bisbenzylprotected pancratistatin, 3.17. Direct 
conversion of the lactone to the lactam has been achieved in refluxing methanol with K2CO3 on 
similar systems by Paulsen and Stubbe, Ohta and Kimoto, Keck et al., and Håkansson et al.28, 81, 
82, 106 
O
O O
OOBn
OBn
HN
OH
O
O NH
OOBn
OH
OBn
HO
i) K2CO3, CH3OH
ii) HOBt, DCC, 0 ºC
OCl3C
OH OH
81 %
3.16 3.17  
Scheme 3.9: Lactone to lactam reorganization. 
 
In accordance with Danishefsky and Lee the lactone to lactam reorganization was not observed 
even on prolonged reflux. Instead further activation was required and accomplished by 
Danishefsky and Lee by the addition of DCC as it was speculated that an amino acid was 
formed. The exact nature of the intermediate remains obscure. In our hands simple addition of 
DCC or DIC did not perform in comparable yields. Only by adding HOBt as a standard peptide 
coupling additive were good yields of 3.17 achieved. 
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Scheme 3.10: Deprotection to yield (+)-pancratistatin. 
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The final debenzylation was accomplished uneventfully using Pearlman’s catalyst and H2 to 
provide pancratistatin with physical data in agreement with literature.67, 73, 107 At this point a 
discrepancy between our synthesized material and reported data in regard to published 13NMR-
data. By careful 2D-NMR analysis (DQF-COSY, NOESY, gHMBC and gHSQC) it was realized 
that several groups has missassigned a single carbon-atom.71, 72, 74, 75 Our analysis showed that 
the signal from carbon 10b was located under the DMSO-d6 septet. 
In connection to the previously synthesized natural products in the Madsen group, acting as 
glucosidase inhibitors,25, 29 we decided to test whether pancratistatin and 7-deoxypancratistatin 
possess any capacity for enzyme inhibition, when tested against almond α-mannosidase, almond 
β-glucosidase and baker’s yeast α-glucosidase. Interestingly, 7-deoxypancratistatin showed 
moderate inhibition of almond β-glucosidase (Ki = 2.8 × 10-5 M), while the parent molecule 
showed no inhibition of the three enzymes. 
 
3.7 Conclusion 
An enantioselective total synthesis of (+)-pancratistatin has been achieved in 15 steps from 
the carbohydrate D-xylose bearing the chiral information to provide pancratistatin in an overall 
7.1 % yield. The longest linear sequence consists of 17 steps from commercially available 
piperonylic acid and supplies pancratistatin in an overall 7.0 % yield. The highlight of the 
synthesis consists of a tandem zinc-mediated reductive fragmentation and allylation of a 
ribofuranoside with ensuing lactonization and ring closing metathesis to intercept the first total 
synthesis of pancratistatin by Danishefsky and Lee.  
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3.8 Experimental Section  
General procedures 
See section 1.6 
 
A solution of NaClO2 (48.0 g, 0.425 mol) in H2O (400 mL) was added 
dropwise to a stirred solution of piperonal (45.04 g, 0.300 mol) in MeCN (300 
mL) containing NaH2PO4 (9.6 g, 0.080 mol) in 120 mL of H2O and 30 mL of 
35 % H2O2. The solution temperature was kept below 15 ºC by an ice-bath. After full addition 
the ice-bath was removed and the solution was stirred for another 2 h. Another 2.4 g of  
NaH2PO4 (0.020 mol) and 8.0 mL of 35 % H2O2 were added along with 12.1 g of NaClO2 
(0.134 mol) in H2O (60 mL). After 1 h another 4.0 g of NaClO2 (0.044 mol) was added and the 
slurry was stirred for 2 h, where it was quenched with 3.0 g of Na2SO3. Then 20 mL of 37 % aq. 
HCl was added and the slurry was filtered. The filtrate was extracted with 400 mL and 200 mL 
of EtOAc. The combined organic phases were dried with MgSO4, filtered and evaporated to a 
white solid. Yield 50.0 g (Q). Rf = 0.58, 1:1:0.02 EtOAc:Heptane:Acetic Acid (v/v). Mp = 225-
227 ºC. IR (KBr) ν 2918, 2560, 1671, 1617, 1452, 1298, 1260, 1113, 1036 cm-1. 1H-NMR (300 
MHz, DMSO-d6): δ 12.77 (bs, 1H), 7.54 (dd, J = 1.7, 8.1, 1H), 7.36 (d, J = 1.6, 1H), 6.99 (d, J = 
8.1, 1H), 6.12 (s, 2H). 13C-NMR (75 MHz, DMSO-d6): δ 166.6, 151.1, 147.4, 124.9, 124.6, 
108.8, 108.0, 101.9. Anal. Cald. for C8H6O4: C, 57.84; H, 3.64; Found C, 57.78; H, 3.73. 
 
Piperonylic acid (74.5 g, 0.446 mol) was suspended in SOCl2 (325 mL, 4.46 
mol) in a 1 L flask with a reflux condenser. The suspension was heated to 
reflux for 1½ h on a heating mantle and the released SO2 and HCl were passed 
into a beaker with water. It was cooled to rt and the excess SOCl2 was removed under reduced 
pressure. Then 300 mL of CH2Cl2 was added and the flask was placed on an ice-bath and 
mounted a reflux condenser. The diethylamine (185.2 mL, 1.78 mol) was added dropwise 
through the condenser and residues washed down with 50 mL of CH2Cl2. The slurry was stirred 
under Ar overnight and then washed with 3 x 1 L of 2 M aq. HCl. The organic phase was dried 
with MgSO4, filtered and concentrated in vacuo. The residue was purified by flash 
chromatography in 30-50 % EtOAc in heptane to yield 3.5: 88.6 g (90 %). Rf = 0.25, 1:1 
EtOAc:Heptane (v/v). Mp = 65-66 ºC. IR (KBr) ν 2983, 2944, 2903, 1610, 1465, 1438, 1291, 
1241, 1036 cm-1. 1H-NMR (300 MHz, CDCl3): δ 6.78-6.88 (m, 3H), 5.97 (s, 2H), 3.37 (bs, 4H), 
1.16 (bs, 6H). 13C-NMR (75 MHz, CDCl3): δ 170.6, 148.2, 147.4, 130.9, 120.4, 108.1, 107.3, 
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101.2, 43.2 (br), 40.1 (br), 13.8 (br). Anal. Calcd. for C12H15NO3: C, 65.14; H, 6.83; N, 6.33; 
Found C, 65.50; H, 6.77; N, 6.28. 
 
The amide 3.5 (40.0 g, 0.181 mol) was dissolved in THF (500 mL) in a 1 L 3-
necked flask fitted with a reflux-condenser, an addition funnel and a 
thermometer. The solution was added 30.0 mL of anhydrous TMEDA (0.199 
mol) and the mixture was cooled to -78 ºC. sBuLi (140 mL, 1.42 M in cyclohexane, 0.199 mol) 
was added dropwise from the addition funnel, the temperature not exceeding -72 ºC. The deeply 
bordeaux solution was stirred for 1 h at -78 ºC after full addition, where dry B(OMe)3 (24.3 mL, 
0.217 mol) was added and the solution warmed to 0 ºC on an ice-bath. Then acetic acid (16.8 
mL, 0.293 mol) was added followed by slow addition of H2O2 (35 %, 42 mL, 0.488 mol). The 
solution stirred overnight at ambient temperature and was concentrated in vacuo. The slurry was 
redissolved in 600 mL of CH2Cl2 and washed with 1 L of 10 % Na2S2O3. The aqueous phase 
was run through a pad of Celite and extracted with another 2 x 400 mL of CH2Cl2. The 
combined organic phases were dried with MgSO4, filtered and evaporated in vacuo: The residue 
was purified by DCVC in 20-30 % EtOAc in heptane to yield of 3.9: 40.5 g (94 %). Rf = 0.30, 
1:1 EtOAc:Heptane (v/v). Mp = 59-60.5 ºC. IR (KBr) ν 2983, 2657, 1639, 1583, 1503, 1457, 
1075, 1033, 801 cm-1. 1H-NMR (300 MHz, CDCl3): δ 10.06 (s, 1H), 6.85 (d, J = 8.3, 1H), 6.40 
(d, J = 8.3, 1H), 6.01 (s, 2H), 3.51 (q, J = 7.1, 4H), 1.26 (t, J = 7.1). 13C-NMR (75 MHz, 
CDCl3): δ 171.1, 150.7, 143.6, 135.2, 121.6, 114.2, 101.9, 99.6, 42.3, 13.3. Anal. Calcd. for 
C12H15NO4: C, 60.75; H, 6.37; N, 5.90; Found C, 60.87; H, 6.31; N, 5.89. MS [M+Na]+: calcd 
260.0899, found 260.1371. 
 
The phenol 3.9 (10.0 g, 42.2 mmol) was dissolved in CH2Cl2 (210 mL) and 
imidazole (5.74 g, 84.3 mmol) was added followed by TBSCl (7.04 g, 46.7 
mmol). The slurry was stirred overnight and run through a pad of Celite, which 
was washed with 30 mL of CH2Cl2, The organic phase was washed with 100 mL of sat. aq. 
NaHCO3 and 250 mL of H2O, dried with MgSO4, filtered and concentrated in vacuo. The yellow 
oil was purified by DCVC in ½ L 5%, ½ L 10% and ½ L 50 % EtOAc in heptane to yield 14.8 g 
of an oil, which solidifies on standing (Q). Rf = 0.47, 1:1 EtOAc:Heptane (v/v). Mp = 65 ºC. IR 
(KBr) ν 2928, 2856, 1638, 1617, 1479, 1280, 1249, 1073, 1035, 865, 838 cm-1. 1H-NMR (300 
MHz, CDCl3): δ 6.68 (d, J = 8.0, 1H), 6.50 (d, J = 8.0, 1H), 5.88-5.97 (m, 2H), 3.51(m, 2H), 
3.03-3.34 (m, 2H), 1.22 (t, J = 7.2, 3H), 1.01 (t, J = 7.1, 3H), 0.94 (s, 9H), 0.21 (s, 3H), 0.18 (s, 
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3H). 13C-NMR (75 MHz, CDCl3): δ 168.4, 148.9, 136.8, 135.3, 125.5, 120.7, 102.5, 100.9, 42.9, 
39.3, 25.6, 18.2, 14.0, 13.2, -4.5. Anal. Calcd. for C18H29NO4Si: C, 61.50; H, 8.32; N, 3.98; 
Found C, 61.69; H, 8.20; N, 4.11. MS [2M+Na]+: calcd 725.3629, found 725.3617. 
 
N,N-Diethyl-4-(tert-butyldimethylsiloxy)-benzo[1,3]dioxole-5-carboxamide 
(1.00 g, 2.85 mmol) was dissolved in THF (14.0 mL) and TMEDA (0.47 mL, 
3.13 mmol) was added. The solution was cooled to -78 ºC and sBuLi (2.30 mL, 
1.36 M in cyclohexane, 3.13 mmol) was added dropwise. The solution was stirred 2 h at -78 ºC 
after full addition at which point it had become yellow. Then I2 (0.870 g in 3.4 mL THF) was 
added dropwise and the cooling bath was removed. The solution warmed up to rt after full 
addition, where it was poured into 100 mL of H2O and 50 mL of sat. aq. Na2S2O3 was added. 
Extraction with 3 x 50 mL of EtOAc. The combined organic phases were dried with MgSO4, 
filtered and concentrated in vacuo. The residue was purified by flash chromatography in 15 % 
EtOAc in heptane to yield 1.20 g (88 %). Rf = 0.47, 3:7 EtOAc:Heptane (v/v). Mp = 66-67 ºC. 
IR (KBr) ν 2932, 2860, 1624, 1465, 1410, 1287, 1266, 1094, 1037, 874, 841 cm-1. 1H-NMR 
(300 MHz, CDCl3): δ 6.92 (s, 1H), 5.95 (d, J = 1.4, 1H), 5.92 (d, J = 1.4, 1H), 3.78-3.92 (m, 
1H), 3.08-3.25 (m, 3H), 1.26 (t, J = 7.1, 3H), 1.11 (t, J = 7.2, 3H), 0.93 (s, 9H), 0.22 (s, 3H), 
0.18 (s, 3H). 13C-NMR (75 MHz, CDCl3): δ 167.4, 149.3, 137.5, 135.9, 130.5, 112.5, 101.4, 
82.2, 43.0, 39.3, 25.5, 18.2, 13.8, 12.6, -4.2, -4.7. Anal. Calcd. for C18H28INO4Si: C, 45.28; H, 
5.91; N, 2.93; Found C, 45.46; H, 5.87; N, 2.84. MS [2M+Na]+: calcd 977.1562, found 
977.1856. 
 
 N,N-Diethyl-4-(tert-butyldimethylsiloxy)-6-iodo-benzo[1,3]dioxole-5-carbox-
amide (12.30 g, 25.8 mmol) was dissolved in CH3CN (129 mL) and Na2HPO4 
(5.49 g, 38.7 mmol) and Me3OBF4 (11.44 g, 77.3 mmol) were added in one 
portion. The suspension was stirred for 3½ h and slowly added 161 mL of sat. aq. NaHCO3 from 
addition funnel under vigorous stirring followed by solid NaHCO3 (10.82 g, 128.8 mmol). The 
slurry was stirred at ambient temperature for 15 h, poured into 500 mL of H2O and extracted 
with 3 x 200 mL of EtOAc. The combined organic phases were dried with MgSO4, filtered and 
evaporated in vacuo. The residue was dissolved in 100 mL of CH2Cl2 and run through a short 
column of silica (packed in CH2Cl2) and the solvent was evaporated to yield 7.867 g (95 %) of 
the ester. Rf = 0.30, 3:7 EtOAc:Heptane (v/v). Mp = 159-160 ºC. IR (KBr) ν 3006, 2947, 1666, 
1503, 1490, 1340, 1301, 1194, 1081, 1036, 986 cm-1. 1H-NMR (300 MHz, CDCl3): δ 11.00 (s, 
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1H), 7.19 (s, 1H), 6.07 (s,2H), 3.96 (s, 3H). 13C-NMR (75 MHz, CDCl3): δ 168.7, 152.6, 146.8, 
135.6, 115.4, 112.4, 102.9, 84.6, 51.9. Anal. Calcd. for C9H7IO5: C, 33.56; H, 2.19; Found C, 
33.43; H, 2.13. HRMS [M+Na]+: calcd 344.9230, found 344.9232. 
 
Methyl 4-hydroxy-6-iodo-benzo[1,3]dioxole-5-carboxylate (19.0 g, 59.0 
mmol) was dissolved in DMF (500 mL) and cooled to 0 ºC. Then NaH (4.0 g, 
55-65 % in mineral oil, 88.5 mmol) was added in small portions and the 
suspension was stirred for 20 min. followed by addition of BnBr (14.0 mL, 118 mmol). The 
solution stirred at ambient temperature overnight, quenched with H2O and poured into 500 mL 
of Et2O, which was washed with 4 x 1 L of H2O. The combined aqueous phases were extracted 
with 2 x 500 mL of Et2O and the organic phases were combined and coevaporated in vacuo with 
toluene. The residue was purified by DCVC in 10 % EtOAc in heptane to yield 3.10: 24.3 g (Q). 
Rf = 0.42, 3:7 EtOAc:Heptane (v/v). Mp = 106-107 ºC. IR (KBr) ν 3029, 2948, 2912, 1727, 
1617, 1466, 1374, 1346, 1271, 1134, 1088, 1037 cm-1. 1H-NMR (300 MHz, CDCl3): δ 7.28-
7.39(m, 5H), 6.96(s, 1H), 5.97(s, 2H), 5.24(s, 2H), 3.87(s, 3H). 13C-NMR (75 MHz, CDCl3): δ 
167.4, 150.7, 139.9, 137.4, 136.4, 128.4, 128.2, 127.9, 127.8, 113.4, 101.9, 81.0, 74.3, 52.7. 
Anal. Calcd. for C16H13IO5: C, 46.62; H, 3.18; Found C, 46.48; H, 3.11. MS [M+Na]+: calcd 
434.9705, found 434.9466. 
 
The iodide 3.10 (1.00 g, 2.43 mmol) was dissolved in DMF (10 mL) and 
degassed by sonication. Then NBu3 (2.9 mL, 12.1 mmol), acrylic acid (0.50 
mL 7.28 mmol), Bu4NI (0.896 g, 2.43 mmol) and Pd(OAc)2 (11.0 mg, 49 
μmol, 2 mol%) were added successively. The solution was heated to 100 ºC for 2½ h and then 
poured into 100 mL of 1 M HCl and 50 mL of EtOAc. The flask was washed with 50 mL of 
EtOAc. Further extraction with 2 x 100 mL of EtOAc was performed. The combined organic 
phases were dried with MgSO4, filtered and concentrated in vacuo. The residue was purified by 
flash chromatography in 50 % EtOAc in heptane with 1 % AcOH to yield 0.861 g of 3.11 as a 
white solid (Q). Rf = 0.21, 1:1:0.01 EtOAc:Heptane:AcOH (v/v). Mp = 185-187 ºC. IR (KBr) ν 
3300-2700, 2675, 1731, 1680, 1628, 1602, 1480, 1430, 1381, 1290, 1265, 1217, 1088, 1034 cm-
1. 1H-NMR (300 MHz, CDCl3): δ 7.67 (d, J = 15.8, 1H), 7.29-7.43 (m, 5H), 6.86 (s, 1H), 6.26 
(d, J = 15.7, 1H), 6.04 (s, 2H), 5.25 (s, 2H), 3.89 (s, 3H). 13C-NMR (75 MHz, CDCl3): δ 171.6, 
166.7, 150.5, 142.9, 139.4, 138.7, 136.4, 128.3, 128.1, 127.8, 127.0, 123.7, 118.4, 102.0, 100.7, 
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74.2, 52.6. Anal. Calcd. for C19H16O7: C, 64.04; H, 4.53; Found C, 63.83; H, 4.62. HRMS 
(ESP+) [M+H]+: calcd 357.0974, found 357.0980. 
 
The carboxylic acid 3.11 (9.369 g, 26.3 mmol) was dissolved in THF (98 
mL) and cooled to -6 ºC, where NEt3 (4.8 mL, 34.2 mmol) was added. Then 
ethyl chloroformate (3.0 mL, 31.6 mmol) was added dropwise and the 
slurry was stirred for 2 h at -5 to -2 ºC. The slurry was filtered and the solid residue was washed 
with 120 mL of THF. To this solution was added 16 mL of H2O and it was cooled to 0 ºC, 
where NaBH4 (34.2 mL 2 M in triglyme, 68.4 mmol) was added dropwise not exceeding 1 ºC. 
The solution was stirred for 2½ h at 0 ºC. The reaction was quenched with 55 mL of 1 M HCl 
and the THF was removed in vacuo. The residue was poured into 95 mL of 1 M HCl and 
extracted with 400 mL of toluene. The aqueous phase was extracted with another 200 mL of 
toluene. The combined organic phases were washed 4 x 500 mL of H2O and the organic phase 
was evaporated in vacuo to yield 8.579 g of the allyl alcohol (95 %). Rf = 0.20, 1:1 
EtOAc:Heptane (v/v). Mp = 88 ºC. IR (KBr) ν 3400-3100, 3008, 2896, 2850, 1727, 1611, 1483, 
1472, 1428, 1375, 1292, 1247, 1142, 1079, 1031 cm-1. 1H-NMR (300 MHz, CDCl3): δ 7.29-7.42 
(m, 5H), 6.74 (s, 1H), 6.51 (dt, J = 1.5, 15.6, 1H), 6.19 (dt, J = 5.6, 15.7, 1H), 5.97 (s, 2H), 5.23 
(s, 2H), 4.25 (dd, J = 1.1, 5.6, 2H), 3.83 (s, 3H). 13C-NMR (75 MHz, CDCl3): δ 167.8, 150.3, 
139.2, 136.8, 136.2, 130.5, 129.9, 128.3, 128.1, 127.8, 127.0, 120.8, 101.6, 100.2, 74.1, 63.5, 
52.4. Anal. Calcd. for C19H18O6: C, 66.66; H, 5.30; Found C, 66.29; H, 5.21. HRMS (ESP+) 
[M+H]+: calcd 343.1176, found 343.1163. 
 
Methyl 4-(benzyloxy)-6-((E)-3-hydroxyprop-1-enyl)-benzo[1,3]dioxole-5-
carboxylate (2.716 g, 7.93 mmol) was dissolved in THF (30.0 mL), and 
NEt3 (1.8 mL, 12.9 mmol) and LiBr (2.02 g, 23.3 mmol) were added. The 
solution was cooled to -40 ºC and Ms2O (2.08 g, 11.9 mmol) was added. The suspension 
warmed to rt – the cooling bath was removed at -10 ºC. The reaction was quenched with 50 mL 
of 4.8 % HBr and 50 mL of EtOAc was added followed by phase separation. The aqueous layer 
was extracted with another 3 x 30 mL of EtOAc after phase-separation. The combined organic 
phases were dried with MgSO4, filtered and concentrated in vacuo. The slightly yellow oil was 
purified by flash chromatography in 25 % EtOAc in heptane to yield 2.973 g of 3.1 as a white 
solid, which is unstable on dry SiO2 (93 %). Rf = 0.58, 1:1 EtOAc:Heptane (v/v). Mp = 69.5-71 
ºC. IR (KBr) ν 3026, 2968, 2894, 1722, 1607, 1497, 1477, 1380, 1290, 1259, 1195, 1146, 1095, 
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1030 cm-1. 1H-NMR (300 MHz, CDCl3): δ 7.28-7.40 (m, 5H), 6.76 (s, 1H), 6.56 (d, J = 15.4, 
1H), 6.24 (dt, J = 7.8, 15.4, 1H), 5.98 (s, 2H), 5.24 (s, 2H), 4.09 (dd, J = 0.9, 7.8, 2H), 3.85 (s, 
3H). 13C-NMR (75 MHz, CDCl3): δ 167.4, 150.4, 139.3, 136.8, 136.7, 130.4, 128.9, 128.4, 
128.1, 127.8, 126.8, 121.2, 101.7, 100.3, 74.1, 52.4, 33.0. Anal. Calcd. for C19H17BrO5: C, 
56.31; H, 4.23; Found C, 56.10; H, 4.13. MS (ESP+) [M+H]+: calcd 405.0338, found 405.0362. 
 
The iodide 3.12 (1.0036 g, 2.10 mmol) was dissolved in anh. THF (30 mL) 
in a 100 mL conical flask and water (10 mL) was added. After addition of 
Zn* (1.371 g, 21.0 mmol) the slurry was sonicated from 22 to 45 ºC, while 
the allylating reagent 3.1 (1.271 g, 3.14 mmol) in anh. THF (10 mL) was added by syringe 
plunger over 5 h. After full addition the mixture was sonicated for another 2 h and filtered 
through a pad of Celite, which was washed with 3 x 20 mL of EtOAc. Then 50 mL of 20 % 
NH4Cl was added and the aqueous phase was extracted with another 3 x 20 mL of EtOAc. The 
combined organic phases were dried with MgSO4, filtered and concentrated in vacuo. The 
residue was redissolved in MeOH (50 mL) and stirred with Amberlite IR-120 overnight. It was 
filtered and the beads were washed with acetone and the filtrate was concentrated in vacuo with 
toluene (2 x 10 mL). This residue was dissolved in anh. CH3CN (25 mL), K2CO3 (1.037 g, 7.50 
mmol) was added and the mixture was refluxed for 1½ h. The slurry was diluted with CH2Cl2 
(30 mL) and poured into 100 mL of 20 % NH4Cl after cooling. Extraction with CH2Cl2 (3 x 20 
mL). The combined organic phases were dried with MgSO4, filtered and concentrated in vacuo. 
The final residue was dissolved in anh. CH2Cl2 (25 mL), degassed by sonication and Ar-purge 
and Hoveyda-Grubbs 2nd gen. catalyst (37.7 mg, 60.2 μmol) was added. The solution was 
refluxed for 1½ h under Ar after which it was concentrated in vacuo and purified by flash 
chromatography in 40-60 % EtOAc in heptane with a 5 % interval-gradient to yield  345 mg (35 
%) of the desired 3.13 and 318 mg (32 %) of 3.14 as white foams, combined yield (67 %). Rf = 
0.24, 1:1 EtOAc:Heptane (v/v), IR (KBr) ν 3600-3170, 3026, 2913, 1718, 1610, 1472, 1369 
1262, 1184, 1118, 1046, 933, 733, 697 cm-1. [α] 23D  - 113.6 (c 1.07, CHCl3). 
1H-NMR (500 MHz, 
CDCl3): δ 7.27-7.56 (m , 10H), 6.50 (s, 1H), 6.04 (d, J = 1.1, 1H), 5.99 (d, J = 1.1, 1H), 5.71-
5.76 (m, 1H), 5.44-5.48 (m, 1H), 5.34 (d, J = 11.4, 1H), 5.29 (d, J = 11.3, 1H), 4.69-4.76 (m, 
3H), 4.51-4.56 (m, 1H), 4.09-4.15 (m, 1H), 3.53-3.57 (m, 1H), 2.45 (d, J = 11.0, 1H). 13C-NMR 
(75 MHz, CDCl3): δ 160.2, 153.3, 143.9, 138.9, 138.0, 137.2, 136.7, 129.8, 128.7, 128.3, 128.0, 
125.8, 111.5, 102.5, 102.0, 74.8, 74.5, 74.1, 73.9, 64.7, 35.4. HRMS calcd. for C28H24NaO7 
[M+Na]+: calcd 495.1415, found 495.1414. 
O
O O
OOBn
OBn
OH
Total Synthesis of Pancratistatin 
 52 
 
3.14: Rf  = 0.08, 1:1 EtOAc: Heptane (v/v). 1H-NMR (300 MHz, CDCl3): δ 
7.24-7.55 (m, 10H), 6.46 (s, 1H), 6.01-6.08 (m, 1H), 6.01(d, J = 1.2, 1H), 
5.97 (d, J = 1.2, 1H), 5.44 (d, J = 9.9, 1H), 5.29 (s, 2H), 4.89 (d, J = 12.0, 
1H), 4.83-4.86 (m, 1H), 4.67 (d, J = 12.0, 1H), 4.39 (m, 1H), 3.66 (dd, J = 1.6, 5.2, 1H), 3.36 (br 
s, 1H), 2.99 (d, J = 10.1, 1H). 13C-NMR (75 MHz, CDCl3): δ 159.6, 153.3, 143.8, 138.0, 137.9, 
137.7, 136.7, 129.5, 128.4, 128.2, 127.9, 127.8, 127.7, 124.8, 111.3, 102.0, 101.9, 75.6, 74.3, 
74.1, 69.9, 63.2, 40.0. HRMS calcd. for C28H24NaO7 [M+Na]+: calcd 495.1415, found 495.1409. 
 
The alcohol 3.13 (0.2912 g, 0.616 mmol) was dissolved in anh. CH2Cl2 
(5.0 mL) under Ar and cooled to -42 ºC, where Cl3CCN (0.31 mL, 3.09 
mmol) was added followed by dropwise addition of DBU (0.15 mL, 1.00 
mmol). The solution warmed to -20 ºC where it was quenched with 30 mL 
of 20 % NH4Cl. After phase-separation the aqueous phase was extracted with CH2Cl2 (3 x 10 
mL). The combined organic phases were dried with MgSO4, filtered and concentrated in vacuo. 
The residue was purified by flash chromatography in 20 % EtOAc in heptane to yield 0.3729 g 
(98 %) of a white foam. The imidate (0.2563 g, 0.416 mmol) was heated neat to 135 ºC in an oil 
bath under high vacuum (~ 0.1 mmHg) for 21 h. The vacuum was released and the black tar was 
dissolved in toluene after cooling and purified by flash chromatography in 20 % EtOAc in 
heptane to yield 166.9 mg (65 %) of 3.15 as a white solid. (64 % - two steps). Rf = 0.46, 1:1 
EtOAc:Heptane (v/v). Decomposes > 145 ºC (lit. 186-187 ºC). IR (neat) ν 3307, 3031, 2909, 
2872, 1701, 1615, 1478, 1305, 1264, 1246, 1088, 1053, 818 cm-1. [α] 21D  -30.0 (c 1.0, CHCl3). 
1H-NMR (500 MHz, CDCl3): δ 7.28-7.55 (m, 10H), 6.80 (d, J = 9.2, 1H), 6.44 (s, 1H), 6.03 (m, 
1H), 6.00 (d, J =1.4, 1H), 5.93 (d, J = 1.3, 1H), 5.88 (dd, J = 1.6, 10.2, 1H), 5.38 (d, J = 11.4, 
1H), 5.32 (d, J = 11.3, 1H), 4.64-4.69 (m, 2H), 4.62 (d, J =11.7, 1H), 4.42-4.48 (m, 1H), 4.06-
4.10 (m, 1H), 3.04 (dd, J = 2.4, 9.9, 1H). 13C-NMR (75 MHz, CDCl3): δ 161.4, 160.8, 152.8, 
144.6, 138.5, 137.9, 137.2, 136.7, 130.8, 128.6, 128.3, 128.1, 128.0, 127.8, 126.5, 111.1, 103.2, 
102.1, 92.3, 75.4, 74.5, 72.2, 70.7, 50.2, 38.9. HRMS calcd. for C30H24Cl3NNaO7 [M+Na]+: 
calcd 638.0511, found 638.0486. 
 
The alkene 3.15 (163.3 mg, 0.265 mmol) was dissolved in THF (2.65 mL) 
followed by addition of NMO (68.0 mg, 0.581 mmol), H2O (0.2 mL) and 
OsO4 (18.4 mg, 72.4 μmol). The solution was stirred in a sealed flask for 
123 h at rt and then poured into 20 mL of 10 % Na2SO3 and 5 mL of 
O
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EtOAc. Extraction with EtOAc (3 x 10 mL). The combined organic phases were dried with 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash chromatography 
in 2-4 % CH3OH in CH2Cl2 to yield the white solid 3.16 (161.7 mg, 94 %). Rf = 0.10, 1:1 
EtOAc:Heptane (v/v). Mp = 201-202 ºC (lit. 202-206 ºC). IR (KBr) ν 3600-3150, 3025, 2923, 
1713, 1701, 1610, 1472, 1374, 1297, 1256, 1092 cm-1. [α] 21D  + 30.0 (c 1.0, DMSO). 
1H-NMR 
(500 MHz, CDCl3 + 2 drops CD3OD): δ 7.24-7.48 (m, 10H), 6.43 (s, 1H), 5.96 (d, J = 1.1, 1H), 
5.85 (d, J = 1.0, 1H), 5.32 (d, J = 11.4, 1H), 5.26 (d, J = 11.4, 1H), 4.64 (d, J = 11.7, 1H), 4.55-
4.59 (m, 2H), 4.22-4.25 (m, 1H), 4.14 (dd, J = 3.1, 10.7, 1H), 4.02 (t, J = 2.7, 1H), 3.97 (t, J = 
11.1, 1H), 3.34 (dd, J = 2.7, 11.4, 1H). 13C-NMR (75 MHz, CDCl3+ 2 drops CD3OD): δ 162.7, 
161.0, 152.9, 143.9, 138.2, 137.0, 136.8, 136.6, 128.4, 128.2, 128.0, 127.9, 127.8, 127.6, 110.7, 
104.2, 102.0, 92.5, 76.3, 75.8, 74.4, 72.7, 70.7, 69.1, 52.0, 39.5. HRMS calcd. for 
C30H26Cl3NNaO9 [M+Na]+: calcd 672.0565, found 672.0540. 
 
The lactone 3.16 (112.2 mg, 0.172 mmol) and K2CO3 (239.2 mg, 1.731 
mmol) were suspended in 7.0 mL of anh. 5:2 CH3OH:CH2Cl2 and refluxed 
under Ar overnight. The suspension was carefully neutralized with 
Amberlite IR-120 after cooling. The beads were filtered off, washed with 
1:1 CH3OH:CH2Cl2 and the solvent was removed in vacuo. The residue was redissolved in 8.0 
mL of CH2Cl2, HOBt (55.5 mg, 0.411 mmol)  was added and the mixture cooled to -5 ºC under 
Ar. Then DCC (43.2 mg, 0.209 mmol) was added and the solution stirred for 5 min. before the 
cooling bath was removed and it warmed to rt over 1 h. The solvent was removed in vacuo and 
the residue was purified by flash chromatography in 1-4 % CH3OH in CH2Cl2 in 1 % intervals 
to afford 71.0 mg of 3.17 as a white solid (81 %). Rf = 0.4, 1:19 MeOH: CH2Cl2 (v/v). Mp = 93-
94 ºC (lit. 98-100 ºC). IR (neat) ν 3500-3200, 2904, 1644, 1612, 1475, 1453, 1366, 1335, 1285, 
1218, 1069, 1030, 730 cm-1. [α] 21D  + 52.0 (c 1.0, CHCl3 ). 
1H-NMR (500 MHz, CDCl3): δ 8.03 
(s, 1H), 7.23-7.54 (m, 10H), 6.66 (s, 1H), 5.95 (d, J = 1.5, 1H), 5.94 (d, J = 1.5, 1H), 5.27 (d, J = 
11.2, 1H), 5.23 (d, J = 11.3, 1H), 4.98 (br s, 1H), 4.64 (d, J = 11.8, 1H), 4.59 (d, J = 11.8, 1H), 
4.45 (br s, 1H), 4.25 (br s, 1H), 4.05 (t, J = 3.0, 1H), 3.99 (m, 2H), 3.82 (dd, J = 10.1, 13.0, 1H), 
3.10 (d, J = 13.1, 1H). 13C-NMR (75 MHz, CDCl3): δ 165.4, 152.0, 143.1, 137.6, 137.5, 136.9, 
136.5, 128.5, 128.4, 128.3, 128.0, 127.9, 127.5, 116.2, 101.7, 101.1, 76.7, 74.9, 72.4, 71.4, 71.0, 
67.6, 49.9, 41.5. HRMS calcd. for C28H27NNaO8 [M+Na]+: calcd 528.1630, found 528.1621. 
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Pancratistatin: The dibenzylether 3.17 (34.2 mg, 67.7 μmol) was 
dissolved in 2.0 mL of EtOAc, Pd(OH)2/C (104 mg) was added and the 
mixture was degassed. The suspension was stirred, while bubbling through 
H2 for 2 h – 1.0 mL of EtOAc was added after 1½ h and stirred for another 
2 h under an H2-atmosphere. It was filtered through a small plug of Celite, which was washed 
with 40 % CH3OH in CH2Cl2. The solvent was removed in vacuo to afford 22.0 mg of an off-
white solid (99 %). Rf = 0.24, 1:9 MeOH:CH2Cl2 (v/v). Decomposes > 250 ºC. IR (neat) ν 3348, 
2926, 1671, 1615, 1597, 1462, 1416, 1347, 1296, 1228, 1082, 1065, 1036, 876 cm-1. [α] 21D + 37 
(c 1.0, DMSO). 1H-NMR (500 MHz, DMSO-d6): δ 13.06 (s, 1H), 7.50 (s, 1H), 6.49 (s, 1H), 
6.06 (s, 1H), 6.04 (s, 1H), 5.36 (d, J = 4.0, 1H), 5.08 (d, J = 5.8, 1H), 5.05 (d, J = 6.1, 1H), 4.83 
(d, J = 7.5, 1H), 4.28 (m, 1H), 3.97 (m, 1H), 3.85 (m, 1H), 3.67-3.74 (m, 2H), 2.97 (br d, J 
=11.8, 1H). 13C-NMR (75 MHz, DMSO-d6): δ 169.4, 152.0, 145.3, 135.6, 131.6, 107.4, 101.7, 
97.6, 73.2, 70.1, 69.9, 68.4, 50.4, 39.5. HRMS calcd. for C14H16NO8 [M+H]+: calcd 326.0870, 
found 326.0864. Pancratistatin can be recovered unchanged from DMSO by distilling off the 
DMSO at reduced pressure (< 10 mbar) into a Heckmann device at 100 ºC (oil bath). 
Pancratistatin is precipitated from the residue by dilution with CH2Cl2 and shortly sonicated. It 
is then purified and isolated by repeating circles of centrifuging, decanting and wash with 
CH2Cl2. 
 
Compound previously prepared by Khaldi et al.108 
Slightly yellow solid, Mp =  58-59 ºC. 1H-NMR (300 MHz, CDCl3): δ 6.66 (d, 
J = 8.0, 1H), 6.52 (d, J = 8.0, 1H), 5.94 (s, 2H), 3.97 (s, 3H), 3.39-3.65 (br m, 
2H), 3.17 (q, J = 7.1, 2H), 1.21 (t, J = 7.1, 3H), 1.03 (t, J = 7.1, 3H). 13C-NMR (75 MHz, 
CDCl3): 168.0, 149.5, 139.6, 136.2, 124.1, 120.3, 102.9, 101.0, 59.9, 42.8, 38.8, 13.9, 12.7. IR 
(neat) ν 2977, 2938, 1608, 1425, 1284, 1254, 1221, 1068, 1038 cm-1. GC-MS [M]+: 251.1. 
 
Slightly yellow solid, Mp =  83-84 ºC. 1H-NMR (300 MHz, CDCl3): δ 6.94 (s, 
1H), 5.96 (d, J = 1.4, 1H), 5.94 (d, J = 1.4, 1H), 3.96 (s, 3H), 3.72-3.85 (m, 
1H), 3.26-3.40 (m, 1H), 3.15 (q, J = 7.2, 2H), 1.25 (t, J = 7.2, 3H), 1.10 (t, J = 
7.2, 3H).13C-NMR (75 MHz, CDCl3): δ 167.3, 150.0, 140.2, 137.9, 129.1, 113.0, 101.6, 82.1, 
60.1, 42.7, 38.7, 13.7, 12.3. IR (neat) ν 2980, 2939, 1608, 1425, 1279, 1250, 1221, 1101, 1034 
cm-1. 
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4 Total Synthesis of Cavicularin 
4.1 Introduction 
Cyclophanes have been known for a long time and are often found in Nature.109, 110 (A 
cyclophane consists of at least one aromatic system in which two non-adjacent positions are 
connected by another ring-system). Only rarely has Nature provided examples of these 
cyclophanes in which an aromatic ring is bent and the aromaticity is retained.111 Bisbibenzyl 
compounds - like cavicularin - are often build up from two units of lunularin, which can be 
combined in several ways to yield an array of structurally different motifs (figure 4.1).112 The 
cyclophane cavicularin comprises the structurally more intriguing representative within the class 
because the macrocyclic core contains a bent aromatic moiety.113 The high strain derived from 
the cyclic array increases the atropisomerism around the biaryl axis and guarantees the 
configurational stability. Hence, the compound exhibits planar and axial chirality, which is not 
derived from a stereogenic isolated moiety like an asymmetric carbon-atom. The isolation of 
enantiopure (+)-cavicularin demonstrates that a biosynthetic route toward the compound must 
exist. 
HO
OH
Lunularin
OH
O
HO
HO
N
HO
HO
H
HO
HO
R = H,    Haouamine A
R = OH, Haouamine B
R
Cavicularin
 
Figure 4.1: Strained para-cyclophanes and lunularin 
 
Indeed, cavicularin and the haouamines could only be isolated because of their inherent lack of 
reactivity elsewhere in the molecules. The strained aromatic ring in cavicularin is bent 15º out of 
plane, while the haouamines are bent approximately 27º out of plane.113, 114 In 2005 Harrowven, 
Woodcock and Howes were the first to complete the synthesis of racemic cavicularin and 
thereby also presenting the first example of a synthetic route to a bent para-cyclophane (scheme 
4.1). Harrowven et al. completed the synthesis by a macrocyclic, radical ring contraction – 
presumably this represents a biomimetic approach to the natural compound.113, 115, 116 
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Riccardin C
1
:
2
 
Scheme 4.1: Endgame toward cavicularin by Harrowven, Woodcock and Howes. 
 
In 2006, Baran and Burns completed the synthesis of the other example of a bent aromatic para-
cyclophane, haouamine A.117 In their studies toward haouamine A, several standard approaches 
completely failed to furnish the target. Eventually, a pyrone-alkyne Diels-Alder with extrusion 
of CO2 was successfully implemented although in low yield (scheme 4.2).  
 
N
AcO
AcO
H
AcO
N
HO
HO
H
HO
HO
O
O
AcO
N
AcO
AcO
H
AcO
O
O
AcO
-CO2
microwave: 
250 ºC, 10 h, 
7.7 eq. BHT, 
1 mM in DCB
then K2CO3, MeOH
21 % (+ 30 % SM)
Haouamine A  
Scheme 4.2: Endgame toward haouamine A by Burns and Baran. 
 
The low yield was ascribed to decomposition under the prolonged heating at 250 ºC because of 
the electron-rich moieties in the molecule, especially the indeno-tetrahydropyridine ring system 
(a similar approach to haouamine B possessing an additional phenol failed). In the ongoing 
studies to improve this critical macrocyclization, the synthesis of cavicularin was perceived as a 
suitable testing ground for improving the reaction due to its similarity to the haouamines, i.e. 
phenolic appendages, but without the tetrahydropyridine.  
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4.2 Retrosynthetic Analysis 
The synthesis of cavicularin was undertaken with the requirement that the bent aromatic ring 
should be produced in a similar manner as haouamine A – a pyrone-alkyne Diels-Alder 
cyclization with CO2-extrusion and cycloreversion leading to a bend aromatic moiety. 
 
OMe
O
MeO
MeO
O O
OH
O
HO
HO
Cavicularin
COOH
MeO
O O
Cl OH
OHHO
COOMe
MeO
OH
Michael addition
Suzuki
coupling
Wittig olefination
Heck coupling
I
A
B
C
B
C
D
D
 
Figure 4.2: Retrosynthetic analysis of cavicularin 
 
The precursor I for this cyclization was planned to arise from a Michael addition of a phenol 
from ring D to the pyrone and connecting the alkyne residue by means of a Suzuki cross 
coupling between ring B and C. In turn this leaves a dihydrophenanthrene, which was 
envisioned to be assembled by a Wittig olefination to obtain the two-carbon link between the 
aromatic rings between ring C and D. The aryl-aryl bond (C to D) in the phenanthrene could 
arise from a Heck-type direct arylation between an aromatic bromide and the other aromatic 
ring. 
 
4.3 Results & Discussion 
The first task was to synthesize the substrates for the Wittig coupling. The aldehyde 
coupling partner for the Wittig olefination was easily produced according to a literature 
procedure (scheme 4.3) from methyl gallate, 4.1.118 Differentiated protection of the most acidic 
phenol first, protection of the two other phenols followed by full reduction of the ester and 
finally oxidation to an aldehyde delivered the carbonyl coupling partner 4.3. 
 
i) MeI, NaH, 
    DMF, 50 %
ii) TBSCl, DMF, 
    Imid., 99 %
i) LAH, THF, 95 %
ii) PCC, DCM,
    Celite, 88 %
OH
OHHO
COOMe
OMe
OTBSTBSO
COOMe
OMe
OTBSTBSO
O
4.34.24.1  
Scheme 4.3: Synthesis of the Wittig coupling partner. 
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It was attempted to synthesize the desired phosphonium salt 4.4 in three steps employing 
bromination conditions, which would override the propensity to halogenate the 4-position by 
normal electrophilic aromatic substitution, scheme 4.4. 
 
R1
OMe
OH
i) I2, PPh3, DCM, 86 %
ii) PPh3, PhMe, 
    reflux, 90 %
OMe
OH
R2
R1 = Br, R2 = H, 4.4
(desired and not formed)
R1 = H, R2 = Br, 4.5
(undesired and formed)
NaBrO3, Na2S2O5, 
1:1 CH3CN:H2O
 93 %
OMe
PPh3,I
Br 4.6
4
6
1
 
Scheme 4.4: Attempted synthesis of the Wittig coupling partner, 4.4. 
 
The bromination could be performed regioselectively by a reported procedure: in situ reduction 
of sodium bromate to hypobromous acid would enable coordination to the ring oxygen and 
subsequently deliver the bromide ortho to the methoxy-group (scheme 4.4).119, 120 Later in the 
synthetic work, it became apparent that this bromination did not brominate the 6-position as 
confirmed by X-ray crystallography (Figure 4.3). 
  
Figure 4.3: X-ray structure of the product from the bromination, compound 4.5. 
 
At this stage it was not realized that the regioselectivity was wrong, and the synthesis was 
carried on with the faulty bromination. The structures will nevertheless from now on be 
presented in their actual form rather than their desired one.  
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Iodination under Garegg conditions followed by reaction with triphenylphosphine delivered the 
phosphonium salt 4.6 (scheme 4.4).121 The Wittig reaction122, 123 was conducted under standard 
conditions producing a 1:1 mixture of E and Z stilbenes (scheme 4.5). Initial studies on the 
reduction of these alkenes with palladium led to extensive dehalogenation. Fortunately, Pt/C 
proved to be a suitable catalyst for the hydrogenation under moderate pressures and produced 
the arylhalide 4.7 for the Suzuki cross coupling quantitatively. 
 
OMe
PPh3,I
TBSO
OMe
OTBS
O
tBuOK, THF
ii) 40 bar H2, Pt/C
Q (2 steps)
i)
Br
TBSO
OMe
OTBS
OMe
Br
4.6
4.74.3  
Scheme 4.5: Synthesis of the arylbromide. 
 
A sequence to the boron-containing coupling partner 4.10 was developed for the Suzuki cross 
coupling, scheme 4.6.124, 125 3-(3-Methoxyphenyl)propanoic acid was brominated exclusively in 
the 4-position. The aldehyde 4.9 - obtained by full reduction of the carboxylic acid followed by 
TEMPO-mediated oxidation with bleach - was protected as its ethylene glycol acetal. After 
halogen-lithium exchange at low temperature and borolane quench, the boronic ester 4.10 was 
produced in excellent yield. 
B
OMe
OO
OMe
COOH
O O
i) Br2, CH2Cl2, 0 ºC, 98 %
ii) LAH, THF, 0 ºC, 93%
iii) TEMPO, NaOCl, 
    KBr, 93 %
B
O
O
OiPr
   PhCH3, reflux, 97 %
ii) nBuLi, -78 ºC, THF, 92 %
OMe
O
Br
HO
OH, PPTSi)
4.8 4.9 4.10
 
Scheme 4.6: Synthesis of the boronic ester. 
 
Although this protocol was a bit lengthy for accessing the coupling substrate 4.10, the sequence 
did not require chromatographic purification in any of the five steps. With both multigram 
quantities of the boronic ester 4.10 and the aryl bromide 4.7 in hand the stage was set for the 
Suzuki cross coupling, scheme 4.7.  
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TBSO
OMe
OTBS
OMe
Br
i) PdCl2(dppf), 2 M NaOH, 
   DME, 80 ºC, 4.10, 75 %
ii) TBAF, THF, 0 ºC, 93 %
iii) NBS, THF, 0 ºC, Q.
OMe
OO
OMe
OH
OMe
OH
Br
4.7 4.11  
Scheme 4.7: Synthesis of the substrate for intramolecular Heck-type direct arylation. 
 
Optimal conditions for the cross coupling was found to include PdCl2(dppf) as the pre-
catalyst in combination with a 1:1.3:1.3 ratio between arylbromide, boronic ester and aqueous 
base in ethereal solvent. Desilylation with TBAF and regioselective bromination of the electron-
rich biphenol was achieved without event. In contrast to the ease by which compound 4.11 was 
synthesized, performing the direct arylation with a multitude of different conditions for Heck-
type couplings only resulted in failure i.e. debromination and decomposition (scheme 4.8).126  
The TBS-, Ac- and Piv-protected derivatives of 4.11 also failed to undergo the direct arylation.  
Due to the electron-richness of the aromatic rings (ring C and D) it was tried to induce the 
formation of the aryl-aryl bond by photochemical means i.e. the Witkop coupling (hν, 
epichlorohydrin, LiOAc),127, 128 however this approach also failed.  
Finally, it was attempted to construct the ring C to D aryl-aryl bond with hypervalent iodine 
i.e. PIFA. After the failure of this approach the synthesis was carried on without having installed 
the aryl-aryl bond. The aim was now to install the ring C to D bond at a late stage. If  the desired 
connectivity had been present in 4.11 (shown in compound 4.11a, scheme 4.8), the 
transformation might have been successful. Although it was realized that any metal-based 
catalyst would have to β-eliminate a hydrogen-atom positioned trans to the metal after insertion 
into the aromatic ring of 4.11a, such eliminations are known in the literature at elevated 
temperatures.126, 129 
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Scheme 4.8: Failed approaches for installing the aryl-aryl phenanthrene bond, R = H-, Ac-, TBS-, Piv-. 
 
The attention was then turned to the differentiation of the two phenol moieties (scheme 4.9). It 
proved impossible to monoprotect compound 4.7b in synthetically useful yields. Instead, a two-
step sequence was employed in which 4.7b was protected as the diester and subsequently mono-
deprotected with Cs2CO3.130 The acetal was removed under standard conditions, and the 
aldehyde was homologated to the alkyne 4.13 with the Ohira-Bestmann reagent.131 The 
relatively poor yield for this transformation can be ascribed to partial acetylation by the reagent 
used and partial deprotection of the pivaloyl ester.  
 
OMe
OO
OMe
OH
OMe
OH
i) PivCl, Pyr., DMAP, 94 %
ii) Cs2CO3, DME, 
   reflux, 80 %
i) 1:1 THF: 1 M HCl, 
    50 ºC, 93 %.
ii) K2CO3, CH3OH, 
    50 %
P
OMe
OMe
O
N2
O
OMe
OO
OMe
OH
OMe
OPiv
OMe
OMe
OH
OMe
OPiv
4.7b 4.12 4.13
 
Scheme 4.9: Monoprotection and Seyferth-Gilbert homologation using the Ohira-Bestmann modification. 
 
Now the stage was set for the Michael addition to the pyrone 4.16, which had to be synthesized 
in four steps, scheme 4.10. Conversion of ketone 4.14 into the vinyl chloride and hydrolysis of 
the methyl esters gave 4.15, which was cyclized to the 4,6-chloropyrone and final dechlorination 
with zinc dust under acidic conditions yielded the desired 4-chloropyrone, 4.16.132 
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i) PCl5, neat, 65 ºC
ii) 6 M HCl, reflux
iii) PCl5, 0-100 ºC 
iv) Zn, AcOH, rt.,
O
Cl
O
COOMe
COOMe
O
COOH
COOH
Cl
(21 % - 4 steps)
4.164.14 4.15  
Scheme 4.10: Synthesis of the 4-chloropyrone, 4.16. 
 
With gram quantities of the pyrone in hand, the Michael addition was accomplished in good 
yield finally delivering 4.18 for the intramolecular pyrone-alkyne Diels-Alder (scheme 4.11).133 
 
OMe
OMe
OH
OMe
OPiv
Cs2CO3, 4.16
DMF, 50 ºC
71 %
OMe
OMe
O
OMe
OPiv
O
O
4.174.13  
Scheme 4.11: Michael addition to the pyrone. 
 
The first attempt to perform the macrocyclization of 4.17 utilized the optimized conditions for 
the successful route to haouamine A, scheme 4.12.117 This led to an initially satisfactory yield of 
5-10 % as a mixture of two inseparable compounds. However, although this result was 
promising, the reaction turned out to be troublesome to improve.  
 
OMe
R
OMe
O
OMe
OPiv
O
O
Br
Br
NO2
0 %
5-10 %
R
Br
Trace
Trace
Yield
4.18,  R' = H 
4.18a R' = Cl/ Br
MeO
OMe
O
OMe
OPiv
R'
Br
15-20 %
a)
b)
c)
d)
e)
 
Scheme 4.12: Approaches to synthesize the macrocycle.  
General conditions: MW: 200-250 ºC, 10-15 h, < 20 mM in o-DCB. 
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Pyrones do not undergo Diels-Alder reactions readily but require rather forcing conditions.132, 134 
Efforts to improve the yield from the simple alkyne 4.17 included Lewis acid activation of the 
pyrone (ScOTf3, BF3·Et2O), which led to further decomposition. Transition metal catalysis 
(Ph3PAuCl, PtCl2, CuTC)135, 136 induced cyclization of the alkyne to ring B or full 
decomposition. It was found that the addition of the radical scavenger BHT had no positive 
effect on the outcome of the reaction. Eventually, it was thought that further functionalization of 
the dienophile could bring about an mprovement. Different vinyl bromide derivatives did not 
lead to any product (scheme 4.12b and c). In the cyclization with the vinyl nitro-group (scheme 
4.12d), a good yield (51 %) of a product was isolated, but it turned out that the nitro moiety had 
reacted as the diene. End-capping the alkyne as a bromide did however improve the yield to 
some extent (scheme 4.12e). The obtained product 4.18a was submitted for X-ray 
crystallography, figure 4.4.  
 
Figure 4.4: X-ray structure of the obtained product from the Diels-Alder reaction, 4.18a. 
See compound 4.18a in scheme 4.12 for printed structure. 
 
Upon inspection on the received structure in figure 4.4 several issues can be addressed. First of 
all, there is a meta-relationship between C23 and C27, where a para-relationship is required. 
This can be explained by a simple attack of alkyne on the wrong side of the pyrone (scheme 
4.13, path B). Apparently, the meta-cyclophane is much lower in energy and hence the only 
isolated product. 
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Scheme 4.13: Modes of macrocyclization. 
 
Second, the connectivity around the C9-C14 aromatic ring is wrong (see figure 4.4 for 
numbering). The two-carbon tether (C8) should be attached to C10 and the C11 methoxy group 
should be attached to C13. This flaw was quickly traced back to wrong regioselectivity in the 
bromination step, scheme 4.4 and figure 4.3. Instead of the desired bromination of the 6-
position, the 4-position was exclusively brominated as confirmed by single crystal X-ray 
analysis of the product from the reaction, figure 4.3. This suggests an erroneous claim of a 
formal total syntheses of Isoplagiochin C and D by Speicher et al. since they applied the 
bromination method depicted in scheme 4.4.119, 137 Speicher et al. have reported NMR-data for 
compound 4.4, which match those found in this study for compound 4.5. Furthermore, they do 
not complete the total synthesis and only report 1D-NMR data with several unresolved signals.  
Third, the C24-halide was found to consist of a 7:3 ratio between compounds having a 
chlorine-atom and a bromine-atom in this position, presumably by radical interchange with the 
solvent at the elevated temperatures. This was of no consequence since the halide had to be 
hydrogenated off in the endgame. Due to the complete breakdown of the applied approach, 
another strategy was devised in order to complete the synthesis. 
 
4.4 Retrosynthetic Analysis – 2nd Strategy 
It was anticipated that cavicularin could be successfully assembled by the same 
disconnections as in the previous strategy, but that the order of he bond formations had to be 
changed, figure 4.5 
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Figure 4.5: 2nd retrosynthetic analysis toward cavicularin. 
 
The idea in the 2nd strategy was to install the aryl-aryl bond between ring C to D and ring B to C 
before the Diels-Alder macrocyclization. This would entail the correct connectivity and augment 
the chance of a successful Diels-Alder reaction since the alkyne inevitably approaches the 
pyrone via rotation around the aryl-aryl bond between ring B and C. 
 
4.5 Results & Discussion – 2nd Strategy 
The boronic ester 4.10 from section 4.3 could be reapplied and successfully cross coupled 
with vanillin triflate under similar conditions as achieved previously (scheme 4.14). 
 
MeO
MeO
OO
BrMeO
HO
MeO
MeO
OO
O
O O
i) Tf2O, pyr, 98 %
ii) PdCl2dppf, 2 M NaOH, 
   4.10, DME, 80 ºC, 73 %
i) NaBH4, MeOH, Q
ii) NBS, THF, 80 %
iii) PCC, CH2Cl2, 
    Celite, 99 %
4.204.19Vanillin  
 Scheme 4.14: Suzuki cross coupling and functionalization to enable further coupling. 
 
Unfortunately, it quickly proved impossible to perform a clean regioselective bromination in the 
desired position of 4.19 without increasing the electron density of the aromatic system. The 
aldehyde was therefore reduced and the bromination was then performed in good yield. 
Reoxidation to the aldehyde with PCC furnished the substrate 4.20 for further elaboration by 
another Suzuki cross coupling with boronic ester 4.22, which was synthesized in two steps 
(scheme 4.15). The phenol of guaiacol was converted into a strong ortho-directing group, 
followed by regioselective ortholithiation and quench with the borolane.  
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Scheme 4.15: Preparation of borolane 4.22. 
 
The following Suzuki cross coupling of 4.20 and 4.22 was accomplished without event, and the 
aldehyde was one-carbon homologated to the alkyne with the Ohira-Bestmann reagent providing 
the precursor for the cycloisomerization, 4.24 (scheme 4.16).131 
PdCl2dppf, 4.22
 
2 M NaOH, DME,
 80 ºC, 86 %.
OMe
O
MeO
MeO
OO
O
O NEt2
MeO
MeO
OO
Br
O
OMe
O
MeO
MeO
OO
O NEt2
P
OMe
OMe
O
N2
O
K2CO3, MeOH,
86 %
4.20 4.23 4.24  
Scheme 4.16: 2nd Suzuki cross coupling and side-chain homologation. 
 
The attention was turned toward the synthesis of the dihydrophenanthrene system (scheme 
4.17). Mamane and Fürstner recently showed the type of cyclization in scheme 4.17 to be very 
effective in providing a phenanthrene with different transition metals.136, 138 
 
OMe
O
MeO
MeO
OMe
O
MeO
MeO
OO
O NEt2 O NEt2
OO
i) PtCl2, PhCH3,
   80 ºC, 57 %
ii) Pd/C, MeOH, 
    28 bar H2,
    84 %
4.24 4.25  
Scheme 4.17: Cycloisomerization to and reduction of the phenanthrene. 
 
While AuCl3 and PdCl2 did produce the desired phenanthrene, decomposition of the starting 
material was fast and only led to a low yield – especially at elevated temperatures. On the other 
hand, treating the alkyne with PtCl2 resulted in minor decomposition of both alkyne and 
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phenanthrene. The relatively low yield of 57 % was due to formation of a by-product, whose 
structure was not elucidated, but seemed to involve the acetal. After some experimentation, 
conditions were found, which were capable of reducing the phenanthrene in good yield to give 
the 4,5-dihydrophenanthrene 4.25.139 
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O NEt2
i) Red Al, PhCH3
    reflux, 51%.
ii) Cs2CO3, DMF,
    50 ºC, 41 %
O
O
Cl
90 % - 2 steps4.25 4.26 4.27
 
Scheme 4.18: Synthesis of the substrate for the intramolecular Diels-Alder. 
 
The experience gained from the first strategy showed that the pyrone should be installed after 
conversion of the aldehyde into the alkyne, because of the high sensitivity of the pyrone toward 
nucleophiles. Therefore, the aldehyde was liberated and homologation to the alkyne 4.26 was 
performed under the previously utilized conditions (scheme 4.18). Removal of the carbamate 
from 4.26 turned out to be unexpectedly difficult. It showed complete resistance toward a series 
of strong reducing agents during prolonged heating. Hence, LiAlH4, superhydride and 
LiAlH(OMe)3 all failed to produce the unprotected phenol. Furthermore, a variety of 
hydroxides, alkoxides and Me3OBF4 followed by hydrolysis also failed.90 Some deprotection 
was observed with anhydrous KOH by the procedure described by Gassmann et al., but this also 
led to isomerization of the alkyne to a mixture of different alkenes.140 Eventually Red Al gave 
rise to the desired phenol, although in a somewhat low yield. The only observed by-product was 
identified as the dihydrophenanthrene, where the carbamate moiety had been removed on the 
aryl-side to ring D. The ensuing Michael addition to pyrone 4.16 furnished the Diels-Alder 
substrate 4.27 although in low yield, because the reaction was stopped prematurely and the 
starting material was recovered.  
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Scheme 4.19: The intramolecular Diels-Alder with CO2-extrusion. 
 
Investigations into the Diels-Alder reaction was then undertaken (scheme 4.19). Again the 
optimized conditions from the synthesis of haouamine A was tried first.117 The reaction 
quantitatively produced a single product as judged by TLC, but NMR analysis revealed a 1:3 
ratio between two compounds. Global deprotection did not furnish any separation of the two 
compounds, but NMR analysis did showed characteristic signals corresponding to the previously 
reported peaks for cavicularin.113, 115 The major isomer was assumed to be the meta-cyclophane. 
Attempts to separate the compounds by HPLC was not performed due to time-constraints. 
Instead, the attention was focused on shifting the ratio between the two products. All attempts to 
cyclize 4.27 in another solvent (DMA, sulfolane, triglyme, neat, BMIMCl) than o-
dichlorobenzene led to pronounced decomposition and multiple products. Addition of the radical 
scavenger BHT, a Lewis acid (Eu(hfc)3) or citric acid,141-143 as well as transition metal catalysis 
(CuTC)135 or end-capping the alkyne with bromine144 did not result in an improved ratio. The 
last attempt to improve the ratio involved reduction of the alkyne 4.27 under Lindlar conditions 
to the alkene and then subjecting this product to prolonged microwave irradiation (scheme 4.20). 
 
OMe
O
MeO
MeO
O O
OMe
O
MeO
MeO
OMe
O
MeO
MeO
ii) Microwave:
    200 ºC, 10 h
    2 mM in o-DCB,
   ~65 %
i) Lindlar cat., H2, 
   pyridine, EtOH, Q
4.27 Cavicularin
 trimethyl ether
ratio   5   :   3
Meta-cyclophane
 
Scheme 4.20: The improved intramolecular Diels-Alder with CO2-extrusion. 
 
This modification translated into a ~65% yield of a mixture between the two compounds in a 5:3 
ratio, the major component being the desired trimethyl ether of cavicularin. Presumably, the 
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compounds are oxidized in air during work-up leading to the aromatic moieties. A third 
compound was isolated in ~35% yield and corresponded to the remaining unoxidized dienes. 
 
4.6 Conclusion 
The naturally occurring paracyclophane cavicularin has been synthesized by using an 
intramolecular pyrone-alkene Diels-Alder reaction with concomitant liberation of CO2. The 
synthesis was completed by 19 ensuing steps. The project is ongoing in Professor Phil Baran’s 
laboratory and current focus is on shortening the synthesis and performing the synthesis 
enantioselectively.  
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4.7 Experimental Section 
General Procedures.  
All reactions were carried out under a nitrogen or an argon atmosphere with dry solvents 
under anhydrous conditions, unless otherwise noted. Dry tetrahydrofuran, triethylamine, 
dichloromethane, methanol, dimethylformamide, dimethoxyethane and benzene were obtained 
by passing commercially available pre-dried, oxygen-free formulations through activated 
alumina columns. Yields refer to spectroscopically (1H-NMR) homogeneous materials, unless 
otherwise stated. Reactions were monitored by thin-layer chromatography (TLC) carried out on 
0.25 mm Merck silica gel 60 F254-plates using UV light as visualizing agent and charring after 
staining with either p-anisaldehyde in ethanol/aqueous H2SO4/CH3COOH or 5:2 
phosphormolybdic acid: Cerium(IV)sulfate in aqueous H2SO4. Preparative TLC was performed 
on 0.25 mm or 0.50 mm Merck silica gel 60 Å F254-plates in the noted solvent. Flash 
chromatography was performed with Merck Geduran 60 Å silica gel (40-63 μm) in the stated 
solvent. Alkyllithiums were titrated before each use according to Burchat et al.44 Microwave 
experiments were performed on a Biotage Initiator. NMR spectra were recorded on either a 
Bruker DRX-600 with a cryoprobe, AMX-400 or a Varian Inova-400 and calibrated using 
residual solvent as an internal reference: CHCl3 (7.26) and CDCl3 (77.0), acetone (2.09), toluene 
(quintuplet, 2.09). The following abbreviations were used to explain the multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, m = multiplet, br = broad. 
Coupling constants are given in hertz. IR spectra were recorded on a Perkin-Elmer Spectrum BX 
FTIR spectrometer. Melting points are uncorrected and were recorded on a Fisher-Johns 12-144 
melting point apparatus. High resolution mass spectra were recorded on an Agilent Mass 
spectrometer using ESI-TOF or a ThermoFinnigan Mass spectrometer using FAB or EI. Low 
resolution mass spectra were recorded on an Agilent LCMS (ESI or APCI-ionization). X-ray 
crystallography was performed at UCSD by Dr. Antonio DiPasquale, Department of Chemistry 
and Biochemistry, Small Molecule X-ray Crystallography Facility. 
 
Methyl gallate (10.0 g, 54.3 mmol) was dissolved in DMF (109 mL) under Ar and 
cooled to 0 ºC. Then NaH (2.17 g, 60 % in mineral oil, 54.3 mmol) was added and 
the slurry was stirred for 30 min at 0 ºC and CH3I (3.6 mL, 57.8 mmol) was added 
dropwise. The cooling bath was removed and the suspension stirred overnight at rt. It was then 
poured into ether (200 mL), which was washed with water (1.0 L). The aqueous layer was 
extracted with 2 x 200 and 2 x 150 mL of ether. The combined organic phases were washed with 
HO
OMe
OH
COOMe
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200 mL of water, dried with MgSO4, filtered and evaporated in vacuo. The solid residue was 
purified by flash chromatography in 30-40 % EtOAc in hexanes. Yield of 4.1a: 5.40 g (50 %). 
Rf = 0.28, 3:2 Hexanes:EtOAc (v/v). White solid, mp = 143-144 ºC (Lit. 147-148 ºC)118. 1H-
NMR (400 MHz, acetone-d6): δ 8.32 (br s, 2H), 7.09 (s, 2H), 3.87 (s, 3H), 3.81 (s, 3H). 13C-
NMR (100.5 MHz, acetone-d6): δ 166.3, 150.5, 137.7, 125.8, 109.1, 60.0, 51.5. IR(film) ν 3050-
3650 2953, 1698, 1596, 1523, 1436, 1351, 1241, 1164, 1056, 1001 cm-1. LCMS [M+H]+: 199. 
 
The diol 4.1a (5.40 g, 27.3 mmol) was dissolved in 80 mL of DMF under Ar 
and 6.51 g of imidazole (95.6 mmol) and 12.3 g of TBSCl (81.8 mmol) were 
added. The solution was stirred at rt for 2 h. It was poured into 600 mL of 
water and extracted with 3 x 150 mL of ether. The combined organic phases were dried with 
MgSO4, filtered and evaporated in vacuo. Purification by flash chromatography in 3 % EtOAc in 
hexanes. Yield of 4.2: 11.48 g (99 %).118 Colorless oil - 9:1 Hexanes:EtOAc (v/v), Rf = 0.53. 
1H-NMR (400 MHz, CDCl3): δ 7.19 (s, 2H), 3.86 (s, 3H), 3.77 (s, 3H), 1.01 (s, 18H), 0.19 (s, 
12H). 13C-NMR (100.5 MHz, CDCl3): δ 166.6, 149.6, 147.3, 125.1, 116.1, 60.0, 52.0, 25.7, 
18.3, -4.7. IR(film) ν 2954, 2932, 2860, 1726, 1578, 1492, 1427, 1353, 1252, 1223, 1090, 1014 
cm-1. LCMS [M+Na]+: 449. 
 
The ester 4.2 (11.48 g, 26.9 mmol) was dissolved in THF (135 mL) under Ar 
and cooled to 0 ºC, where 1.5 g of LAH (39.5 mmol) was added in portions. 
After full addition the cooling bath was removed and the slurry was stirred for 
1 h. It was cooled to 0 ºC and quenched by slow addition of water (1.5 mL), 10 % NaOH (3.0 
mL) and water (4.5 mL). The cooling bath was removed and the suspension was allowed to 
warm to rt, where it was dried with MgSO4. The white salts were filtered off and the organic 
phase was evaporated in vacuo. Yield of 4.2a: 10.19 g (95 %).118 Colorless oil - 9:1 
Hexanes:EtOAc  (v/v), Rf = 0.25. 1H-NMR (400 MHz, CDCl3): δ 6.51 (s, 2H), 4.51 (s, 2H), 3.71 
(s, 2H), 1.00 (s, 18H), 0.17 (s, 12H). 13C-NMR (100.5 MHz, CDCl3): δ 149.8, 142.3, 136.2, 
113.2, 65.1, 59.9, 25.7, 18.3, -4.7. IR(film) ν 2931, 1578, 1495, 1472, 1463, 1433, 1346, 1252, 
1228, 1090, 1006 cm-1. 
 
The alcohol 4.2a (9.88 g, 24.8 mmol) was dissolved in CH2Cl2 (125 mL). Then 
PCC (10.68 g, 49.6 mmol) and Celite (11 g) were added. The slurry was stirred 
for 1 h and filtered. The dark organic phase was concentrated in vacuo and 
TBSO
OMe
OTBS
COOMe
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OH
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O
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purified by flash chromatography in CH2Cl2. Yield of 4.3: 8.60 g (88 %). White Solid, mp = 71-
72 ºC (Lit. 75-77 ºC).118 9:1 Hexanes:EtOAc  (v/v), Rf = 0.53. 1H-NMR (400 MHz, CDCl3): δ 
9.78 (s, 1H), 7.03 (s, 2H), 3.81 (s, 3H), 1.02 (s, 18H), 0.20 (s, 12H). 13C-NMR (100.5 MHz, 
CDCl3): δ 191.1, 150.4, 148.8, 131.8, 115.9, 60.1, 25.7, 18.3, -4.7. IR(film) ν 2955, 2931, 2858, 
1697, 1576, 1489, 1440, 1389, 1346, 1259, 1215, 1090, 1007 cm-1. HRMS [M+H]+: calcd 
397.2225, found 397.2236. 
 
3-Methoxybenzyl alcohol (10.00 g, 72.38 mmol) was dissolved in 1:1 
CH3CN:H2O (500 mL) and NaBrO3 (19.15 g, 126.9 mmol) and Na2S2O5 (13.83 
g, 72.8 mmol) were added. The solution was stirred for 1 h and quenched with 
sat. aq. Na2S2O3 (50 mL).  The aqueous phase was extracted with 3 x 100 mL of ether after phase 
separation. The combined organic phases were dried with MgSO4 and evaporated in vacuo. 
Yield of 4.5: 14.62 g (93 %). White solid, mp = 42 ºC. 4:1 Hexanes:EtOAc (v/v), Rf = 0.23. 1H-
NMR (400 MHz, CDCl3): δ 7.39 (d, J = 8.7 Hz, 1H), 7.04 (d, J = 2.9 Hz, 1H), 6.69 (dd, J = 3.0, 
8.7, 1H), 4.68 (s, 2H), 3.79 (s, 3H), 2.28 (br s, 1H). 13C-NMR (100.5 MHz, CDCl3): δ 159.1, 
140.7, 133.0, 114.5, 114.0, 112.3, 64.7, 55.4. IR(film) ν 3000-3650, 2899, 2837, 1595, 1575, 
1471, 1420, 1296, 1272, 1241, 1161, 1051, 1014 cm-1. LCMS [M+Na]+: 239. 
 
 The benzyl alcohol 4.5 (19.42 g, 89.47 mmol) was dissolved in CH2Cl2 (500 
mL) and cooled to -3 ºC, where imidazole (8.53 g, 0.125 mol) and PPh3 (30.44 g, 
0.116 mol) were added. After complete dissolution of the phosphine, the I2 
(30.70 g, 0.121 mol) was added in portions keeping the temperature below 10 ºC. After 
complete addition the cooling was removed and the slurry stirred for 1.5 h under Ar. It was then 
passed through a pad of silica, which was washed with 3 x 100 mL of ether. The organic phase 
was quenched with sat. aq. Na2S2O3 (600 mL). The aqueous phase was extracted with 2 x 100 
mL of ether after phase separation. The combined organic phases were dried with MgSO4, 
filtered and evaporated in vacuo. Yield of 4.5a: 24.99 g (86 %). The compound 
disproportionates to eliminate I2 on prolonged storage in solution and solid state at rt. White 
solid, mp = 79-80 ºC. 4:1 Hexanes:EtOAc  (v/v), Rf = 0.60. 1H-NMR (400 MHz, CDCl3): δ 7.40 
(d, J = 8.8, 1H), 6.96 (d, J = 2.8, 1H), 6.70 (dd, J = 2.8, 8.7, 1H), 4.49 (s, 2H), 3.79 (s, 3H). 13C-
NMR (100.5 MHz, CDCl3): δ 159.1, 139.1, 134.0, 115.7, 114.4, 55.5, 5.9. IR(film) ν 2938, 
2840, 1596, 1571, 1474, 1411, 1296, 1282, 1250, 1153, 1012 cm-1. GCMS [M]+: 326. 
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The iodide 4.5a (25.87 g, 79.12 mmol) was dissolved in toluene (158 mL) and 
PPh3 (20.76 g, 79.15 mmol) was added. The suspension was refluxed for 4 h 
under Ar. After cooling, it was filtered and the salt was washed with 3 x 100 mL 
of ether. Yield of 4.6: 41.97 g (90 %). 
 
Prepared according to Afarinkia et al.132 1H-NMR (400 MHz, Acetone-d6): δ (7:3 
E:Z) 8.18 (br s, 2H), 6.38 & 6.28 (s, 1H), 4.12 (s, 2H).  
 
Prepared according to Afarinkia et al.132 Pale yellow solid, mp = 41-42 ºC (Lit. 43-
44 ºC132). CH2Cl2, Rf = 0.76. 1H-NMR (400 MHz, CDCl3): δ 6.30 (s, 2H). 13C-
NMR (100.5 MHz, CDCl3): δ 158.4, 152.1, 150.4, 111.1, 106.6. IR(film) ν 3089, 
1758, 1617, 1598, 1524, 1374, 1288, 1166, 1084, 1057, 823 cm-1.  
 
Prepared according to Afarinkia et al.132 White needles, mp = 57-58 ºC (Lit. 59 ºC132). 
CH2Cl2, Rf = 0.51. 1H-NMR (400 MHz, CDCl3): δ 7.44 (dd, J = 0.8, 5.6, 1H), 6.40 
(dd, J = 0.8, 2.0, 1H), 6.28 (dd, J = 2.0, 5.6, 1H). 13C-NMR (100.5 MHz, CDCl3): δ 
160.0, 151.2, 150.7, 114.6, 108.8. IR(film) ν 3078, 1720, 1612, 1535, 1413, 1240, 1170, 1039, 
864, 824, 780, 689 cm-1.  
 
The 3-(3-methoxyphenyl)propionic acid (10.00 g, 55.5 mmol) was dissolved in 
CH2Cl2 (140 mL) and cooled to 0 ºC, where Br2 (2.9 mL, 56.6 mmol) was added 
dropwise over 10 min. After 15 min. the solution was poured into 200 mL of 
water and extracted with 2 x 50 mL of CH2Cl2. The combined organic phases were dried with 
MgSO4, filtered and evaporated in vacuo. Yield of 4.8a: 14.10 g (98 %). White Solid, mp = 80-
81 ºC (Lit. 81-83 ºC)145. 1H-NMR (400 MHz, CDCl3): δ 7.42 (d, J = 8.8, 1H), 6.82 (d, J = 3.0, 
1H), 6.66 (dd, J = 3.0, 8.8), 3.78 (s, 3H), 3.03 (t, J = 7.8, 2H), 2.71 (t, J = 7.8, 2H). 13C-NMR 
(100.5 MHz, CDCl3): δ 179.0, 159.0, 140.3, 133.4, 116.1, 114.7, 113.8, 55.4, 33.8, 31.2. 
IR(film) ν 2936, 1706, 1595, 1572, 1472, 1413, 1241, 1162, 1057, 1023, 802  cm-1. LCMS 
[M+K]+: 297. 
 
LAH (3.1 g, 81.7 mmol) was suspended in THF (252 mL) at 0 ºC under Ar. The 
acid 4.8a (14.10 g, 54.4 mmol) in THF (20 mL) was added dropwise. (Flask 
rinsed with 3 x 7 mL of THF and added successively). The cooling bath was 
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removed and the suspension warmed to rt over 2 h. It was then recooled to 0 ºC and quenched 
by slow addition of H2O (3.1 mL), 10 % NaOH (6.2 mL) and H2O (9.3 mL). The cooling bath 
was removed and the slurry was dried with MgSO4 at rt. The white salts were filtered off and the 
solvent was evaporated in vacuo. Yield of 4.8b: 12.34 g (93 %). Colorless oil - 3:2 
Hexanes:EtOAc (v/v), Rf = 0.38. 1H-NMR (400 MHz, CDCl3): δ 7.39 (d, J = 8.7, 1H), 6.79 (d, J 
= 3.1, 1H), 6.62 (dd, J = 3.1, 8.7, 1H), 3.76 (s, 3H), 3.69 (t, J = 6.4, 2H), 2.75-2.82 (m, 2H), 2.00 
(s, 1H), 1.84-1.92 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 158.9, 142.0, 133.2, 116.0, 114.8, 
113.1, 62.0, 55.3, 32.6, 32.5. IR(film) ν  3050-3600, 2952, 2836, 1596, 1571, 1474, 1275, 1241, 
1161, 1053, 1013 cm-1. LCMS [M+Na]+: 267. 
 
Solution 1: The alcohol 4.8b (11.46 g, 46.76 mmol) was dissolved in CH2Cl2 (117 
mL) and the mixture was cooled to 0 ºC. Solution 2: Aqueous NaHCO3 (7.0 g in 
70 mL of H2O) was mixed with 70 mL of 0.83 M NaOCl (58.1 mmol). Solution 2 
was cooled to 12 ºC and added to solution 1 after addition of TEMPO (77.5 mg, 0.5 mmol). 
Then KBr (557 mg, 4.68 mmol) was added and the biphasic system was stirred vigorously for 1 
h. It was quenched sat. aq. Na2S2O3 (20 mL). The phases were separated and the aqueous phase 
was extracted with 2 x 100 mL of CH2Cl2. The combined organic phases were dried with 
MgSO4, filtered and evaporated in vacuo. Yield of 4.9: 10.58 g (93 %). Colorless oil - 4:1 
Hexanes:EtOAc (v/v), Rf = 0.35. 1H-NMR (400 MHz, CDCl3): δ 9.82 (t, J = 1.3, 1H), 7.40 (d, J 
= 8.8, 1H), 6.79 (d, J = 3.0, 1H), 6.64 (dd, J = 3.0, 8.8, 1H), 3.77 (s, 1H), 3.01 (t, J = 7.6, 2H), 
2.76-2.81 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 200.9, 159.0, 140.6, 133.4, 116.2, 114.5, 
113.6, 55.4, 43.6, 28.8. IR(film) ν 2832, 2722, 1720, 1595, 1572, 1474, 1406, 1277, 1242, 1162, 
1058, 1013 cm-1. 
 
The aldehyde 4.9 (11.42 g, 46.98 mmol) was dissolved in toluene (59 mL), and 
ethylene glycol (3.0 mL, 53.65 mmol) and 593 mg of PPTS (2.36 mmol) were 
added. The solution was refluxed for 3 h and then poured into 400 mL of H2O and 
100 mL of EtOAc. The organic phase was washed with 2 x 200 mL of H2O, dried with MgSO4, 
filtered and evaporated in vacuo. Yield of 4.9a: 13.07 g (97 %). Pale yellow oil - 4:1 
Hexanes:EtOAc (v/v), Rf = 0.35. 1H-NMR (400 MHz, CDCl3): δ 7.39 (d, J = 8.7 1H), 6.80 (d, J 
= 3.1, 1H), 6.62 (dd, J = 3.1, 8.7, 1H), 4.93 (t, J = 4.6, 1H), 3.96-4.03 (m, 2H), 3.86-3.92 (m, 
2H), 3.76 (s, 3H), 2.79-2.85 (m, 2H), 1.94-2.01 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 
158.9, 141.8, 133.2, 115.9, 114.8, 113.3, 103.7, 64.9, 55.4, 33.6, 30.8. IR(film) ν 2955, 2881, 
Br
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1596, 1572, 1474, 1413, 1280, 1240, 1138, 1033, 1013 cm-1. HRMS [M+Na]+: calcd 309.0097, 
found 309.0098. 
 
The bromide 4.9a (11.46 g, 39.91 mmol) was dissolved in THF (200 mL) under Ar 
and cooled to -78 ºC. Then n-BuLi (43.68 mmol, 2.08 M in hexanes, 21 mL) was 
added dropwise. After full addition the slurry was stirred for 30 min. before the 
addition of 11.0 mL of 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(53.92 mmol). The cooling bath was removed and the solution was allowed to warm to rt, where 
it was quenched with H2O (500 mL) and extracted with 3 x 100 mL of CH2Cl2. The combined 
organic phases were dried with MgSO4, filtered and evaporated in vacuo. Yield of 4.10: 12.20 g 
(92 %). Colorless oil - 4:1 Hexanes:EtOAc (v/v), Rf = 0.32. 1H-NMR (400 MHz, CDCl3): δ 7.74 
(d, J = 8.2, 1H), 6.76 (d, J = 2.4, 1H), 6.72 (dd, J = 2.5, 8.2, 1H), 4.91 (t, J = 5.0, 1H), 3.94-4.01 
(m, 2H), 3.84-3.92 (m, 2H), 3.80 (s, 3H), 2.97-3.03 (m, 2H), 1.89-1.95 (m, 2H), 1.33 (s, 12H). 
13C-NMR (100.5 MHz, CDCl3): δ 161.7, 151.1, 138.1, 115.0, 110.5, 104.4, 83.1, 64.8, 55.0, 
37.0, 30.7, 24.8. IR(film) ν 2976, 2884, 1600, 1566, 1380, 1347, 1316, 1231, 1144, 1126 cm-1. 
HRMS [M+Na]+: calcd 357.1844, found 357.1842. 
 
The phosphonium salt 4.6 (13.67 g, 23.20 mmol) was suspended in THF 
(116 mL) under Ar and cooled to 0 ºC. Then 2.22 g of tBuOK (19.78 
mmol) was added and the suspension stirred for 1 h. The aldehyde 4.3 
(7.08 g, 17.85 mmol) in THF (15 mL) was added – the flask was rinsed 
with 3 x 3 mL of THF. The cooling bath was removed and the slurry 
stirred overnight. The suspension was run through a pad of silica, which was washed with 5 x 50 
mL of 1 % EtOAc in hexanes. The solvent was removed in vacuo and the residue flash 
chromatographed on a short column in 1 % EtOAc in hexanes. Yield: 10.35 g as a 1:1 mixture 
of E:Z stilbenes (Q). The stilbenes (2.00 g, 3.45 mmol) were dissolved in EtOAc (15 mL), 5 % 
Pt/C (2.1 g) was added and the mixture stirred vigorously under a 42 bar H2-atmosphere for 3 h. 
The slurry was filtered through a pad of Celite and the solvent was removed in vacuo. Yield of 
4.7: 2.00 g (Q). Colorless oil - 4:1 Hexanes:EtOAc (v/v), Rf = 0.78. 1H-NMR (400 MHz, 
CDCl3): δ 7.41 (d, J = 8.7, 1H), 6.67 (d, J = 3.0, 1H), 6.62 (dd, J = 3.1, 8.7, 1H), 6.35 (s, 2H), 
3.73 (s, 3H), 3.70 (s, 3H), 2.83 (ddd, J = 7.1, 10.1, 15.9, 4H), 1.01 (s, 18H), 0.16 (s, 12H). 13C-
NMR (100.5 MHz, CDCl3): δ 158.8, 149.5, 141.8, 141.1, 136.5, 133.2, 116.2, 114.8, 113.3, 
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59.9, 55.3, 38.5, 35.6, 25.8, 18.3, -4.7. IR(film) ν 2953, 2930, 2857, 1576, 1491, 1472, 1432, 
1356, 1250, 1226, 1087, 1016, 832, 784 cm-1. 
 
The bromide 4.7 (2.773 g, 4.767 mmol) and borolane 4.10 (2.07 g, 6.19 
mmol) were dissolved in dioxane (24 mL) and degassed by sonication 
under Ar-purging. Then 2 M NaOH (3.1 mL, 6.2 mmol) and 175 mg of 
PdCl2(dppf) (0.239 mmol, 5 mol %) were added. The solution was heated 
to 80 ºC, where it was stirred for 5 h. The dark solution was poured into 
200 mL of H2O and extracted with 3 x 100 mL of CH2Cl2. The combined organic phases were 
washed with brine (400 mL), dried with MgSO4, filtered and the solvent was removed in vacuo. 
Purification by flash chromatography in 10 % EtOAc in hexanes. Yield of 4.7a: 2.539 g (75 %). 
White solid, mp = 93 ºC. 4:1 Hexanes:EtOAc (v/v), Rf = 0.40. 1H-NMR (400 MHz, CDCl3): δ 
7.02 (d, J = 8.3, 1H), 6.99 (d, J = 8.3, 1H), 6.85 (d, J = 2.6, 1H), 6.80 (d, J = 2.6, 1H), 6.77 (d, 
J = 2.56 , 1H), 6.75 (d, J = 2.6, 1H), 6.08 (s, 2H), 4.70 (t, J = 4.9, 1H), 3.85-3.90 (m, 2H), 3.83 
(s, 6H), 3.75 (m, 2H), 3.66 (s, 3H), 2.38-2.62 (m, 6H), 1.73-1.82 (m, 2H), 0.98 (s, 18H), 0.12 (s, 
12H). 13C-NMR (100.5 MHz, CDCl3): δ 158.8, 158.7, 149.3, 141.3, 141.1, 140.8, 137.0, 132.9, 
131.3, 114.5, 114.2, 111.0, 110.9, 103.9, 64.7, 59.9, 55.2, 55.1, 37.1, 36.1, 34.8, 28.1, 25.7, 18.3, 
-4.7. IR(film) ν 2952, 2931, 2890, 2857, 1605, 1576, 1484, 1431, 1355, 1231, 1085, 1052, 1004, 
831 cm-1. 
 
The disilylether 4.7a (3.23 g, 4.56 mmol) was dissolved in THF (45 mL) 
under Ar and cooled to 0 ºC. Then 1 M TBAF (18 mL) was added and 
the cooling bath was removed. The solution darkened as it stirred for 3 h, 
where it was extracted from 30 % NH4Cl with 1 x 100 and 2 x 50 mL of 
EtOAc. The combined organic phases were dried with MgSO4, filtered 
and evaporated in vacuo. Purification by flash chromatography in 40-50 % EtOAc in hexanes. 
Yield of 4.7b: 2.03 g (93 %). Slightly pink foam. 3:2 Hexanes:EtOAc (v/v), Rf = 0.15. 1H-NMR 
(400 MHz, CDCl3): δ 7.01 (d, J = 8.2, 1H), 6.99 (d, J = 8.3, 1H), 6.86 (d, J = 2.6, 1H), 6.80 (d, J 
= 2.6, 1H), 6.74-6.79 (m, 2H), 6.11 (s, 2H), 5.45 (br s, 2H), 4.72 (t, J = 4.9, 1H), 3.88-3.91 (m, 
2H), 3.84 (s, 3H), 3.82 (s, 3H), 3.81 (s, 3H), 3.77-3.80 (m, 2H), 2.39-2.65 (m, 6H), 1.72-1.82 
(m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 158.7, 158.6, 148.6, 141.0, 138.6, 132.9, 132.7, 
131.3, 131.2, 114.3, 111.0, 110.9, 107.9, 103.9, 64.7, 61.0, 55.2, 36.4, 35.1, 34.6, 28.0. IR(film) 
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ν 3150-3600, 2936, 2836, 1604, 1526, 1508, 1483, 1458, 1346, 1278, 1231, 1163, 1136, 1048, 
1001 cm-1. HRMS [M+Na]+: calcd 503.2046, found 503.2042. 
 
The diol 4.7b (1.660 g, 3.45 mmol) was dissolved in CH2Cl2 (14 mL) 
under Ar and pyridine (4.2 mL, 51.8 mmol), PivCl (4.3 mL, 34.5 mmol) 
and DMAP (89 mg, 0.69 mmol) were added. The solution was stirred at 
rt for 18 h, quenched with 20 % NH4Cl (200 mL) and extracted with 3 x 
50 mL of CH2Cl2. The combined organic phases were washed with sat. 
aq. NaHCO3 (100 mL), dried with MgSO4, filtered and evaporated in vacuo. Purification by 
flash chromatography in 20-25 % acetone in hexanes to yield 2.11 g of diester 4.7c (94%). 
White solid, mp = 126 ºC. 3:2 Hexanes:EtOAc (v/v), Rf = 0.58. 1H-NMR (400 MHz, CDCl3): δ 
7.03 (dd, J = 0.7, 7.9, 1H), 6.99 (d, J = 8.3, 1H), 6.85 (d, J = 2.6, 1H), 6.75-6.80 (m, 3H), 6.46 
(s, 2H), 4.70 (t, J = 4.9, 1H), 3.86-3.90 (m, 2H), 3.83 (s, 3H), 3.82 (s, 2H), 3.75-3.79 (m, 2H), 
3.69 (s, 3H), 2.37-2.67 (m, 6H), 1.73-1.82 (m, 2H), 1.36 (s, 9H). 13C-NMR (100.5 MHz, 
CDCl3): δ 176.3, 158.8, 158.7, 144.5, 142.0, 141.1, 140.9, 137.7, 132.9, 132.8, 131.3, 120.3, 
114.3, 114.2, 111.3, 110..9, 103.8, 64.7, 61.2, 55.2, 55.1, 39.0, 36.6, 35.5, 34.7, 28.0, 27.1. 
IR(film) ν 2974, 1757, 1606, 1576, 1502, 1482, 1278, 1235, 1106, 1039 cm-1. 
 
The diester 4.7c (1.598 g, 2.46 mmol) was dissolved in DME (25 mL) 
and 1.601 g of Cs2CO3 (4.93 mmol) was added. The suspension was 
refluxed under Ar for 16 h, where more DME (10 mL) was added. The 
suspension was further refluxed for 27 h. After cooling to rt the slurry 
was poured into 100 mL of CH2Cl2 and washed with 20 % NH4Cl (200 
mL). The aqueous phase was extracted with 3 x 50 mL of CH2Cl2. The combined organic phases 
were dried with MgSO4, filtered and evaporated in vacuo. The residue was purified by flash 
chromatography in 30 % acetone in hexanes. Yield of 4.12: 1.109 g (80 %) (brsm 94 %). White 
solid, mp = 72-75 ºC. 3:2 Hexanes:EtOAc (v/v), Rf = 0.33. 1H-NMR (400 MHz, CDCl3): δ 7.02 
(d, J = 8.3, 1H), 6.98 (d, J = 8.3, 1H), 6.86 (d, J = 2.7, 1H), 6.80 (d, J = 2.6, 1H), 6.78 (dd, J = 
1.2, 2.7, 1H), 6.76 (dd, J = 1.1, 2.7, 1H), 6.40 (d, J = 2.0, 1H), 6.17 (d, J = 2.0, 1H), 5.68 (br s, 
1H), 4.71 (t, J = 4.9, 1H), 3.86-3.91 (m, 2H), 3.84 (s, 3H), 3.82 (s, 3H), 3.75-3.79 (m, 2H), 2.38-
2.66 (m, 6H), 1.74-1.81 (m, 2H), 1.37 (s, 9H). 13C-NMR (100.5 MHz, CDCl3): δ 176.3, 158.8, 
158.7, 149.3, 143.4, 141.1, 141.0, 138.4, 137.0, 132.9, 131.3, 114.4, 114.3, 113.0, 111.1, 111.0, 
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103.9, 64.7 61.4, 55.2, 39.0, 36.7, 35.4, 34.7, 28.0, 27.1. IR(film) ν 3200-3600, 2958, 1753, 
1605, 1483, 1278, 1233, 1119, 1043, 1001 cm-1. 
 
The acetal 4.12 (0.3747 g, 0.665 mmol) was dissolved in THF (9 mL), 1 
M HCl (4.5 mL) was added and the mixture was stirred overnight at 50 
ºC. The solution was extracted from sat. aq. NH4Cl with CH2Cl2. The 
combined organic phases were dried with MgSO4, filtered and 
evaporated in vacuo. Purification by flash chromatography in 40 % 
EtOAc in hexanes. Yield of 4.12a: 0.3201 g (93 %). Colorless oil - 3:2 Hexanes:EtOAc (v/v), Rf 
= 0.37. 1H-NMR (400 MHz, CDCl3): δ 9.61 (t, J = 1.4, 1H), 6.98-7.04 (m, 2H), 6.75-6.84 (m, 
4H), 6.41 (d, J = 2.0, 1H), 6.17 (d, J = 2.0, 1H), 5.79 (br s, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.75 
(s, 3H), 2.48 (m, 8H), 1.38 (s, 9H). 13C-NMR (100.5 MHz, CDCl3): δ 201.6, 176.3, 158.9, 
149.3, 143.4, 141.0, 139.8, 138.2, 137.0, 132.8, 132.5, 131.5, 131.2, 114.4, 113.0, 111.3, 111.2, 
61.4, 55.2, 44.6, 39.0, 36.8, 35.4, 27.1, 26.0. IR(film) ν 3200-3600, 2965, 2831, 1752, 1719, 
1605, 1482, 1458, 1277, 1233, 1165, 1117, 1042, 1002 cm-1. 
 
The aldehyde 4.12a (0.1069 g, 0.205 mmol) was dissolved in MeOH (2.5 
mL), K2CO3 (68.1 mg, 0.493 mmol) and 50.0 mg of the Ohira-Bestmann 
reagent (0.260 mmol) in 0.2 mL of MeOH were added. The suspension 
was stirred for 2½ h at rt, where 2 drops of the Ohira-Bestmann reagent 
was added. The mixture was stirred for another 2 h. The reaction was 
diluted with 10 mL of Et2O, quenched with sat. aq. NH4Cl and extracted with 2 x 10 mL of 
Et2O. The combined organic phases were dried with MgSO4, filtered and evaporated in vacuo. 
Purification by flash chromatography in 25 % EtOAc in hexanes. Yield of 4.13: 53.1 mg (50 %). 
White solid, mp = 116-118 ºC. 3:2 Hexanes:EtOAc (v/v), Rf = 0.51. 1H-NMR (400 MHz, 
CDCl3): δ 7.03 (d, J = 8.3, 1H), 7.00 (d, J = 8.3, 1H), 6.91 (d, J = 2.3), 6.77-6.83 (m, 3H), 6.42 
(d, J = 2.0, 1H), 6.17 (d, J = 2.0, 1H), 5.58 (br s, 1H), 3.85 (s, 3H), 3.84 (s, 3H), 3.76 (s, 3H), 
2.50-2.65 (m, 6H), 2.24-2.30 (m, 2H), 1.91 (t, J = 2.6, 1H9, 1.40 (s, 9H). 13C-NMR (100.5 MHz, 
CDCl3): δ 176.6, 159.0, 158.9, 149.5, 143.6, 141.3, 140.0, 138.6, 137.2, 133.0, 132.9, 131.6, 
131.5, 114.8, 114.7, 114.6, 113.2, 111.5, 111.4, 84.1, 69.1, 61.7, 55.4, 39.3, 37.0, 35.6, 32.6, 
27.4, 19.7. IR(film) ν 3200-3600, 2959, 2937, 2835, 1752, 1605, 1506, 1482, 1459, 1278, 1233, 
1162, 1117, 1044, 1002 cm-1. 
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The phenol 4.13 (58.2 mg, 0.113 mmol) and 29.4 mg of pyrone 4.16 
(0.225 mmol) were dissolved in DMF (2.3 mL), 40.9 mg of Cs2CO3 
(0.126 mmol) was added and the mixture was stirred in a 50 ºC oil bath 
for 1½ h. The solution was cooled < 10 ºC and diluted with 10 mL of 
Et2O, 4 % brine (50 mL) was added and the mixture was extracted with 
2 x 10 mL of Et2O. The combined organic phases were dried with 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography in 25 % 
EtOAc in hexanes. Yield of 4.17: 48.8 mg (71 %). Pale yellow oil. 3:2 Hexanes:EtOAc (v/v), Rf 
= 0.37. 1H-NMR (600 MHz, CDCl3): δ 7.45 (d, J = 5.9, 1H), 7.04 (dd, J = 1.3, 7.4, 1H), 6.98 (d, 
J = 8.3, 1H), 6.90 (d, J = 2.6, 1H), 6.78-6.81 (m, 3H), 6.55 (d, J = 2.0, 1H), 6.45 (d, J = 2.0, 1H), 
6.12 (dd, J = 2.4, 5.9, 1H), 5.36 (d, J = 2.4, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.69 (s, 3H), 2.50-
2.69 (m, 6H), 2.25-2.29 (m, 6H), 1.89 (t, J = 2.6, 1H), 1.36 (s, 9H). 13C-NMR (100.5 MHz, 
CDCl3): δ 176.6, 168.9 163.8, 159.1, 159.0, 152.5, 145.2, 142.2, 140.7, 140.0, 138.6, 132.9, 
132.8, 131.6, 121.5, 119.9, 114.8, 111.6, 111.5, 102.4, 94.5, 84.0, 69.1, 61.4, 55.5, 55.4, 39.3, 
36.6, 35.6, 32.6, 27.3, 19.7. IR(film) ν  3290, 2959, 2936, 2836, 1753, 1726, 1641, 1606, 1561, 
1482, 1432, 1326, 1278, 1234, 1199, 1162, 1110, 1056, 1037, 1002 cm-1. LCMS [M+Na]+: 633. 
HRMS [M+H]+: calcd 611.2639, found 611.2645. 
 
The alkyne 4.17 (91.4 mg, 0.150 mmol) was dissolved in acetone (2.0 
mL), 3.1 mg of AgNO3 (18.2 μmol) and 31.2 mg of NBS (0.175 mmol) 
were added. The solution was stirred for 1½ h and concentrated in 
vacuo. Purification by flash chromatography in 30 % EtOAc in hexanes. 
Yield of 4.17a: 86.9 mg (84 %). 1H-NMR (400 MHz, CDCl3): δ 7.45 
(dd, J = 0.6, 5.9, 1H), 7.03 (d, J = 8.8, 1H), 6.98 (d, J = 8.3, 1H), 6.86 (d, 
J = 2.6, 1H), 6.80 (d, J = 2.9, 1H), 6.77-6.79 (m, 3H), 6.55 (d, J = 2.1, 1H), 6.44 (d, J = 2.1, 1H), 
6.13 (dd, J = 2.4, 5.9, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.69 (s, 3H), 2.47-2.66 (m, 6H), 2.28 (t, J 
= 7.3, 2H), 1.36 (s, 9H). 
 
Vanillin (0.740 g, 4.86 mmol) was dissolved in CH2Cl2 (6.0 mL), and 1.5 mL of 
pyridine was added. The mixture was cooled to 0 ºC, and 0.9 mL of Tf2O (5.35 
mmol) in CH2Cl2 (3.0 mL) was added. After full addition the cooling bath was removed and the 
solution was allowed to warm to rt over 1 h. The solution was quenched with 20 % NH4Cl and 
extracted three times with CH2Cl2. The combined organic phases were dried with MgSO4, 
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filtered and concentrated in vacuo to yield 1.351 g (98 %) of vanillin triflate, which was used 
immediately.146 Pale yellow oil. 3:2 Hexanes:EtOAc (v/v), Rf = 0.41. 1H-NMR (400 MHz, 
CDCl3): δ 9.98 (s, 1H), 7.56 (d, J = 1.8, 1H), 7.50 (dd, J = 1.8, 8.2, 1H), 7.40 (d, J = 8.2, 1H), 
3.99 (s, 3H). 
 
The triflate of vanillin (3.150 g, 11.08 mmol) and the boronic ester 4.10 
(4.30 g, 12.87 mmol) were dissolved in DME (55 mL), and the solution was 
degassed by sonication. Then 2 M NaOH (12.0 mL) was added, followed by 
343 mg of PdCl2dppf (0.469 mmol). The dark solution was placed in an 80 
ºC oil bath and stirred for 1 h. The black solution was poured into 100 mL of 
CH2Cl2 after cooling and washed with 8 % NH4Cl (500 mL). The aqueous phase was extracted 
with 4 x 50 mL of CH2Cl2. The combined organic phases were washed with 12 % NaCl (300 
mL), dried with MgSO4, filtered and concentrated in vacuo. Purification by flash 
chromatography in 25-30 % EtOAc in hexanes. Yield of 4.19: 2.769 g (73 %). Pale yellow oil. 
3:2 Hexanes:EtOAc (v/v), Rf = 0.38. 1H-NMR (400 MHz, CDCl3): δ 10.02 (s, 1H), 7.50 (dd, J = 
1.3, 7.5, 1H), 7.45-7.47 (m, 1H), 7.31 (d, J = 7.5, 1H), 7.07 (d, J = 8.4, 1H), 6.87 (d, J = 2.5, 
1H), 6.81 (dd, J = 2.6, 1H), 4.71 (t, J = 4.8, 1H), 3.84-3.89 (m, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 
3.74-3.79 (m, 2H), 2.48-2.58 (m, 2H), 1.75-1.85 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 
191.9, 159.4, 157.5, 141.4, 137.3, 136.9, 132.1, 130.9, 129.5, 124.2, 114.3, 111.3, 108.9, 103.9, 
64.8, 55.6, 55.2, 34.7, 27.9. 
 
The aldehyde 4.19 (0.840 g, 2.45 mmol) was dissolved in MeOH (25 mL), 
and NaBH4 (0.141 g, 3.73 mmol) was added. The solution was stirred for 1 
h and then concentrated in vacuo. The residue was dissolved in EtOAc (50 
mL) and washed with 100 mL of 20 % NH4Cl. The aqueous phase was 
extracted with EtOAc (3 x 10 mL). The combined organic phases were 
dried with MgSO4, filtered and concentrated in vacuo. Yield of 4.19a: 0.845 g (Q). Colorless oil. 
3:2 Hexanes:EtOAc (v/v), Rf = 0.10. 1H-NMR (400 MHz, CDCl3): δ 7.10 (d, J = 7.5, 1H), 7.06 
(d, J = 8.4, 1H), 6.95-6.99 (m, 2H), 6.86 (d, J = 2.6, 1H), 6.79 (dd, J = 2.7, 8.4, 1H), 4.74 (s, 
2H), 4.72 (t, J = 4.9, 1H), 3.87-3.89 (m, 2H), 3.83 (s, 3H), 3.76 (s, 3H), 3.76-3.78 (m, 2H), 2.50-
2.59 (m, 2H), 1.76-1.84 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 158.9, 157.2, 141.6, 141.4, 
131.6, 131.3, 130.5, 129.6, 118.8, 114.2, 111.1, 109.2, 104.1, 65.4, 64.8, 55.4, 55.2, 34.6, 28.0. 
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The alcohol 4.19a (0.7908 g, 2.296 mmol) was dissolved in THF (46 mL) 
under N2 and the flask was wrapped in tin foil. Then 0.452 g of NBS (2.540 
mmol) was added in one portion and the solution stirred for 1 h at rt, where 
it was quenched with 10 mL of sat. aq. Na2S2O3. The solution was 
concentrated in vacuo and the residue was taken up in EtOAc (50 mL), and 
washed with 100 mL of 10 % NH4Cl. The aqueous phase was extracted with 4 x 25 mL of 
CH2Cl2. The combined organic phases were dried with MgSO4, filtered and concentrated in 
vacuo. Purification by flash chromatography in 40 % EtOAc in hexanes. Yield of 4.19b: 0.7725 
g (80 %). Colorless oil. 3:2 Hexanes:EtOAc (v/v), Rf = 0.16. 1H-NMR (400 MHz, CDCl3): δ 
7.30 (s, 1H), 7.14 (s, 1H), 7.04 (d, J = 8.4, 1H), 6.86 (d, J = 2.6, 1H), 6.78 (dd, J = 2.7, 8.4, 1H), 
4.72-4.76 (m, 3H), 3.86-3.90 (m, 2H), 3.81 (s, 3H), 3.74-3.78 (m, 2H), 3.75 (s, 3H), 3.00 (br s, 
1H), 2.50-2.60 (m, 2H), 1.79-1.88 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 159.0, 156.3, 
141.4, 139.6, 134.5, 131.1, 130.9, 128.9, 114.0, 111.7, 111.0, 110.7, 103.7, 64.6, 64.5, 55.5, 
55.0, 34.4, 27.6. 
 
The alcohol 4.19b (0.6287 g, 1.485 mmol) was dissolved in CH2Cl2 (8.0 
mL), and 0.650 g of PCC (3.02 mmol) and 0.75 g of Celite were added. The 
slurry was stirred for 3 h at rt, where it was filtered through a pad of Celite, 
which was rinsed thoroughly with CH2Cl2. The filtrate was concentrated in 
vacuo and the residue was run through a short column with 20 % EtOAc in 
hexanes. Yield of 4.20: 0.6165 g (99 %). 2:3 Hexanes:EtOAc (v/v), Rf = 0.73. 1H-NMR (400 
MHz, CDCl3): δ  10.34 (s, 1H), 7.47 (s, 1H), 7.42 (s, 1H), 7.05 (d, J = 8.4, 1H), 6.86 (d, J = 2.6), 
6.81 (dd, J = 2.6, 8.4, 1H), 4.73 (t, J = 4.7, 1H), 3.87-3.91 (m, 2H), 3.83 (s, 3H), 3.80 (s, 3H), 
3.76-3.81 (m, 2H), 2.47-2.57 (m, 2H), 1.79-1.86 (m, 2H). 13C-NMR (100.5 MHz, CDCl3): δ 
191.7, 159.7, 156.7, 141.4, 138.7, 136.2, 132.9, 130.8, 128.1, 118.1, 114.4, 111.4, 110.5, 103.7, 
64.8,  55.9, 55.2, 34.6, 27.7. 
 
Guaiacol (10.0 g, 80.6 mmol) was dissolved in pyridine (322 mL), and 10.8 mL 
of carbamoyl chloride (84.6 mmol) was added. The solution was refluxed for 6 h 
and then concentrated in vacuo. The residue was taken up in 200 mL of Et2O, 
washed with 200 mL of 20 % NH4Cl. The aqueous phase was extracted with 4 x 50 mL of Et2O. 
The combined organic phases were dried with MgSO4, filtered and concentrated in vacuo. 
Purification by flash chromatography in 20 % EtOAc in hexanes. Yield of 4.21: 10.5 g (58 %). 
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3:2 Hexanes:EtOAc (v/v), Rf = 0.51. 1H-NMR (400 MHz, CDCl3): δ 7.06-7.26 (m, 2H), 6.88-
6.96 (m, 2H), 3.82 (s, 3H), 3.35-3.50 (m, 4H), 1.17-1.31 (m, 6H). 
 
tBuLi (5.0 mL, 1.15 M in pentane, 5.75 mmol) was added dropwise to THF (27 
mL) at -78 ºC. Then 0.7 mL of TMEDA (4.67 mmol) was added, followed by 
1.00 g of carbamate 4.21 (4.48 mmol) in THF (20 mL). After full addition the 
yellow solution was stirred for 1 h, where 6.1 mL of 2-isopropoxy-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (6.72 mmol) was added. The mixture warmed to rt in the 
cooling bath overnight. The solution was transferred to a separatory funnel with 100 mL of 
CH2Cl2 and washed with 300 mL of 13 % NH4Cl. The aqueous phase was extracted with 4 x 50 
mL of CH2Cl2. The combined organic phases were dried with MgSO4, filtered and evaporated in 
vacuo. Yield of 4.22: 1.55 g (99 %). 3:2 Hexanes:EtOAc (v/v), Rf = 0.44. 1H-NMR (400 MHz, 
CDCl3): δ 7.33 (dd, J = 1.6, 7.5, 1H), 7.14 (dd, J = 7.4, 8.1, 1H), 7.03 (dd, J = 1.5, 8.2), 3.81 (s, 
3H), 3.50 (br q, J = 6.9, 13.8, 2H), 3.39 (br q, J = 6.5, 13.7, 2H), 1.28-1.34 (m, 15H), 1.20 (br t, 
J = 7.0, 3H). 13C-NMR (100.5 MHz, CDCl3): δ 154.2, 151.7, 145.2, 127.2, 125.5, 115.3, 83.4, 
56.1, 42.0, 41.7, 24.8, 14.0, 13.4. IR(film) ν 2976, 2937, 1718, 1577, 1465, 1417, 1355, 1320, 
1271, 1160, 1051 cm-1. 
 
The bromide 4.20 (0.548 g, 1.30 mmol) and the boronic ester 4.22 
(0.548 g, 1.56 mmol) were dissolved in DME (6.5 mL) and the mixture 
was degassed by N2-purge during sonication. Then 0.80 mL of 2 M 
NaOH and 48.2 mg of PdCl2dppf (65.9 μmol) were added and the dark 
solution was stirred in an 80 ºC oil bath for 2 h. After cooling the solution was transferred to a 
separatory funnel with 50 mL of CH2Cl2 and washed with 100 mL of 18 % NaCl. The aqueous 
phase was extracted with 3 x 25 mL of CH2Cl2. The combined organic phases were dried with 
MgSO4, filtered and concentrated in vacuo. Purification by flash chromatography in 40 % 
EtOAc in hexanes. Yield of 4.23: 0.630 g (86 %). 2:3 Hexanes:EtOAc (v/v), Rf = 0.43. 1H-NMR 
(400 MHz, CDCl3): δ 9.86 (s, 1H), 7.54 (s, 1H), 7.18-7.23 (m, 2H), 7.05 (br d, J = 8.2, 1H), 7.00 
(dd, J = 1.4, 8.3, 1H), 6.91 (br d, J = 6.5, 1H), 6.85 (d, J = 2.6, 1H), 6.76 (dd, J = 2.6, 8.4, 1H), 
4.73 (t, J = 4.8, 1H), 3.85 (s, 3H), 3.84-3.87 (m, 2H), 3.83 (s, 3H), 3.80 (s, 3H), 3.73-3.77 (m, 
2H), 3.15-3.26 (br m, 4H), 2.46-2.64 (br m, 2H), 1.77-1.91 (br m, 2H), 0.90-1.07 (br m, 6H). 
LCMS: [M+H]+: 564. [M+Na]+: 586. 
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The aldehyde 4.23 (1.360 g, 2.413 mmol) was dissolved in MeOH (24 
mL), 0.669 g of K2CO3 (4.840 mmol) and 0.715 g of Ohira-Bestmann’s 
reagent (3.72 mmol) were added – the flask was rinsed with 1.0 mL of 
MeOH. The suspension was stirred at rt for 2 h under N2, where it was 
diluted with 100 mL of Et2O and poured into 300 mL of 12 % NaCl. The aqueous phase was 
extracted with 3 x 50 mL of Et2O. The combined organic phases were dried with MgSO4, 
filtered and concentrated in vacuo. Purification by flash chromatography in 40-60 % EtOAc in 
hexanes. Yield of 4.24: 1.1473 g (86 %). White solid. 2:3 Hexanes:EtOAc (v/v), Rf = 0.48. 1H-
NMR (400 MHz, CDCl3): δ 7.16-7.21 (m, 2H), 7.13 (s, 1H), 7.03-7.07 (m, 2H), 6.95 (dd, J = 
1.5, 8.2, 1H), 6.84 (d, J = 2.6, 1H), 6.75 (dd, J = 2.7, 8.4, 1H), 4.75 (t, J = 4.8, 1H), 3.86-3.90 
(m, 2H), 3.85 (s, 3H), 3.81 (s, 3H), 3.77 (s, 3H), 3.75-3.79 (m, 2H), 3.19-3.36 (m, 4H), 3.50-
3.62 (m, 2H), 3.03 (s, 1H), 1.78-1.90 (m, 2H), 0.97-1.09 (m, 6H). 13C-NMR (100.5 MHz, 
CDCl3): δ 158.9, 155.6, 153.4, 152.0, 141.4, 138.3, 134.4, 133.1, 132.8, 131.1, 130.9, 129.6, 
124.9, 123.1, 121.1, 114.5, 113.9, 111.5, 111.0, 103.9, 82.9, 79.6, 64.6, 56.0, 55.4, 55.0, 41.9, 
41.8, 34.5, 27.4, 13.8, 13.2. 
 
The alkyne 4.24 (1.0212 g, 1.825 mmol) and 48.6 mg of PtCl2 (0.183 
mmol) were dissolved in toluene (9.0 mL) and stirred under N2 at 80 ºC 
for 2½ h. The brown suspension was concentrated in vacuo to ¼ of the 
volume and purified by flash chromatography in 45 % EtOAc in 
hexanes. Yield of 4.24a: 0.5846 g (57 %). White foam. 2:3 Hexanes:EtOAc (v/v), Rf = 0.41. 1H-
NMR (400 MHz, d6-acetone): δ 8.87-8.95 (m 1H), 7.81 (d, J = 8.8, 1H), 7.73 (d, J = 8.9, 1H), 
7.66 (d, J = 7.66, 1H), 7.48 (s, 1H), 7.43 (d, J = 8.8, 1H), 7.09-7.20 (m, 1H), 6.92 (d, J = 2.4, 
1H), 6.85 (dd, J = 2.7, 8.3, 1H), 4.59 (t, J = 4.8, 1H), 3.93 (s, 3H), 3.89 (s, 3H), 3.85 (s, 3H), 
3.66-3.75 (m 2H), 3.56-3.65 (m, 2H), 3.13-3.47 (m, 4H), 2.47-2.65 (m, 2H), 1.65-1.80 (m, 2H), 
0.95-1.15 (m, 6H). LRMS: [M+H]+: 560. [M+Na]+: 582. 
 
The phenanthrene 4.24a (0.610 g, 1.090 mmol) was dissolved in MeOH 
(12.0 mL), 640 mg of 10 % Pd/C was added, and the mixture was stirred 
under a 28 bar H2-atmosphere for 21 h. The slurry was filtered, 
concentrated in vacuo and purified by flash chromatography in 40 % 
EtOAc in hexanes. Yield of 4.25: 511 mg (84 %). Colorless oil. 2:3 Hexanes:EtOAc (v/v), Rf = 
0.45. 1H-NMR (400 MHz, acetone- d6): δ 7.72 (s, 1H), 7.08 (d, J = 8.3, 1H), 7.03 (d, J = 8.2, 
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1H), 6.98 (s, 1H), 6.88 (d, J = 8.3, 1H), 6.86 (d, J = 2.7, 1H), 6.80 (dd, J = 2.6, 8.3, 1H), 4.66 (t, 
J = 4.7, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 3.76 (s, 3H), 3.67-3.84 (m, 4H), 3.09-3.55 (m, 4H), 2.73-
2.85 (m, 4H), 2.48-2.60 (m, 2H), 1.68-1.80 (m, 2H), 0.93-1.12 (m, 6H). LRMS: [M+Na]+: 584. 
 
The acetal 4.25 (0.4345 g, 0.7736 mmol) was dissolved in MeOH (10.5 
mL), 1 M HCl (5.5 mL) was added and the solution was stirred at 50 ºC 
overnight. The reaction was poured into 100 mL of 20 % NH4Cl and 
extracted with 4 x 50 mL of CH2Cl2. The combined organic phases were 
dried with MgSO4, filtered and concentrated in vacuo to afford a quantitative yield of 4.25a, 
0.399 g. 2:3 Hexanes:EtOAc (v/v), Rf = 0.45. 1H-NMR (400 MHz, CDCl3): δ 9.63 (s, 1H), 7.70 
(s, 1H), 7.05 (d, J = 8.2, 1H), 7.07-7.10 (m, 1H), 6.81 (s, 1H), 6.75-6.79 (m, 3H), 3.82 (s, 3H), 
3.81 (s, 3H), 3.77 (s, 3H), 3.12-3.51 (m, 4H), 2.68-2.89 (m, 6H), 2.47-2.61 (m, 2H), 0.93-1.14 
(m, 6H). 
 
The aldehyde 4.25a (0.395 g, 0.763 mmol) was dissolved in MeOH (8.0 
mL), 214 mg of K2CO3 (1.55 mmol) and 211 mg of the Ohira-Bestmann 
reagent (1.10 mmol) were added – the flask was rinsed with 0.5 mL of 
MeOH. The suspension was stirred overnight and diluted with 50 mL of 
Et2O and washed with 100 mL of H2O. The aqueous phase was extracted with 2 x 50 and 2 x 25 
mL of Et2O. The combined organic phases were dried with MgSO4, filtered and concentrated in 
vacuo. The residue was purified by flash chromatography in 40 % EtOAc in hexanes. Yield of 
4.26: 0.354 g (90 %). 3:2 Hexanes:EtOAc (v/v), Rf = 0.35. 1H-NMR (400 MHz, CDCl3): δ 7.70 
(s, 1H), 7.08 (d, J = 8.4, 1H), 7.05 (d, J = 8.2, 1H), 6.90 (d, J = 2.6, 1H), 6.81 (s, 1H), 6.76-6.80 
(m, 2H), 3.83 (s, 3H), 3.81 (s, 3H), 3.78 (s, 3H), 3.08-3.55 (m, 4H), 2.76-2.90 (m, 4H), 2.62-
2.73 (m, 2H), 2.31 (dt, J = 2.5, 7.5, 2H), 1.92 (t, J = 2.6, 1H), 0.96-1.11 (m, 6H). LCMS 
[M+H]+: 514. 
 
The carbamate 4.26 (0.1913 g, 0.373 mmol) was dissolved in benzene 
(10.0 mL), and 1.2 mL of Vitride (65 % in toluene) was added. The 
solution was heated to reflux under N2. After 6 h an additional 0.6 mL of 
Vitride was added, and the mixture refluxed for another 4 h. The dark 
solution was quenched with 1.2 mL of 2 M NaOH after cooling, dried with MgSO4, filtered and 
concentrated in vacuo. The residue was purified by flash chromatography in 20 % EtOAc in 
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hexanes. Yield og 4.26a: 79 mg (51 %). 3:2 Hexanes:EtOAc (v/v), Rf = 0.55. 1H-NMR (400 
MHz, CDCl3): δ 8.23 (s, 1H), 7.18 (d, J = 8.4, 1H), 6.92 (d, J = 2.7, 1H), 6.83 (dd, J = 2.7, 8.4, 
1H), 6.82 (s, 1H), 6.74 (d, J = 8.1, 1H), 6.70 (d, J = 8.1, 1H), 6.13 (br s, 1H), 3.90 (s, 3H), 3.84 
(s, 3H), 3.79 (s, 3H), 2.79-2.89 (m, 4H), 2.75 (t, J = 7.8, 2H), 2.33-2.40 (m, 2H), 1.91 (t, J = 2.6, 
1H). LCMS [M+Na]+: 437.  
 
The phenol 4.26a (6.0 mg, 14.5 µmol), Cs2CO3 (10.1 mg, 31 µmol) and 
pyrone 4.16 (22.0 mg, 0.169 mmol) were dissolved in DMF (2.0 mL) 
and stirred at 50 ºC for 24 h and then 80 ºC for 5 h. The solvent was 
removed in vacuo and the residue was purified by prep. TLC in 40 % 
EtOAc in hexanes. Yield of 4.27: 3.0 mg (41 %). White solid, mp = 175-177 ºC. 3:2 
Hexanes:EtOAc (v/v), Rf = 0.25. 1H-NMR (400 MHz, toluene- d8): δ 8.03 (s, 1H), 7.06 (d, J = 
8.4, 1H), 6.89 (d, J = 2.7, 1H), 6.84 (d, J = 8.3, 1H), 6.70 (dd, J = 2.7, 8.4, 1H), 6.54 (dd, J = 
0.7, 5.9, 1H), 6.46 (s, 1H), 6.37 (d, J = 8.3, 1H), 5.60 (dd, J = 2.4, 5.9, 1H), 5.29 (dd, J = 0.7, 
2.4, 1H), 3.41 (s, 3H), 3.25 (s, 3H), 3.21 (s, 3H), 2.67-2.80 (m, 2H), 2.49-2.58 (m, 4H), 2.19 (dt, 
J = 2.6, 7.8, 2H), 1.65 (t, J = 2.6, 1H). 1H-NMR (400 MHz, CDCl3): δ 7.74 (s, 1H), 7.38 (d, J = 
5.8, 1H), 7.15 (d, J = 8.3, 1H), 6.97 (d, J = 8.3, 1H), 6.89 (d, J = 2.6, 1H), 6.78-6.84 (m, 3H), 
6.16 (dd, J = 2.3, 5.8, 1H), 5.14 (d, J = 2.3, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 3.77 (s, 3H), 2.83 (br 
s, 4H), 2.62 (t, J = 7.8, 2H), 2.18-2.24 (m, 2H), 1.26 (t, J = 7.1, 1H). IR(film) ν 3275, 2938, 
2836, 1722, 1640, 1603, 1558, 1511, 1494, 1436, 1397, 1326, 1282, 1236, 1200, 1159, 1101, 
1042 cm-1. HRMS [M+H]+: calcd 509.1959, found 509.1960, HRMS [M+Na]+: calcd 531.1778, 
found 531.1780. 
 
The alkyne 4.27 (5.3 mg,10.4 µmol) was dissolved in EtOH, 1 drop of 
pyridine and 1.8 mg of Lindlar’s catalyst were added and the mixture 
was stirred under H2 for ½ h. Purification by prep. TLC in 60 % EtOAc 
in hexanes after filtration through a small plug of Celite to yield 4.27a 
quantitatively. 1H-NMR (500 MHz, CDCl3): δ 7.74 (s, 1H), 7.35 (d, J = 
5.9, 1H), 7.14 (d, J = 8.3, 1H), 6.98 (d, J = 8.3, 1H), 6.79-6.83 (m, 3H), 6.77 (dd, J = 2.7, 8.3, 
1H), 6.14 (dd, J = 2.4, 5.8, 1H), 5.60-5.70 (m, 1H), 5.15 (d, J = 2.4, 1H), 4.81-4.86 (m, 2H), 
3.84 (s, 3H), 3.79 (s, 3H), 3.76 (s, 3H), 2.80-2.87 (m, 4H), 2.43-2.48 (m, 2H), 2.07-2.15 (m, 
2H). 
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The alkene 4.27a (5.5 mg, 10.8 μmol) was dissolved in o-DCB (5.5 
mL) and heated to 200 ºC for 10 h under microwave irradiation. The 
solvent was removed in vacuo and the residue was purified by prep. 
TLC in 10 % EtOAc in hexanes to yield 3.2 mg of a mixture of two 
compounds in a ratio of 5:3 in favor of cavicularin trimethyl ether.  
 
Cavicularin: The alkyne 4.27 (3.0 mg, 5.90 μmol) was dissolved in o-
DCB (3.0 mL) and heated to 225 ºC for 10.5 h under microwave 
irradiation. The solvent was removed in vacuo and the residue was 
purified by prep. TLC in 10 % EtOAc in hexanes. This residue was 
dissolved in 0.2 mL of CH2Cl2, and BBr3 (50 μmol, 50 μL, 1 M in CH2Cl2) was added. The 
solution was stirred for 3 h at rt and quenched with MeOH. The mixture was concentrated in 
vacuo several times with MeOH. The solids were purified by prep. TLC in 40 % EtOAc in 
hexanes to yield a mixture of two compounds.  
1H-NMR showed signals characteristic with those reported earlier for cavicularin.113, 115
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5 Ruthenium-catalyzed Amidation 
5.1 Introduction 
Traditionally, the generation of an amide relies extensively on the reaction between an 
activated carboxylic acid and an amine. This constitutes a strategy that often produces a 
stoichiometric amount of unfortuitous by-products. In recent years catalytic approaches that do 
not produce harmful by-products have appeared. Remarkably different systems all based on a 
variety of transition metal catalysts have been developed (scheme 5.1).147-151 
 
N HN
RuH2(PPh3)4 (3 mol%)
H2O (2 eq.)
DME, 160°C, 24 h
Sealed tube, 97 %
O
N(A)147
NH2
Ru(OH)x/ Al2O3 (5 mol% Ru)
H2O, 5 atm O2,
140 °C, 10 h, 92 %
NH2
O
(B)148
NH2(C)149 OH
5
N
H
N
PtBu2
NEt2
Ru CO
H
(0.1 mol%)
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7 h, 96 %
4
N
H
O
NN
iPr iPr, Cl
[Ru(COD)Cl2]n (2 mol%)
(2 mol%)
PCyp3•HBF4 (2 mol%)
tBuOK (8 mol%)
PhCH3, reflux, 93 %
O
NH2(D)150
OH
(E)151
[Rh(trop2NH)PPh3]OTf (0.2 mol%)
tBuOK (0.2 mol%), THF
OH
H2N
O
N
H
COOMe
(300 mol %)
-30 - rt °C, 4 h, 93 %  
Scheme 5.1: Transition metal-based amidation protocols. 
 
A simple catalytic system for the conversion of alcohols and amines into amides with a 
ruthenium catalyst by H2-liberation was recently developed in the Madsen group, scheme 5.1, 
eq. D.150 Although, the reaction provided a diverse array of amides under standard conditions 
with commercially available reagents and in that sense performed excellently, the mechanism 
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was poorly understood. Nordstrøm et al. suggested a tentative mechanism based on the initial 
findings (scheme 5.2).150 It was shown that the reaction does not go through an imine or ester, 
but rather through a hemiaminal intermediate with overall liberation of two equivalents of 
dihydrogen. On the other hand, the exact role and nature of the catalyst remains ambiguous, 
since the catalytically active species was generated in situ.  
 
 
 
Scheme 5.2: Suggested mechanism according to Nordstrøm et al. 
 
Milstein et al. had earlier on reported the same transformation with a fully preformed catalyst, 
scheme 5.1, eq. C.149 This catalyst did not involve an NHC-ligand, but instead a PNN-pincer 
ligand. It was clear from Milstein et al.’s report that the PNN-pincer was participating in the 
reaction by an aromatization/dearomatization-shift.  In connection to this it was unclear to us 
whether the NHC-ligand was involved in the catalytic cycle in a similar manner, i.e. C-H-
activation of the ligand by ruthenium. Multiple reports have shown that ruthenium is able to 
activate a C-H-bond on its NHC-ligand.152 In order to gain some insight into the mechanism viz. 
the nature of the catalytic active species and the rate-determining step, we set out to synthesize a 
pre-catalyst containing an NHC-ligand that would perform equally well as the previously 
reported system. The idea was to install the proper NHC-ligand on the ruthenium metal-center, 
isolate the complex and test it in the amidation reaction. When a suitable catalyst was obtained 
an actual mechanistic study could then be initiated.  
Ruthenium-catalyzed Amidation 
 89 
 
5.2 Results & Discussion 
It was anticipated that the simplest route to a pre-catalyst was to generate the NHC-ligand in 
the presence of [Ru(COD)Cl2]n and isolate the formed catalyst. Therefore, the first thing 
attempted was to install an NHC-ligand on [Ru(COD)Cl2]n by different modes of carbene-
addition or -transfer. It was quickly realized that a ruthenium-complex containing both an NHC-
ligand and a COD-ligand was too sensitive to be isolated and applied in the amidation reaction 
without applying glove-box or Schlenk techniques. Furthermore, addition of an NHC-ligand to 
Ru(PPh3)3Cl2 and Ru(PPh3)3HCl according to Whittlesey et al. in order to obtain a pre-catalyst 
with both a phosphine and an NHC-ligand (i.e. fully elaborated pre-catalyst) failed due to 
purification difficulties.152 Instead, we turned to a more stable ligand, i.e. an 18-electron 
complex with the cymene ligand. The cymene ligand was envisioned to depart from ruthenium 
at elevated temperature (85 ºC) and generate the same catalytically active species, although 
separate addition of a phosphine ligand would be required.153 One-pot silver-carbene formation 
and NHC-transfer to ruthenium afforded the desired complex in excellent yield after flash 
chromatography (scheme 5.3).154  
NN R, ClR
[Ru(p-Cymene)Cl2]2
CH2Cl2, reflux
N N
Ru Cl
Cl
RR
Ag2O
5.1, R = Cy, 93 %
5.2, R = iPr, Q  
Scheme 5.3: Synthesis of an amidation pre-catalyst 
 
The catalysts 5.1 and 5.2 proved to be equally efficient at producing the amide from 2-
phenylethanol and benzylamine as the in situ generated catalyst from [Ru(COD)Cl2]n (scheme 
5.4 and table 5.1). This alcohol and amine were chosen as the standard test substrates for the 
amidation like the previous study in the group.150 The 3-hour conversion of starting material into 
the desired amide was taken as a measure of how well different catalysts performed compared to 
each other. The yield (GC-yield obtained by comparison to an internal standard) at no further 
conversion is also shown (after 20-24 h).  
 
OH
NH2
O
H
N
Ru-catalyst (5 mol%)
Phosphine (5 mol%)
KHMDS (10 mol%)
PhCH3, Δ  
Scheme 5.4: Benchmark amidation reaction for this study. 
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Table 5.1: Performance of different catalysts. GC-yields after 3/ 20+ h. 
Entry 
 
 
PCy3 PCyp3·HBF4 PCyp3 Without 
phosphine 
1 [Ru(COD)Cl2]n 
 
56/ 89A 92B 98B - 
2 N N
Ru Cl
Cl
 
 
65/ 95 
 
19/ 61 
 
53/ 100 
 
55/ 70 
3 N N
Ru Cl
Cl
CyCy
 
 
61/ 97 
 
30/ 70 
 
56/ 91 
 
38/ 57 
4 N N
Ru I
I
CyCy
 
 
In situ: 56/ 90
22/ 50 
 
 
- 
 
In situ: 63/ 87 
 
 
- 
5 
N N
Ru Cl
Cl
 
 
 
0 / 5 
 
 
- 
 
 
- 
 
 
- 
6 
Ru Cl
Cl
N
N
 
 
 
25/ 45 
 
 
- 
 
 
- 
 
 
- 
 
A) With ICy, this work. B) Reaction performed with IiPr, isolated yield, ref. 150.  
 
Table 5.1 shows that both the NHC-ligands ICy and IiPr (entry 2 & 3) perform equally well as 
the initial system depicted in scheme 5.1D, which provided the amide in 56 and 89 % yield after 
3 and 20+ h respectively (entry 1). In our hands the use of either PCy3 or PCyp3 proved superior 
to the more stable salt PCyp3·HBF4. With the NHC-ligand installed on the ruthenium as little as 
10 mol% base could be used at a 5 mol% catalyst loading. The strong base KHMDS (in toluene) 
was the base of choice since it gave consistent yields, although tBuOK usually performed well 
too. Interestingly, with KHMDS the solution was homogenous at all times during the reaction. 
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It was tried to alter different parts of the catalyst in order to improve the system. Exchange 
of the chlorides bonded to the ruthenium with iodides did not bring about any improvement 
(compare entry 3 & 4). By transferring the carbene to [Ru(p-cymene)I2]2 in analogy to scheme 
5.3 two compounds – a red and yellow band by preparative thin layer chromatography – were 
isolated. The yellow band-compound showed identical 1H-NMR shifts and elemental analysis as 
the corresponding chloride catalyst, entry 3. The red band diiodide catalyst (entry 4) did not 
work as well as the dichloride catalyst 5.1 in the amidation reaction. Running the reaction by in 
situ generation of the catalyst from [Ru(p-cymene)I2]2 and ICyHCl showed similar reactivity to 
that of catalyst 5.1. 
Early studies taught us that saturated NHC-ligands performed poorly.150 An NHC-ligand 
where the backbone was fused to an aromatic system could provide a different reactivity (entry 
5, table 5.1), since the NHC-ligand is still unsaturated, but the electrons are now less available. 
Indeed, such a modification altered the reactivity to generate an almost completely inactive 
catalyst. In turn it was envisioned that reducing the sterics around the ruthenium center would 
enhance the reactivity. An abnormal carbene as shown in entry 6 was chosen as a suitable 
testing ground. The complex was synthesized in analogy to scheme 5.2 according to the methods 
described by Peris et al.155 As it turned out the catalyst only provided conversion to the desired 
amide to some extent. The lower degree of reactivity could not only be ascribed to less steric 
demand on the metal center, but also enhanced σ-donation from the ligand.155, 156 Returning to 
the ICy-catalyst 5.1 and changing the solvent to dioxane or heptane (because of their boiling 
points) did not affect the course of the reaction. Furthermore, addition of 10 mol% of MsOH 
quenched the reaction completely as did silver triflate (10 mol%). Addition of up to 10 mol% of 
LiCl or omitting the phosphine only showed minor inhibition of the reaction progress, which 
eventually provided the amide.  
At this point attention was directed toward the report by Grubbs et al. which stated that 
applying an H2-atmosphere after ring closing metathesis with Grubbs 1st gen. catalyst would 
generate the effective hydrogenation catalyst RuHCl(H2)(PCy3)2.157 They showed that the 
benzylidene ligand for starting the RCM had been hydrogenated off. This allowed for the 
synthesis of a fully elaborated pre-catalyst (with a phosphine and an NHC-ligand) for the 
amidation reaction that would produce the proper catalytic species, because the H2 formed in the 
reaction would remove the benzylidene. Indeed, it was found that simply applying Grubbs 1st 
without any NHC-ligand under standard conditions provided the amide in 71 % yield after ~20 
h. Upon addition of ICyHCl or IiPrHCl the amidation had taken place in 76 % yield after 3 h and 
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affording the amide quantitatively overnight. A screening of different metathesis catalysts was 
carried out to answer whether these would supply us with a ready-to-use catalyst, table 5.2.  
 
Table 5.2: Screening of metathesis catalysts’ performance in the amidation. Loading: 5 mol%. 
Entry Yield (3/ 20+ h) Entry Yield (3/ 20+ h) 
1 
Ru
PCy3
PCy3
Cl
Cl Ph
Grubbs 1st  
 
48/ 71 
 
76/ 96A 
5
Ru
PCy3
PCy3
Cl
Cl
S
 
 
9/ 15 
 
34/ 78A 
2 
Grubbs 2nd
Ru
PCy3
Cl
Cl
NN
Ph
MesMes
 
 
29/ 49 
6
Ru
PCy3
PCy3
Cl
Cl Ph
Neolyst M1  
 
25/ 42 
 
67/ 100A 
 
3 
Ru
PCy3
Cl
Cl
O
Hoveyda-Grubbs 1st  
 
41/ 60 
 
84/ 100A 
7
Ru
PCy3
Cl
Cl
NN MesMes Ph
catMETium® IMesPCy
 
45/ 69 
4 
Hoveyda-Grubbs 2nd
Ru
Cl
Cl
NN MesMes
O
 
 
48/ 65 
41/ 58B 
 
8
Grubbs 3rd
Ru
PCy3
Cl
Cl
NN
Ph
oToloTol
 
 
63/ 92 
 A) With 5 mol% ICy generated in situ. B) 5 mol% PCy3 added. 
 
From table 5.2 it is seen that no metathesis catalyst on its own brings any improvement. The 
newer generation metathesis catalyst (entry 8) did however show comparable reactivity to the 
complexes containing the cymene ligand, catalysts 5.1 and 5.2. This was surprising since it 
contained an NHC-ligand with a saturated backbone. By generating ICy in situ with the catalysts 
without any NHC-ligand (entry 1, 3 and 6) very effective amidation catalysts were formed. 
Delighted by this finding a small screening of other NHC-ligands was undertaken (table 5.3) 
with the conditions from scheme 5.4. 
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Table 5.3: Screening of NHC-ligands for amidation with Grubbs 1st. 
Entry Yield (3/ 20+ h) Entry Yield (3/ 20+ h)
 
1 
 
None 
 
48/ 71 
 
8 NN
Me,Me
S
O
OMeO
Me
O
 
 
37/ 55 
2 
NN Cy, ClCy
 
76/ 96 9 
N
N Me, I
Me
 
30/ 50 
3 
NN
iPr, CliPr
 
76/ 100 10 S N Cy, Br
 
5/ 7 
4 
NN
tBu, CltBu
 
23/ 53 11 NN Cy, HBF4Cy
 
72/ 100 
5 
NN Mes, ClMes
 
44/ 71 12 NN
oTol, CloTol
 
36/ 65 
6 NN Me,Me P
O
(OMe)2O  
65/ 91 13 NN
pTol, ClpTol
 
41/ 65 
7 
NN Me, OctSO4
nBu
 
27/ 75    
 
In accordance with previous findings by Nordstrøm, Vogt and Madsen ItBu and IMes (table 5.3, 
entry 4 and 5) did not perform well in the reaction. On the other hand, IMe (entry 6) performed 
much better showing that the N-methyl substitutions work well.150 In connection to this the 
increased σ-donation of abnormal NHC-ligands (entry 8 and 9) must decrease their reactivity. 
Grubbs and Vougioukalakis had earlier on synthesized a range of effective thiazol-2-ylidene 
substituted metathesis catalysts, which displayed increased heat stability.158 Inspired by this the 
N-cyclohexyl thiazolium salt (entry 10) was synthesized in two steps and applied to the 
amidation reaction only to find that the salt quenched the reaction. Most likely the thiazol-2-
ylidene dimerizes readily when deprotonated as reported by Arduengo et al.159 and the silver-
carbene transfer procedure applied by Grubbs and Vougioukalakis was unsuccessfully employed 
both in situ with Grubbs 1st and with [Ru(p-cymene)Cl2]2. The commercially available ICyHBF4 
(entry 11) was included in the screening to establish that this type of counter ion had little 
influence on the reaction progress. Surprised by the efficiency of the Grubbs 3rd (Table 5.2, 
entry 8) both IoTolHCl and IpTolHCl were synthesized and applied with Grubbs 1st. 
Unfortunately, it provided a reactivity similar to that of IMes (entry 5) and the catMETium-
catalyst (entry 7, table 5.2) although the sterics should be somewhat different, and as a result 
further NHC-screening was abandoned at this point. 
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On the basis of the findings in table 5.2 and 5.3 the synthesis of the known Grubbs 2nd-
analoque, 5.3, was undertaken (scheme 5.5).160, 161 Following the original procedure reported by 
Herrmann et al. the isolated solid proved inferior in the amidation reaction.161 They noted that 
low temperature was required in order to achieve the mono-carbene complex in THF. Only by 
applying the conditions reported by Nolan et al. were we able to produce a capable complex 
showing similar efficiency as the in situ generated system: 74 % yield in 3 h and 97 % 
overnight.162, 163 
 
Ru
PCy3
Cl
Cl
NN
Ph
CyCy
Ru
PCy3
PCy3
Cl
Cl Ph
NN Cy, ClCy
tBuOK, hexane
rt, 53 %
5.3  
Scheme 5.5: Synthesis of the more effective amidation pre-catalyst according to Nolan et al. 
 
With the most capable and easy to isolate pre-catalyst yet in hand it was tested whether it was 
able to provide amides from more demanding substrates i.e. anilines and secondary amines. It 
was quickly found that the amide from aniline and 2-phenylethanol in both mesitylene, toluene 
or under neat conditions afforded the desired amide in only 26 % yield. A substantial amount of 
alcohol had been turned into the analogous ester. This did not represent an improvement 
compared to the in situ generated catalyst from Nordstrøm et al.150 On the other hand, catalyst 
5.3 produced the desired tertiary amide from 2-phenylethanol and N-benzylmethylamine in 
toluene in 65 % isolated yield. Excited by this, the original conditions with the IiPr-ligand and 
[Ru(COD)Cl2]n in toluene were applied to confirm the improvement.150 Surprisingly, 70 % 
amide was isolated, which is in contrast to the reported 40 %. Presumably, the difference in 
yield is a result of different isolation procedures. Originally, the amide was isolated by flash 
chromatography, but the amides are hard to develop with a range of different stains and 
furthermore possess low UV-absorption when dilute. Hence, some amount of the product may 
have been lost. In this work the amide was isolated by preparative TLC. Overall the system is 
capable of producing tertiary amides in contrast to Milstein’s catalyst, which however handles 
anilines much better.149 
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5.3 Mechanistic Considerations 
In 2007 Burling et al. showed that heating ruthenium-complex 5.4 in the presence of a 
dihydrogen acceptor resulted in reversible C-H-activation of the NHC-side chains (scheme 
5.6).164 They verified the structure of complex 5.5 by X-ray crystallography. The activation was 
reversed by the introduction of dihydrogen or an alcohol. Also, strong base (KHMDS or tBuOK) 
will abstract a proton from the NHC-ligand and lead to C-H-activation.165 
 
Ru
H
Ph3P H
PPh3OC
NN
Ru
H
Ph3P
PPh3OC
NNTMS
Δ,
H2 or iPrOH,
Δ
5.4 5.5  
Scheme 5.6: C-H-activation in a ruthenium-complex with IiPr. 
 
Chatwin et al. have reported that hydrogen-transfer from an alcohol or an amine to a Ru-hydride 
and ensuing elimination of dihydrogen is kinetically and thermodynamically feasible.166 In view 
of these reports, initial studies toward a mechanistic understanding were begun. In order to 
elucidate whether ruthenium performs C-H-activation on the NHC-ligand a deutorated analogue 
of catalyst 5.2 was synthesized, scheme 5.7.  
N N
Ru Cl
Cl
D
CD3
CD3
D
D3C
D3C
 
Scheme 5.7: Deutorated analogue of catalyst 5.2. 
 
The reaction was run on a 2 mmol scale as depicted in scheme 5.4 with a catalyst loading of 10 
mol% to achieve a reasonable distribution between the possible gases. In assuring not to obtain a 
false positive the gas sample was taken before the reaction had gone to completion and therefore 
before the idle catalyst would perform C-H-activation in its last turn-over. By employing 
selected ion monitoring on the liberated gases (H2/ H-D) we were able to demonstrate the 
formation of H-D by C-H-activation. The two gases were found to be present in a ratio of H2:H-
D 50:1. Although KHMDS can abstract deuterium directly from the catalyst it cannot deliver the 
deuterium back to the catalyst and deuterium abstracted in this fashion would not appear in the 
gas. If KHMDS deprotonates the alcohol, this alkoxide would presumably abstract deuterium 
from the catalyst to a minor extent, based of the strength of the alkoxide as a base. In any case, 
Ruthenium-catalyzed Amidation 
 96 
 
the presence of D2 was found negligible. These pathways are therefore not dominating in 
releasing deuterium in the gas. Hence, the presence of H-D suggests that the catalyst is able to 
perform C-H-activation somewhere in the catalytic cycle, but the relatively small amount of 
deuterium imply that C-H-activation is not a major pathway. Based on this a tentative 
mechanism for the amidation reaction is proposed, scheme 5.8.  
 
N N
Ru Cl
N N
Ru ClΔ
BnNH2
BnOH
KHMDS,
BnOH
N N
Ru Cl
O
Ph
H
-Cl
N N
Ru Cl
O
Ph
-H2↑
HN
H
Ph
N N
Ru Cl
O
Ph
H H
ClCl
H
NBn
H
N N
Ru Cl
O
Ph
NBn
H
H
- H2↑
N N
Ru Cl
O H
HPh O
NHBn
BnO
N N
Ru Cl
O H2
Ph
H
BnNH2
 
Scheme 5.8: Tentative mechanism for the amidation.  
 
The catalytic cycle is initiated upon heating the ruthenium-complex 5.2, which leads to loss of 
the cymene ligand. An alkoxide coordinates to the metal and is in turn oxidized to the aldehyde. 
In this fashion a ruthenium-hydride is generated and the cycle is entered. At this point a 
previously coordinated amine attacks the aldehyde to form a hemiaminal, neither the aldehyde 
nor the hemiaminal leaves the coordination-sphere of the metal at any point as shown by 
Nordstrøm et al.150 Hydrogen transfer from the hemiaminal produces a molecule of dihydrogen 
and H2 is liberated.166, 167 The amide is produced by β-hydride elimination of the hemiaminal. 
Another alcohol coordinates to the metal and by hydrogen-transfer a molecule of dihydrogen is 
produced and liberated. The catalytic cycle is reentered by β-hydride elimination of the alcohol 
to form an aldehyde and ruthenium-hydride. It is improbable that a ruthenacycle formed by C-
H-activation persists through the whole catalytic cycle in the presence of alcohols and amines at 
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elevated temperatures. Rather - according to scheme 5.6 - it represents a stabilized source of 
catalyst capable of producing a coordinatively unsaturated complex. The driving force of the 
productive catalytic cycle is the irreversible liberation of dihydrogen along with the formation of 
the unreactive amide. In accordance to the mechanism for ruthenium catalyzed transfer-
hydrogenation with BINAP, ruthenium remains in the same oxidation state (II) throughout the 
catalytic cycle.168, 169 As depicted by the screening (table 5.3) the substituent on the NHC-ligand 
matters, i.e. only a certain extent of steric bulk is tolerated. At some point during the cycle 
additional electron-density or bulk is needed and hence the addition of PCy3 is necessary. Most 
likely the phosphine is responsible for stabilizing the catalyst resting state. 
 
5.4 Conclusion 
Two isolatable catalysts – [RuCl2(p-cymene)IiPr] and [RuCl2(p-cymene)ICy] –  have been 
prepared and proven to be equally active as the original system employing the in situ generated 
catalyst from [Ru(COD)Cl2]n and IiPrHCl. Furthermore, it was discovered that an array of 
different metathesis catalysts are able to perform the amidation under the conditions developed 
in the Madsen group. Especially, the 1st generation catalysts with ICy- or IiPr-ligands proved 
very effective in the transformation. Also, a second generation metathesis catalyst 5.3 has been 
synthesized and found to be performing very well in the reaction. By means of deuterium-
labeling, data suggests that C-H-activation of the ruthenium NHC-ligand is not a major pathway 
and a tentative catalytic cycle is suggested. 
 
Ruthenium-catalyzed Amidation 
 98 
 
5.5 Experimental Section 
General procedures 
See section 1.6 
 
The reactions were analyzed by GC using a 15 m x 0.10 mm x 0.10 μm Supelco Equity-1 
capillary column with the following retention times:   
Benzylamine: 2-Phenylethanol: Dodecane: N-Benzyl-2-phenylacetamide: 
4.09 min. 4.63 min. 5.11 min. 7.72 min. 
 
GC-program for Ru-catalyzed amidation: 
Temperature (ºC) Hold Time (min.) 
50.0 2.0 (ramp 40) 
300.0 5.0 
 
 
General Procedure for the Ru-catalyzed Amidation with Grubbs I 
Grubbs I (25 μmol, 5 mol%), ICyHCl (25 μmol, 5 mol%), the amine (0.5 mmol) and the alcohol 
(0.5 mmol) were mixed in a Schlenk flask and three cycles of high vacuum/Ar-backfill were 
performed. A cold finger was mounted and 1.0 mL of anhydrous and degassed toluene was 
added followed by KHMDS (in toluene, 75 μmol, 15 mol%). The solution was heated to reflux 
for 20-24 h under a positive flow of Ar. The reaction could then be purified directly by flash 
chromatography in 20-50% EtOAc in pentane.  
 
General Procedure for the Ru-catalyzed Amidation with Complex 5.1 
The complex 5.1 (25 µmol, 5 mol%), PCy3 (25 µmol, 5 mol%), the amine (0.5 mmol) and the 
alcohol (0.5 mmol) were mixed in a Schlenk flask and three cycles of high vacuum/Ar-backfill 
were performed. A cold finger was mounted and 1.0 mL of anhydrous and degassed toluene was 
added followed by KHMDS (in toluene, 75 µmol, 15 mol%). The solution was heated to reflux 
for 20-24 h under a positive flow of Ar. The reaction could then be purified directly by flash 
chromatography in 20-50% EtOAc in pentane. 
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General Procedure for Installing an NHC-ligand on [Ru(p-Cymene)Cl2]2 exemplified with 
ICyHCl: ICyHCl (200.2 mg, 0.75 mmol) and Ag2O (86.1 mg, 0.37 mmol) were suspended in 
7.0 mL of dry and degassed CH2Cl2 under Ar and refluxed for 1 h in a Schlenk flask with a 
reflux condenser. Then [Ru(p-Cymene)Cl2]2 (226.0 mg, 0.37 mmol) in 3.0 mL of anhydrous, 
degassed CH2Cl2 was added and the solution was refluxed for 1 h and concentrated in vacuo. 
The residue was filtered through a short column of SiO2 in 10 % iPrOH in CH2Cl2. Yield 0.3684 
g (93%) of a red-orange solid. 
 
Prepared according to Nolan et al.162 ICyHCl (56.1 mg, 0.209 mmol), tBuOK 
(36.0 mg, 0.320 mmol) and Grubbs I (164 mg, 0.20 mmol) were suspended in 5.0 
mL of anhydrous, degassed hexane in a dry Schlenk flask and stirred under Ar at 
rt overnight. The slurry was Schlenk-filtered and the solid residue was washed with 2 x 5 mL of 
degassed H2O and 2 x 5 mL of anhydrous, degassed hexane. The green solid was dried under 
high vacuum. Yield 81.0 mg (53 %).160, 161 
 
Yield: 93 % as a red-orange solid.170 Rf = 0.64, 9:1 CH2Cl2:iPrOH (v/v). 1H-NMR 
(300 MHz, CDCl3): δ 1.14-2.44 (m, 20H), 1.36 (d, J = 6.9, 6H), 2.13 (s, 3H), 2.84 
(m, 1H), 4.84 (m, 2H), 5.14 (d, J = 6.0, 2H), 5.46 (d, J = 6.0, 2H), 7.04 (s, 2H). 
13C-NMR (50 MHz, CDCl3): δ 18.8, 23.1, 25.3, 25.4, 26.0, 31.2, 35.4, 35.8, 59.3, 
83.6, 85.3, 97.3, 105.1, 119.3, 171.4. IR (neat) ν 3091, 2957, 2921, 2848, 1466, 1455, 1446, 
1418, 1380, 1290, 1276, 1232, 1190, 897, 747, 697 cm-1. MS [M-Cl]+: calcd 503.1762, found 
503.1456. Anal. Calcd for C25H38Cl2N2Ru: C, 55.75; H, 7.11; N, 5.20. Found: C, 55.14; H, 6.84; 
N, 5.16. 
 
Yield: Q as a red-orange solid.171 Rf = 0.64, 9:1 CH2Cl2:iPrOH (v/v). 1H-NMR 
(300 MHz, CDCl3): δ 1.31 (d, J = 6.9, 6H), 1.44 (br d, J = 6.2, 12H), 2.08 (s, 
3H), 2.92 (m, 1H), 5.15 (d, J = 6.0, 2H), 5.31 (m, 2H), 5.47 (d, J = 6.0, 2H), 7.07 
(s, 2H). 13C-NMR (75 MHz, CDCl3): δ 18.6, 22.8, 25.0, 30.8, 52.0, 83.4, 85.1, 
97.1, 106.4, 118.9, 171.1. IR (neat) ν 3152, 3099, 3077, 2958, 2930, 2870, 1473, 1412, 1391, 
1369, 1297, 1265, 1213, 1133, 856, 770, 700 cm-1. MS [M-Cl]+: calcd 423.1136, found 
423.0657. Anal. Calcd for C19H30Cl2N2Ru: C, 49.78; H, 6.60; N, 6.11. Found: C, 49.84; H, 6.44; 
N, 6.05. 
  
Ru
PCy3
Cl
Cl
NN
Ph
CyCy
N N
Ru Cl
Cl
CyCy
N N
Ru Cl
Cl
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Purified by prep. TLC in 10 % acetone in CH2Cl2. Combined yield: 56 % Red 
band: Rf = 0.89, 9:1 CH2Cl2:iPrOH (v/v). 1H-NMR (300 MHz, CDCl3): δ 1.20-
2.46 (m, 20H), 1.35 (d, J = 6.9, 6H), 1.97 (s, 3H), 3.31 (m, 1H), 5.03 (d, J = 5.9, 
2H), 5.14 (m, 2H), 5.80 (d, J = 5.9, 2H), 7.10 (s, 2H). 13C-NMR (50 MHz, 
CDCl3): δ 20.0, 23.4, 24.7, 25.3, 26.1, 31.4, 35.3, 35.8, 61.8, 80.5, 88.1, 100.4, 107.3, 119.9, 
167.7. IR (neat) ν 2924, 2853, 1439, 1371 1284, 1224, 1189, 995, 908, 725 cm-1. Anal. Calcd for 
C25H38I2N2Ru: C, 41.62; H, 5.31; N, 3.88. Found: C, 42.50; H, 5.67; N, 3.78. 
 
Yield: Q as a dark red solid. Rf = 0.22, 9:1 CH2Cl2:iPrOH (v/v). 1H-NMR (300 
MHz, CDCl3): δ 1.38 (d, J = 6.9, 6H), 1.69 (d, J = 7.2, 6H), 1.75 (d, 6.8, 6H), 
2.12 (s, 3H), 2.97 (m, 1H), 5.23 (d, J = 6.1, 2H), 5.61 (d, J = 6.1, 2H), 5.80 (m, 
2H), 7.20 (dd, J = 3.2, 6.2, 2H), 7.66 (dd, J = 3.2, 6.2, 2H). 13C-NMR (50 MHz, 
CDCl3): δ 18.6, 22.3, 22.6, 22.9, 31.0, 53.7, 83.5, 86.6, 97.4, 106.8, 112.9, 121.8, 
134.2, 187.5. IR (neat) ν 2963, 2935, 2875, 1478, 1344, 1285, 1093, 764 cm-1. Anal. Calcd for 
C23H32Cl2N2Ru: C, 54.33; H, 6.34; 5.51. Found: C, 53.42; H, 6.01; N, 5.41. 
 
Yield: 36 % of an orange solid.155 Rf = 0.64, 9:1 CH2Cl2:iPrOH (v/v). 1H-NMR 
(300 MHz, CDCl3): δ 1.18 (d, J = 6.9, 6H), 2.06 (s, 3H), 2.70 (m, 1H), 3.80 (s, 3H), 
4.00 (s, 3H), 5.08 (d, J = 5.9, 2H), 5.23 (d, J = 5.9, 2H), 6.46 (d, J = 2.8, 1H), 7.34 
(d, J = 2.8, 1H). 13C-NMR (50 MHz, CDCl3): δ 18.4, 22.3, 30.5, 37.3, 37.5, 83.9, 
84.2, 99.1, 104.3, 116.6, 132.8, 179.7. IR (neat) ν 2957, 2923, 2870, 1523, 1480, 1430, 1383, 
1358, 1274, 923, 785, 723 cm-1. Anal. Calcd for C15H22Cl2N2Ru: C, 44.78; H, 5.51; N, 6.96. 
Found: C, 43.78; H, 5.23; N, 6.44. 
 
Cyclohexylformamide (5.0 g, 39.3 mmol) was dissolved in 40 mL of anhydrous 
benzene and P4S10 (4.4 g, 9.9 mmol) was added. The slurry was refluxed under Ar 
for 1 h, where acetone (30 mL) was added and the slurry was cooled to 0 ºC. The cooling bath 
was removed after addition of 25 mL of 5.3 M aq. K2CO3 and the suspension was stirred for 1½ 
h. It was diluted further with water and extracted several times with EtOAc. The combined 
organic phases were washed with dilute aq. K2CO3, brine and finally dried with MgSO4. The 
solvent was removed in vacuo and the residue was distilled under high vacuum (~1 mmHg) at 
115-125 ºC to yield 3.4 g of an orange liquid (60 %).  1H-NMR (300 MHz, CDCl3): δ Two 
H
N S
N N
Ru I
I
CyCy
N N
Ru Cl
Cl
Ru Cl
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N
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rotamers in ratio 1:2.25; 1.12-2.13 (m, 20H) Major rotamer: 4.49 (m, 1H), 9.33 (s, 1H). Minor 
rotamer: 3.47 (m, 1H), 9.19 (s, 1H). GC-MS [M]+: 143.1. 
 
The cyclohexylthioformamide (1.334 g, 9.38 mmol) was dissolved in 8.0 mL of 
toluene and 5.5 mL of THF. Bromoacetaldehyde diethyl acetal (3.0 mL, 19.9 
mmol) and 15 drops of 96 % H2SO4 were added and the solution was stirred at rt for 87 h. The 
salt was filtered off and the mother liquor was concentrated in vacuo, redissolved in CH2Cl2 and 
precipitated by addition of Et2O and EtOAc. The solids were combined and purified by flash 
chromatography in 25 % EtOH in CH2Cl2 to yield a white solid. Yield 1.23 g (53 %). 1H-NMR 
(300 MHz, CDCl3): δ 1.27-2.35 (m, 10H), 5.05 (m, 1H), 8.43 (dd, J = 2.4, 3.7, 1H), 8.65 (dd, J 
= 1.4, 3.8, 1H), 11.24 (dd, J = 1.5, 2.3, 1H). 13C-NMR (75 MHz, CDCl3): δ 24.3, 25.0, 33.6, 
66.2, 127.3, 135.1, 158.9. HRMS calcd. for C9H14NS [M-Br]+: 168.0842, found 168.0844. 
 
Prepared according to Mistryukov.172 1H-NMR (300 MHz, CDCl3): δ 1.15-2.32 
(m, 20H), 4.52 (tt, J = 3.9, 11.9, 2H), 7.37 (s, 1H), 7.38 (s, 1H), 10.88 (s, 1H). 
13C-NMR (75 MHz, CDCl3): δ 24.5, 24.8, 33.5, 59.7, 119.3, 136.1. 
 
Prepared according to Arduengo.173 1H-NMR (300 MHz, CD3OD): δ 10.00 
(s, 1H), 8.24 (s, 2H), 7.71 (d, J = 8.5, 4H), 7.50 (d, J = 8.5, 4H), 2.47 (s, 6H).  
 
Prepared according to Delaude et al.174 1H-NMR (500 MHz, DMSO-d6): δ 
9.95 (s, 1H), 8.36 (s, 2H), 7.48-7.71 (m, 8H), 2.34 (m, 6H). 13C-NMR (75 
MHz, DMSO-d6): δ 17.1, 124.0, 126.7, 127.3, 130.7, 131.6, 133.4, 134.0, 137.7. 
 
Prepared according to Arduengo.173 Paraformaldehyde (0.172 g, 5.73 
mmol) was suspended in 2.0 mL of toluene, and isopropyl-d7-amine (0.48 
mL, 5.62 mmol, >98 atom % D from Isotec) was added. The mixture was gently heated with a 
heatgun to give a clear solution with a gummy, white precipitate. Cooled to 0 ºC and another 
portion of isopropyl-d7-amine (0.48 mL, 5.62 mmol, >98 atom % D from Isotec) was added 
along with 6 M aq. HCl (0.95 mL, 5.70 mmol) keeping T < 10 ºC. The cooling bath was 
removed and the solution warmed to rt over 30 min. Then aq. glyoxal (40 %, 0.65 mL, 5.69 
mmol) was added and the suspension was stirred vigorously for 1 h. Water was removed 
azeotropically with toluene and a dean-stark trap. Toluene was removed in vacuo and the 
NN Cy, ClCy
S N Cy, Br
NN
pTol, ClpTol
NN
oTol, CloTol
NN
D3C D, Cl
CD3
CD3D
D3C
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residue crystallized under high vacuum overnight. Yield 1.11 g (97 %). 1H-NMR (300 MHz, 
CD3OD): δ 7.76 (s, 2H), 9.14 (s, 1H). 
 
Silver oxide (164.0 mg, 0.71 mmol) and the imidazolium salt IiPrHCl-d14 
(304.0 mg, 1.5 mmol) were suspended in 8.0 mL of CH2Cl2 under Ar and 
refluxed for 2 h. Then [Ru(p-cymene)Cl2]2 (306 mg, 0.5 mmol) was added 
in one portion and the suspension was refluxed for another 1 h. The 
reaction was concentrated in vacuo and purified by flash chromatography in 10 % iPrOH in 
CH2Cl2. Yield: 0.429 g (90 %) as a red-orange solid.171 Rf = 0.64, 9:1 CH2Cl2:iPrOH (v/v). 1H-
NMR (300 MHz, CDCl3): δ 1.32 (d, J = 6.9, 6H), 2.09 (s, 3H), 2.93 (m, 1H), 5.16 (d, J = 5.8, 
2H), 5.48 (d, J = 5.8, 2H), 7.07 (s, 2H). 13C-NMR (50 MHz, CDCl3): δ 18.6, 22.8, 24.0 (m), 
30.8, 51.8 (t), 83.3, 85.2, 97.2, 106.5, 119.0, 171.1. IR (neat) ν 3032, 2964, 2930, 2874, 1467, 
1416, 1348, 1294, 1261, 1202, 1050, 859, 719, 684 cm-1. 
 
Procedure 1: The complex 5.3 (19.4 mg, 25 µmol, 5 mol%), N-benzyl-N-
methylamine (65 μL, 0.5 mmol) and 2-phenylethanol (60 μL, 0.5 mmol) 
were mixed in a Schlenk flask and three cycles of high vacuum/Ar-backfill 
were performed. A cold finger was mounted and 1.0 mL of anhydrous and degassed toluene was 
added followed by 0.17 mL of 0.44 M KHMDS (in toluene, 75 µmol, 15 mol%). The solution 
was heated to reflux for 20-24 h under a positive flow of Ar and concentrated in vacuo. It was 
then redissolved in CH2Cl2 and purified by prep. TLC in 40 % EtOAc in heptane. Yield of the 
tertiary amide: 77.7 mg (65 %). Procedure 2: [Ru(COD)Cl2]n (7.0 mg, 25 μmol, 5 mol%), PCy3 
(7.0 mg, 25 μmol, 5 mol%), tBuOK (8.5 mg, 75 μmol, 15 mol%),  IiPrHCl (4.7 mg, 25 μmol, 5 
mol%), N-benzyl-N-methylamine (65 μL, 0.5 mmol) and 2-phenylethanol (60 μL, 0.5 mmol) 
were mixed in a Schlenk flask and three cycles of high vacuum/Ar-backfill were performed. A 
cold finger was mounted and 1.0 mL of anhydrous and degassed toluene was added. The 
solution was heated to reflux for 20-24 h under a positive flow of Ar and concentrated in vacuo. 
It was then redissolved in CH2Cl2 and purified by prep. TLC in 40 % EtOAc in heptane. Yield 
of the tertiary amide: 83.8 mg (70 %). Two rotamers were present in ratio of 1:1.5 by 1H-NMR 
(300 MHz, CDCl3): δ major rotamer 7.20-7.39 (m, 9H), 7.07-7.11 (m, 1H), 4.61 (s, 2H), 3.79 (s, 
2H), 2.95 (s, 3H), minor rotamer 7.20-7.39 (m, 9H), 7.07-7.11 (m, 1H), 4.52 (s, 2H), 3.76 (s, 
2H), 2.90 (s, 3H).  
 
N N
Ru Cl
Cl
D
CD3
CD3
D
D3C
D3C
N
O
Ruthenium-catalyzed Amidation 
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Procedure for amidation with deutorated analogue of catalyst 5.2:  
Catalyst 5.2-d14 (94.5 mg, 0.2 mmol, 10 mol%), PCy3 (56.1 mg, 0.2 mmol, 10 mol%), 
benzylamine (218 μL, 2.0 mmol), 2-phenylethanol (240 μL, 2.0 mmol) and dodecane (180 μL, 
0.8 mmol) were mixed in a Schlenk flask and three cycles of high vacuum/Ar-backfill were 
performed. A cold finger was mounted and 4.0 mL of anhydrous and degassed toluene was 
added followed by 1.27 mL of 0.47 M KHMDS (in toluene, 0.6 mmol, 15 mol%). The reaction 
was monitored by measuring the evolution of dihydrogen. The Schlenk flask was connected to 
the top of a burette filled with water. The bottom of the burette was further connected to a water 
reservoir. The solution was heated to reflux for 20-24 h at which point the GC-yield was 84 %. 
After 1 h and 4 h a sample of gas (1.0 mL) was taken out with a gas-tight syringe and the ratio 
between H2:H-D was measured to 51:1 and 44:1 by selected ion monitoring, respectively. 
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7 Appendix 
7.1 X-ray Crystal Structure  
 
 
A colorless block 0.45 x 0.14 x 0.07 mm in size was mounted on a Cryoloop with Paratone oil.  
Data were collected in a nitrogen gas stream at 100(2) K using phi and omega scans.  Crystal-to-
detector distance was 60 mm and exposure time was 60 seconds per frame using a scan width of 
1.0°.  Data collection was 98.7% complete to 25.00° in θ.  A total of 12636 reflections were 
collected covering the indices, -13<=h<=13, -14<=k<=14, -15<=l<=15.  5563 reflections were 
found to be symmetry independent, with an Rint of 0.0591.  Indexing and unit cell refinement 
indicated a primitive, triclinic lattice.  The space group was found to be P-1 (No. 2).  The data were 
integrated using the Bruker SAINT software program and scaled using the SADABS software 
program.  Solution by direct methods (SIR-2004) produced a complete heavy-atom phasing model 
consistent with the proposed structure.  All non-hydrogen atoms were refined anisotropically by 
full-matrix least-squares (SHELXL-97).  All hydrogen atoms were placed using a riding model.  
Their positions were constrained relative to their parent atom using the appropriate HFIX command 
in SHELXL-97.
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Table 7.1: Crystal data and structure refinement for baran45. 
X-ray ID  baran45 
Sample/notebook ID  188A-D 
Empirical formula  C36 H37 Br0.29 Cl0.71 O6 
Formula weight  614.04 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.8243(24) Å α= 105.447(3)°. 
 b = 12.2121(26) Å β= 113.778(3)°. 
 c = 13.1784(28) Å γ = 90.441(3)°. 
Volume 1523.4(6) Å3 
Z 2 
Density (calculated) 1.339 Mg/m3 
Absorption coefficient 0.528 mm-1 
F(000) 646.5 
Crystal size 0.45 x 0.14 x 0.07 mm3 
Crystal color/habit colorless block 
Theta range for data collection 1.74 to 25.49°. 
Index ranges -13<=h<=13, -14<=k<=14, -15<=l<=15 
Reflections collected 12636 
Independent reflections 5563 [R(int) = 0.0591] 
Completeness to theta = 25.00° 98.7 %  
Absorption correction Analytical 
Max. and min. transmission 0.9472 and 0.7193 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5563 / 0 / 395 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0619, wR2 = 0.0910 
R indices (all data) R1 = 0.1183, wR2 = 0.1057 
Largest diff. peak and hole 0.295 and -0.259 e.Å-3 
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Table 7.2:  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for baran45.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 2190(3) -3350(3) -1951(3) 24(1) 
C(2) 1170(3) -2734(3) -2454(3) 23(1) 
C(3) 636(3) -1996(3) -1782(3) 20(1) 
C(4) 1153(3) -1886(3) -603(3) 22(1) 
C(5) 2183(3) -2504(3) -106(3) 22(1) 
C(6) 2715(3) -3256(3) -772(3) 23(1) 
C(7) -474(3) -1291(2) -2276(3) 21(1) 
C(8) 51(3) -14(3) -1908(3) 21(1) 
C(9) 1081(3) 299(3) -2326(3) 18(1) 
C(10) 1035(3) -352(3) -3401(3) 21(1) 
C(11) 1965(3) -73(3) -3800(3) 20(1) 
C(12) 2959(3) 863(3) -3140(3) 23(1) 
C(13) 3012(3) 1512(3) -2086(3) 23(1) 
C(14) 2075(3) 1253(3) -1666(3) 18(1) 
C(15) 2101(3) 2049(3) -567(3) 18(1) 
C(16) 1055(3) 2722(2) -638(3) 20(1) 
C(17) 1019(3) 3516(3) 317(3) 21(1) 
C(18) 2062(3) 3634(3) 1401(3) 20(1) 
C(19) 3112(3) 2952(3) 1499(3) 20(1) 
C(20) 3162(3) 2171(2) 542(3) 18(1) 
C(21) 4370(3) 1503(3) 662(3) 21(1) 
C(22) 5206(3) 1353(3) 1867(3) 21(1) 
C(23) 4466(3) 588(3) 2240(3) 19(1) 
C(24) 4448(3) 859(3) 3333(3) 23(1) 
C(25) 3857(3) 74(3) 3658(3) 25(1) 
C(26) 3288(3) -1005(3) 2910(3) 26(1) 
C(27) 3268(3) -1283(3) 1809(3) 23(1) 
C(28) 3842(3) -501(3) 1480(3) 20(1) 
C(29) 2258(4) -5134(3) -3176(3) 27(1) 
C(30) 3038(4) -5751(3) -3844(3) 28(1) 
C(31) 2242(4) -6929(3) -4579(3) 40(1) 
C(32) 3195(5) -5063(3) -4604(4) 64(1) 
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C(33) 4453(4) -5872(3) -2963(3) 39(1) 
C(34) 1048(3) -1704(3) -5494(3) 31(1) 
C(35) 1188(4) 5178(3) 2327(3) 38(1) 
C(36) 3280(4) -4839(3) -69(3) 35(1) 
O(1) 2803(2) -4017(2) -2622(2) 29(1) 
O(2) 1304(3) -5543(2) -3095(3) 55(1) 
O(3) 1969(2) -663(2) -4844(2) 26(1) 
O(4) 2165(2) 4388(2) 2415(2) 30(1) 
O(5) 2695(2) -2384(2) 1080(2) 28(1) 
O(6) 3756(2) -3865(2) -301(2) 30(1) 
Cl(1) 5233(1) 2243(1) 4405(1) 31(1) 
Br(1) 5233(1) 2243(1) 4405(1) 31(1) 
________________________________________________________________________________ 
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Table 7.3:   Bond lengths [Å] and angles [°] for baran45. 
_____________________________________________________ 
C(1)-C(2)  1.383(4) 
C(1)-C(6)  1.395(4) 
C(1)-O(1)  1.409(4) 
C(2)-C(3)  1.387(4) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.389(4) 
C(3)-C(7)  1.514(4) 
C(4)-C(5)  1.389(4) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.391(4) 
C(5)-O(5)  1.396(4) 
C(6)-O(6)  1.379(3) 
C(7)-C(8)  1.534(4) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.514(4) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(14)  1.400(4) 
C(9)-C(10)  1.408(4) 
C(10)-C(11)  1.388(4) 
C(10)-H(10)  0.9500 
C(11)-O(3)  1.374(3) 
C(11)-C(12)  1.384(4) 
C(12)-C(13)  1.382(4) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.405(4) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.503(4) 
C(15)-C(16)  1.392(4) 
C(15)-C(20)  1.416(4) 
C(16)-C(17)  1.384(4) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.387(4) 
C(17)-H(17)  0.9500 
C(18)-O(4)  1.368(3) 
C(18)-C(19)  1.399(4) 
C(19)-C(20)  1.385(4) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.522(4) 
C(21)-C(22)  1.541(4) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(23)  1.518(4) 
C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
C(23)-C(24)  1.399(4) 
C(23)-C(28)  1.399(4) 
C(24)-C(25)  1.393(4) 
C(24)-Cl(1)  1.819(3) 
C(25)-C(26)  1.375(4) 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.392(4) 
C(26)-H(26)  0.9500 
C(27)-C(28)  1.383(4) 
C(27)-O(5)  1.391(4) 
C(28)-H(28)  0.9500 
C(29)-O(2)  1.198(4) 
C(29)-O(1)  1.361(4) 
C(29)-C(30)  1.521(5) 
C(30)-C(31)  1.522(5) 
C(30)-C(32)  1.524(5) 
C(30)-C(33)  1.541(4) 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
C(31)-H(31C)  0.9800 
C(32)-H(32A)  0.9800 
C(32)-H(32B)  0.9800 
C(32)-H(32C)  0.9800 
C(33)-H(33A)  0.9800 
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C(33)-H(33B)  0.9800 
C(33)-H(33C)  0.9800 
C(34)-O(3)  1.434(4) 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-O(4)  1.428(3) 
C(35)-H(35A)  0.9800 
C(35)-H(35B)  0.9800 
C(35)-H(35C)  0.9800 
C(36)-O(6)  1.445(4) 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
C(2)-C(1)-C(6) 122.0(3) 
C(2)-C(1)-O(1) 119.3(3) 
C(6)-C(1)-O(1) 118.4(3) 
C(1)-C(2)-C(3) 120.1(3) 
C(1)-C(2)-H(2) 120.0 
C(3)-C(2)-H(2) 120.0 
C(2)-C(3)-C(4) 118.8(3) 
C(2)-C(3)-C(7) 122.7(3) 
C(4)-C(3)-C(7) 118.5(3) 
C(5)-C(4)-C(3) 120.7(3) 
C(5)-C(4)-H(4) 119.6 
C(3)-C(4)-H(4) 119.6 
C(4)-C(5)-C(6) 121.1(3) 
C(4)-C(5)-O(5) 120.2(3) 
C(6)-C(5)-O(5) 118.7(3) 
O(6)-C(6)-C(5) 122.5(3) 
O(6)-C(6)-C(1) 120.1(3) 
C(5)-C(6)-C(1) 117.3(3) 
C(3)-C(7)-C(8) 112.7(3) 
C(3)-C(7)-H(7A) 109.0 
C(8)-C(7)-H(7A) 109.0 
C(3)-C(7)-H(7B) 109.0 
C(8)-C(7)-H(7B) 109.0 
H(7A)-C(7)-H(7B) 107.8 
C(9)-C(8)-C(7) 116.5(3) 
C(9)-C(8)-H(8A) 108.2 
C(7)-C(8)-H(8A) 108.2 
C(9)-C(8)-H(8B) 108.2 
C(7)-C(8)-H(8B) 108.2 
H(8A)-C(8)-H(8B) 107.3 
C(14)-C(9)-C(10) 118.8(3) 
C(14)-C(9)-C(8) 120.7(3) 
C(10)-C(9)-C(8) 120.4(3) 
C(11)-C(10)-C(9) 121.2(3) 
C(11)-C(10)-H(10) 119.4 
C(9)-C(10)-H(10) 119.4 
O(3)-C(11)-C(12) 115.9(3) 
O(3)-C(11)-C(10) 124.2(3) 
C(12)-C(11)-C(10) 120.0(3) 
C(13)-C(12)-C(11) 119.4(3) 
C(13)-C(12)-H(12) 120.3 
C(11)-C(12)-H(12) 120.3 
C(12)-C(13)-C(14) 121.7(3) 
C(12)-C(13)-H(13) 119.1 
C(14)-C(13)-H(13) 119.1 
C(9)-C(14)-C(13) 118.9(3) 
C(9)-C(14)-C(15) 121.6(3) 
C(13)-C(14)-C(15) 119.4(3) 
C(16)-C(15)-C(20) 118.0(3) 
C(16)-C(15)-C(14) 118.8(3) 
C(20)-C(15)-C(14) 123.1(3) 
C(17)-C(16)-C(15) 123.2(3) 
C(17)-C(16)-H(16) 118.4 
C(15)-C(16)-H(16) 118.4 
C(16)-C(17)-C(18) 118.5(3) 
C(16)-C(17)-H(17) 120.7 
C(18)-C(17)-H(17) 120.7 
O(4)-C(18)-C(17) 124.9(3) 
O(4)-C(18)-C(19) 115.7(3) 
C(17)-C(18)-C(19) 119.4(3) 
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C(20)-C(19)-C(18) 122.1(3) 
C(20)-C(19)-H(19) 119.0 
C(18)-C(19)-H(19) 119.0 
C(19)-C(20)-C(15) 118.7(3) 
C(19)-C(20)-C(21) 121.0(3) 
C(15)-C(20)-C(21) 120.2(3) 
C(20)-C(21)-C(22) 116.6(3) 
C(20)-C(21)-H(21A) 108.2 
C(22)-C(21)-H(21A) 108.2 
C(20)-C(21)-H(21B) 108.2 
C(22)-C(21)-H(21B) 108.2 
H(21A)-C(21)-H(21B) 107.3 
C(23)-C(22)-C(21) 114.9(3) 
C(23)-C(22)-H(22A) 108.5 
C(21)-C(22)-H(22A) 108.5 
C(23)-C(22)-H(22B) 108.5 
C(21)-C(22)-H(22B) 108.5 
H(22A)-C(22)-H(22B) 107.5 
C(24)-C(23)-C(28) 116.9(3) 
C(24)-C(23)-C(22) 124.4(3) 
C(28)-C(23)-C(22) 118.5(3) 
C(25)-C(24)-C(23) 121.5(3) 
C(25)-C(24)-Cl(1) 117.2(3) 
C(23)-C(24)-Cl(1) 121.3(3) 
C(26)-C(25)-C(24) 120.6(3) 
C(26)-C(25)-H(25) 119.7 
C(24)-C(25)-H(25) 119.7 
C(25)-C(26)-C(27) 118.7(3) 
C(25)-C(26)-H(26) 120.6 
C(27)-C(26)-H(26) 120.6 
C(28)-C(27)-O(5) 122.1(3) 
C(28)-C(27)-C(26) 120.7(3) 
O(5)-C(27)-C(26) 117.2(3) 
C(27)-C(28)-C(23) 121.5(3) 
C(27)-C(28)-H(28) 119.3 
C(23)-C(28)-H(28) 119.3 
O(2)-C(29)-O(1) 121.9(3) 
O(2)-C(29)-C(30) 126.8(3) 
O(1)-C(29)-C(30) 111.2(3) 
C(29)-C(30)-C(31) 107.7(3) 
C(29)-C(30)-C(32) 109.8(3) 
C(31)-C(30)-C(32) 110.9(3) 
C(29)-C(30)-C(33) 108.3(3) 
C(31)-C(30)-C(33) 110.2(3) 
C(32)-C(30)-C(33) 109.9(3) 
C(30)-C(31)-H(31A) 109.5 
C(30)-C(31)-H(31B) 109.5 
H(31A)-C(31)-H(31B) 109.5 
C(30)-C(31)-H(31C) 109.5 
H(31A)-C(31)-H(31C) 109.5 
H(31B)-C(31)-H(31C) 109.5 
C(30)-C(32)-H(32A) 109.5 
C(30)-C(32)-H(32B) 109.5 
H(32A)-C(32)-H(32B) 109.5 
C(30)-C(32)-H(32C) 109.5 
H(32A)-C(32)-H(32C) 109.5 
H(32B)-C(32)-H(32C) 109.5 
C(30)-C(33)-H(33A) 109.5 
C(30)-C(33)-H(33B) 109.5 
H(33A)-C(33)-H(33B) 109.5 
C(30)-C(33)-H(33C) 109.5 
H(33A)-C(33)-H(33C) 109.5 
H(33B)-C(33)-H(33C) 109.5 
O(3)-C(34)-H(34A) 109.5 
O(3)-C(34)-H(34B) 109.5 
H(34A)-C(34)-H(34B) 109.5 
O(3)-C(34)-H(34C) 109.5 
H(34A)-C(34)-H(34C) 109.5 
H(34B)-C(34)-H(34C) 109.5 
O(4)-C(35)-H(35A) 109.5 
O(4)-C(35)-H(35B) 109.5 
H(35A)-C(35)-H(35B) 109.5 
O(4)-C(35)-H(35C) 109.5 
H(35A)-C(35)-H(35C) 109.5 
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H(35B)-C(35)-H(35C) 109.5 
O(6)-C(36)-H(36A) 109.5 
O(6)-C(36)-H(36B) 109.5 
H(36A)-C(36)-H(36B) 109.5 
O(6)-C(36)-H(36C) 109.5 
H(36A)-C(36)-H(36C) 109.5 
H(36B)-C(36)-H(36C) 109.5 
C(29)-O(1)-C(1) 117.1(3) 
C(11)-O(3)-C(34) 117.3(3) 
C(18)-O(4)-C(35) 116.9(2) 
C(27)-O(5)-C(5) 115.4(2) 
C(6)-O(6)-C(36) 112.1(2) 
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Table 7.4:   Anisotropic displacement parameters (Å2x 103) for baran45.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 24(2)  14(2) 34(2)  2(2) 15(2)  -1(2) 
C(2) 19(2)  21(2) 24(2)  4(2) 6(2)  -2(2) 
C(3) 16(2)  17(2) 26(2)  4(2) 8(2)  -2(1) 
C(4) 24(2)  15(2) 28(2)  2(2) 16(2)  1(2) 
C(5) 25(2)  20(2) 22(2)  7(2) 11(2)  -4(2) 
C(6) 16(2)  20(2) 32(2)  13(2) 8(2)  2(2) 
C(7) 18(2)  22(2) 21(2)  4(2) 8(2)  1(2) 
C(8) 17(2)  24(2) 23(2)  6(2) 11(2)  6(2) 
C(9) 16(2)  21(2) 19(2)  8(2) 8(2)  9(2) 
C(10) 16(2)  20(2) 24(2)  8(2) 6(2)  5(1) 
C(11) 21(2)  24(2) 17(2)  9(2) 9(2)  12(2) 
C(12) 21(2)  28(2) 28(2)  14(2) 14(2)  7(2) 
C(13) 21(2)  23(2) 25(2)  10(2) 9(2)  5(2) 
C(14) 21(2)  20(2) 16(2)  10(2) 8(2)  9(2) 
C(15) 19(2)  14(2) 22(2)  4(2) 10(2)  1(1) 
C(16) 19(2)  18(2) 20(2)  6(2) 6(2)  0(1) 
C(17) 20(2)  17(2) 30(2)  10(2) 13(2)  6(1) 
C(18) 26(2)  17(2) 23(2)  4(2) 16(2)  3(2) 
C(19) 20(2)  21(2) 19(2)  7(2) 7(2)  1(2) 
C(20) 19(2)  15(2) 21(2)  7(2) 10(2)  2(1) 
C(21) 22(2)  20(2) 24(2)  7(2) 11(2)  5(2) 
C(22) 16(2)  20(2) 21(2)  3(2) 5(2)  4(1) 
C(23) 14(2)  23(2) 21(2)  9(2) 6(2)  10(2) 
C(24) 19(2)  26(2) 21(2)  6(2) 7(2)  10(2) 
C(25) 23(2)  39(2) 19(2)  12(2) 11(2)  12(2) 
C(26) 18(2)  41(2) 29(2)  22(2) 12(2)  7(2) 
C(27) 18(2)  27(2) 25(2)  11(2) 7(2)  5(2) 
C(28) 21(2)  26(2) 16(2)  6(2) 9(2)  6(2) 
C(29) 26(2)  24(2) 28(2)  6(2) 9(2)  2(2) 
C(30) 36(2)  24(2) 23(2)  5(2) 13(2)  6(2) 
C(31) 30(2)  35(2) 35(2)  -3(2) 4(2)  9(2) 
C(32) 117(4)  49(3) 52(3)  21(2) 59(3)  26(3) 
C(33) 29(2)  35(2) 40(2)  -6(2) 12(2)  0(2) 
Appendix 
 120 
 
C(34) 40(2)  27(2) 26(2)  3(2) 18(2)  8(2) 
C(35) 50(3)  32(2) 33(2)  7(2) 20(2)  27(2) 
C(36) 36(2)  28(2) 45(2)  24(2) 14(2)  3(2) 
O(1) 30(1)  19(1) 41(2)  2(1) 20(1)  5(1) 
O(2) 55(2)  33(2) 79(2)  -10(2) 46(2)  -12(1) 
O(3) 28(1)  29(1) 22(1)  5(1) 14(1)  5(1) 
O(4) 39(2)  27(1) 24(1)  5(1) 16(1)  16(1) 
O(5) 32(1)  27(1) 26(1)  13(1) 10(1)  0(1) 
O(6) 26(1)  23(1) 47(2)  21(1) 15(1)  6(1) 
Cl(1) 38(1)  29(1) 21(1)  3(1) 11(1)  13(1) 
Br(1) 38(1)  29(1) 21(1)  3(1) 11(1)  13(1) 
______________________________________________________________________________ 
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Table 7.5:  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for baran45. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(2) 834 -2816 -3260 28 
H(4) 797 -1384 -133 26 
H(7A) -1198 -1382 -2016 25 
H(7B) -883 -1588 -3134 25 
H(8A) -741 401 -2192 25 
H(8B) 466 269 -1050 25 
H(10) 354 -994 -3861 25 
H(12) 3599 1057 -3409 28 
H(13) 3700 2149 -1633 27 
H(16) 331 2632 -1378 24 
H(17) 295 3970 232 25 
H(19) 3814 3026 2246 24 
H(21A) 4990 1893 446 26 
H(21B) 4029 733 92 26 
H(22A) 6043 1030 1869 25 
H(22B) 5489 2118 2450 25 
H(25) 3847 285 4402 31 
H(26) 2915 -1550 3142 32 
H(28) 3813 -708 722 24 
H(31A) 2116 -7341 -4077 59 
H(31B) 2746 -7361 -4990 59 
H(31C) 1350 -6842 -5144 59 
H(32A) 2294 -4943 -5126 95 
H(32B) 3656 -5483 -5063 95 
H(32C) 3736 -4319 -4112 95 
H(33A) 4952 -5109 -2488 59 
H(33B) 4961 -6288 -3379 59 
H(33C) 4345 -6295 -2462 59 
H(34A) 1240 -2237 -5026 46 
H(34B) 1165 -2053 -6206 46 
H(34C) 109 -1535 -5696 46 
H(35A) 1227 5623 1820 57 
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H(35B) 1392 5698 3100 57 
H(35C) 274 4756 2002 57 
H(36A) 2944 -4572 531 52 
H(36B) 4033 -5284 201 52 
H(36C) 2542 -5323 -780 52 
________________________________________________________________________________ 
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